Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 933
Encontrada(s) 10 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Relationship between the risk of gastric cancer and adherence to the mediterranean diet according to different estimators. MCC—Spain Study

  • Álvarez Álvarez, Laura
  • Vitelli Storelli, Facundo Ezequiel
  • Rubín García, María
  • Aragonés, Nuria
  • Ardanaz, Eva
  • Castaño Vinyals, Gemma
  • Obón Santacana, Mireia
  • Dierssen Sotos, Trinidad
  • Salas Trejo, Dolores
  • Tardón, Adonina
  • Jiménez Moleon, José Juan
  • Alguacil, Juan
  • Chirlaque, María Dolores
  • Perez Gomez, Beatriz
  • Pollán, Marina
  • Kogevinas, Manolis
  • Martín Sánchez, Vicente
[EN]The aim was to assess the effect of adherence to the Mediterranean Diet, measured with five different indexes, on the risk of gastric cancer. Data come from the multicase-control study MCC—Spain, which included 354 gastric cancer cases and 3040 controls with data on diet. We used five indexes to evaluate adherence to the Mediterranean diet and assess the association between each pattern with the risk of gastric cancer, using multivariate logistic regression. The analyses were performed for the whole set of gastric cancer cases, by anatomical location (cardia and noncardia) and by histological type (intestinal and diffuse). According to the used index, a high adherence protects one from gastric cancer (between 48% (aOR = 0.52; CI 95% = 0.28–0.94) and 75% (aOR = 0.25; CI 95% = 0.12–0.52)), fromnon-cardia (between 48%(aOR = 0.52; CI 95% = 0.36–0.75) and 65% (aOR = 0.35; CI 95% = 0.23–0.52)), and from the intestinal type (between 41% (aOR = 0.59; CI 95% = 0.36–0.95) and 72% (aOR = 0.28; CI 95% = 0.16–0.50)), but not from the diffuse type. In conclusion, high adherence to a Mediterranean diet pattern is a protective factor for the risk of gastric cancer, with greater adherence leading to greater protection., SI, The study was partially funded by the “Accion Transversal del Cancer”, approved on the Spanish Ministry Council on 11 October 2007; by the Instituto de Salud Carlos III-FEDER (PI08/1770, PI08/0533, PI08/1359, PS09/00773-Cantabria, PS09/01286-León, PS09/01903-Valencia, PS09/02078- Huelva, PS09/01662-Granada, PI11/01403, PI11/01889-FEDER, PI11/00226, PI11/01810, PI11/02213, PI12/00488, PI12/00265, PI12/01270, PI12/00715, PI12/00150, PI14/01219, PI14/0613, PI15/00069, PI15/00914, PI15/01032, PI17CIII/00034); by the Fundación Marqués de Valdecilla (API 10/09); by the ICGC International Cancer Genome Consortium CLL (the ICGC CLL-Genome Project is funded by Spanish Ministerio de Economía y Competitividad (MINECO) through the Instituto de Salud Carlos III (ISCIII) and Red Temática de Investigación del Cáncer (RTICC) del ISCIII (RD12/0036/0036)); by the Junta de Castilla y León (LE22A10-2); by the Consejería de Salud of the Junta de Andalucía (PI-0571-2009, PI-0306-2011, salud201200057018tra); by the Conselleria de Sanitat of the Generalitat Valenciana (AP_061/10); by the Recercaixa (2010ACUP 00310); by the Regional Government of the Basque Country; by the Consejería de Sanidad de la Región de Murcia; by the European Commission grants FOOD-CT-2006-036224-HIWATE; by the Spanish Association Against Cancer (AECC) Scientific Foundation—grant GCTRA18022MORE; by the Catalan Government—Agency for Management of University and Research Grants (AGAUR) grants 2017SGR723 and 2014SGR850; by the Fundación Caja de Ahorros de Asturias; and by the University of Oviedo. ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya. M Obón-Santacana received a post-doctoral fellowship from the Spanish Association Against Cancer (AECC) Scientific Foundation. M Obón-Santacana is part of group 55 of CIBERESP and AGAUR 2017SGR723. M. R-G. is supported by the Ministry of Education of Spain (FPU17/06488).
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Metabolic syndrome criteria and severity and carbon dioxide (CO2) emissions in an adult population

  • García, Silvia
  • Pastor, Rosario
  • Monserrat Mesquida, Margalida
  • Álvarez Álvarez, Laura
  • Rubín García, María
  • Martínez González, Miguel Ángel
  • Salas Salvadó, Jordi
  • Corella, Dolores
  • Goday, Albert
  • Martínez, J. Alfredo
  • Alonso Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • Romaguera, Dora
  • Lopez Miranda, José
  • Estruch, Ramon
  • Tinahones, Francisco J.
  • Lapetra, José
  • Serra Majem, Lluís
  • Riquelme Gallego, Blanca
  • Pintó, Xavier
  • Gaforio, José J.
  • Matía, Pilar
  • Vidal, Josep
  • Vázquez, Clotilde
  • Daimiel, Lidia
  • Ros, Emilio
  • Sayón Orea, Carmen
  • Guillem Saiz, Patricia
  • Valle Hita, Cristina
  • Cabanes, Robert
  • Abete, Itziar
  • Goicolea Güemez, Leire
  • Gómez Gracia, Enrique
  • Tercero Maciá, Cristina
  • Colom, Antoni
  • García Ríos, Antonio
  • Castro Barquero, Sara
  • Fernández García, José C.
  • Santos Lozano, José Manuel
  • Cenoz, Juan Carlos
  • Barragán, Rocío
  • Khoury, Nadine
  • Castañer, Olga
  • Zulet, María Ángeles
  • Vaquero Luna, Jessica
  • Bes-Rastrollo, Maira
  • Heras Delgado, Sara de las
  • Ciurana, Ramón
  • Martín Sánchez, Vicente
  • Tur, Josep A.
  • Bouzas, Cristina
[EN] Background Metabolic syndrome (MetS) has become a growing risk factor of some non-communicable diseases. Increase of greenhouse gas emissions affects the planet. Aims To assess the association between MetS severity and amount of carbon dioxide ( CO2) emitted in an adult population. Design Cross-sectional study (n = 6646; 55-76-year-old-men; 60-75-year-old-women with MetS). Methods Dietary habits were assessed using a pre-validated semi quantitative 143-item food frequency questionnaire. The amount of CO2 emitted due to the production of food consumed by person and day was calculated using a European database, and the severity of the MetS was calculated with the MetS Severity Score. Results Higher glycaemia levels were found in people with higher CO2 emissions. The risk of having high severe MetS was related to high CO2 emissions. Conclusions Low CO2 emissions diet would help to reduce MetS severity. Advantages for both health and the environment were found following a more sustainable diet. Trial registration ISRCTN, ISRCT N8989 8870. Registered 05 September 2013., SI, We thank all PREDIMED-Plus participants and investigators. CIBEROBN, CIBERESP, and CIBERDEM are initiatives of the Instituto de Salud Carlos III (ISCIII), Madrid, Spain. The Hojiblanca (Lucena, Spain) and Patrimonio Comunal Olivarero (Madrid, Spain) food companies donated extra-virgin olive oil. The Almond Board of California (Modesto, CA), American Pistachio Growers (Fresno, CA), and Paramount Farms (Wonderful Company, LLC, Los Angeles, CA) donated nuts for the PREDIMED-Plus pilot study., Funding This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund (six coordinated FIS projects leaded by JS-S and JVi, including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to JS-S; the European Research Council (Advanced Research Grant 2014–2019; agreement #340918) granted to MÁM-G.; the Recercaixa (number 2013ACUP00194) grant to JS-S; grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); the PROMETEO/2017/017 grant from the Generalitat Valenciana; the SEMERGEN grant. J.S-S is partially supported by ICREA under the ICREA Academia programme. C.B. was granted by Juan de la Cierva grant. None of the funding sources took part in the design, collection, analysis, interpretation of the data, or writing the report, or in the decision to submit the manuscript for publication., info:eu-repo/grantAgreement/MINECO/ Programa Estatal de I+D+I Orientada a los Retos de la Sociedad /PI16/01120/ES/ Efecto de una pérdida de peso con dieta mediterránea hipocalórica y promoción de la actividad física en la prevención primaria cardiovascular: Estudio PREDIMED-PLUS, info:eu-repo/grantAgreement/MINECO/ Programa Estatal de I+D+I Orientada a los Retos de la Sociedad /PI16/01522//ES/ Efecto de una pérdida de peso con dieta mediterránea hipocalórica y promoción de la actividad física en la prevención primaria cardiovascular: Estudio PREDIMED-PLUS
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

The β-amyloid peptide compromises Reelin signaling in Alzheimer’s disease

  • Cuchillo Ibáñez, Inmaculada
  • Mata Balaguer, Trinidad
  • Balmaceda, Valeria
  • Arranz Santos, Juan José
  • Nimpf, Johannes
  • Sáez Valero, Javier
[EN] Reelin is a signaling protein that plays a crucial role in synaptic function, which expression is influenced by β-amyloid (Aβ). We show that Reelin and Aβ oligomers co-immunoprecipitated in human brain extracts and were present in the same size-exclusion chromatography fractions. Aβ treatment of cells led to increase expression of Reelin, but secreted Reelin results trapped together with Aβ aggregates. In frontal cortex extracts an increase in Reelin mRNA, and in soluble and insoluble (guanidine-extractable) Reelin protein, was associated with late Braak stages of Alzheimer's disease (AD), while expression of its receptor, ApoER2, did not change. However, Reelin-dependent induction of Dab1 phosphorylation appeared reduced in AD. In cells, Aβ reduced the capacity of Reelin to induce internalization of biotinylated ApoER2 and ApoER2 processing. Soluble proteolytic fragments of ApoER2 generated after Reelin binding can be detected in cerebrospinal fluid (CSF). Quantification of these soluble fragments in CSF could be a tool to evaluate the efficiency of Reelin signaling in the brain. These CSF-ApoER2 fragments correlated with Reelin levels only in control subjects, not in AD, where these fragments diminished. We conclude that while Reelin expression is enhanced in the Alzheimer's brain, the interaction of Reelin with Aβ hinders its biological activity, SI, We thank Prof. T. Curran (Eppley Institute, University of Nebraska Medical Center, Omaha, USA) for generously providing cDNAs, and Drs M. Calero (CIBERNED, Spain) and José-Manuel Mingot (Inst. Neurociencias, Universidad Miguel Hernández-CSIC, Spain) for technical advice. This work was supported by grants from the Fundación Ramón Areces, Fondo de Investigaciones Sanitarias (PI11/03026; PI12/00593; PI15/00665 cofunded by the Fondo Europeo de Desarrollo Regional), and under the aegis of the EU BIOMARKAPD-Joint Programming on Neurodegenerative Diseases (JPND) project; and through CIBERNED (Instituto de Salud Carlos III, Spain). VB was supported by a JAE-Predoctoral fellowship from the CSIC (Spain), co-funded by the Fondo Social Europeo (FSE), E.C.
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity

  • Fernández Tussy, Pablo
  • Rodríguez Agudo, Rubén
  • Fernández Ramos, David
  • Barbier Torres, Lucía
  • Zubiete Franco, Imanol
  • Davalillo, Sergio López de
  • Herráez, Elisa
  • Goikoetxea Usandizaga, Naroa
  • Lachiondo Ortega, Sofía
  • Simón, Jorge
  • Lopitz Otsoa, Fernando
  • Gutiérrez de Juan, Virginia
  • McCain, Misti V.
  • Perugorría, María J.
  • Mabe, Jon
  • Navasa Mayo, Nicolás
  • Rodrigues, Cecilia M. P.
  • Fabregat, Isabel
  • Boix, Loreto
  • Sapena, Víctor
  • Anguita, Juan
  • Lu, Shelly C.
  • Mato, José M.
  • Banales, Jesus M.
  • Villa, Erica
  • Reeves, Helen L.
  • Bruix, Jordi
  • Reig, María
  • Marín, José J. G.
  • Delgado, Teresa C.
  • Martínez Chantar, María L.
[EN]Dysregulation of miRNAs is a hallmark of cancer, modulating oncogenes, tumor suppressors, and drug responsiveness. The multi-kinase inhibitor sorafenib is one of the first-line drugs for advanced hepatocellular carcinoma (HCC), although the outcome for treated patients is heterogeneous. The identification of predictive biomarkers and targets of sorafenib efficacy are sorely needed. Thus, selected top upregulated miRNAs from the C19MC cluster were analyzed in different hepatoma cell lines compared to immortalized liver human cells, THLE-2 as control. MiR-518d-5p showed the most consistent upregulation among them. Thus, miR-518d-5p was measured in liver tumor/non-tumor samples of two distinct cohorts of HCC patients (n = 16 and n = 20, respectively). Circulating miR-518d-5p was measured in an independent cohort of HCC patients receiving sorafenib treatment (n = 100), where miR-518d-5p was analyzed in relation to treatment duration and patient’s overall survival. In vitro and in vivo studies were performed in human hepatoma BCLC3 and Huh7 cells to analyze the effect of miR-518d-5p inhibition/overexpression during the response to sorafenib. Compared with healthy individuals, miR-518d-5p levels were higher in hepatic and serum samples from HCC patients (n = 16) and in an additional cohort of tumor/non-tumor paired samples (n = 20). MiR-518d-5p, through the inhibition of c-Jun and its mitochondrial target PUMA, desensitized human hepatoma cells and mouse xenograft to sorafenib-induced apoptosis. Finally, serum miR-518d-5p was assessed in 100 patients with HCC of different etiologies and BCLC-stage treated with sorafenib. In BCLC-C patients, higher serum miR-518d-5p at diagnosis was associated with shorter sorafenib treatment duration and survival. Hence, hepatic miR-518d-5p modulates sorafenib resistance in HCC through inhibition of c-Jun/PUMA-induced apoptosis. Circulating miR-518d-5p emerges as a potential lack of response biomarker to sorafenib in BCLC-C HCC patients., SI, This work was supported by grants from NIH (US Department of Health and Human services) R01CA172086 (to S.C.L., J.M.M. and M.L.M.-C.) and P01CA233452 (to S.C.L.), Gobierno Vasco-Departamento de Salud 2013111114 (to M.L.M.-C), MINECO: SAF2017-87301-R, SAF2014-52097-R, RTI2018-096759-A-100, SAF2016-75197-R and SAF2015-64149-R, integrated in the Plan Estatal de Investigación Cientifica y Técnica e Innovación 2017-2020 cofounded by FEDER funds/Development Fund—a way to build Europe (to M.L.M.-C., J.M.M., T.C.D., J.J.G.M., and I.F., respectively), Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain: PI16/00598 and PI19/00819 (to J.J.G.M.), PI15/01132 and PI18/01075 (to J.M.B.), PI14/00399 and PI17/00022 (to M.J.P.), PI18/0358 (to M.R.), BIOEF (Basque Foundation for Innovation and Health Research): EITB Maratoia BIO15/CA/014 and BIO15/CA/016/BD (to M.L.M.-C and J.M.B., respectively); Mitotherapeutix (to M.L.M.-C), Consejería de Educación, Junta de Castilla y León: SA063P17 (J.J.G.M.), Asociación Española Contra el Cáncer (T.C. D, P.F.-T., and M.L.M-C), Basque Government Postdoctoral Program (P.F.-T.), Daniel Alagille award from EASL (to T.C.D.), Asociación Española contra el Cáncer, Canceres raros (M.L.M.-C., J.M.B., and J.J.G.M.), La Caixa Foundation (to M.L.M.-C. and J.M.B.), Ayudas Fundación BBVA a equipos de Investigación Científica 2018 (to M.L.M.-C.), Fondo Europeo de Desarrollo Regional’ (FEDER) (to J.M.B.); CIBERehd, Spain (to J.M.B.); IKERBASQUE, Basque foundation for Science, Spain (to J.M.B.), Department of Health of the Basque Country (2017111010) (to J.M.B.), Euskadi RIS3 (2019222054, 2020333010) (to J.M.B.); Department of Industry of the Basque Country (J.M.B.: Elkartek: KK-2020/00008) (to J.M.B.), Ayudas para apoyar grupos de investigación del sistema Universitario Vasco IT971, Instituto de Salud Carlos III PI18/00768 (J.B.), AECC PI044031 (J.B.), Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement 2014 SGR 605 (J.B.), WCR (AICR) 16-0026 (J.B.), Programma di ricerca Regione-Università 2007–2009 and 2011–2012, Regione Emilia- Romagna (E.V.).
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis

  • Fernández Ramos, David
  • Fernández Tussy, Pablo
  • Lopitz Otsoa, Fernando
  • Gutiérrez de Juan, Virginia
  • Navasa Mayo, Nicolás
  • Barbier Torres, Lucía
  • Zubiete Franco, Imanol
  • Simón, Jorge
  • Fernández, Agustín F.
  • Arbelaiz, Ander
  • Aransay, Ana M.
  • Lavín, José Luis
  • Beraza, Naiara
  • Perugorria, Maria J.
  • Banales, Jesus M.
  • Villa, Erica
  • Fraga, Mario F.
  • Anguita, Juan
  • Ávila, Matías A.
  • Berasain, Carmen
  • Iruzibieta, Paula
  • Crespo, Javier
  • Lu, Shelly C.
  • Varela Rey, Marta
  • Mato, José M.
  • Delgado, Teresa C.
  • Martínez Chantar, María L.
[EN]Glycine N-methyltransferase (GNMT) is the most abundant methyltransferase in the liver and a master regulator of the transmethylation flux. GNMT downregulation leads to loss of liver function progressing to fibrosis, cirrhosis, and hepatocellular carcinoma. Moreover, GNMT deficiency aggravates cholestasis-induced fibrogenesis. To date, little is known about the mechanisms underlying downregulation of GNMT levels in hepatic fibrosis and cirrhosis. On this basis, microRNAs are epigenetic regulatory elements that play important roles in liver pathology. In this work, we aim to study the regulation of GNMT by microRNAs during liver fibrosis and cirrhosis. Luciferase assay on the 3ʹUTR-Gnmt was used to confirm in silico analysis showing that GNMT is potentially targeted by the microRNA miR-873-5p. Correlation between GNMT and miR-873-5p in human cholestasis and cirrhosis together with miR-873-5p inhibition in vivo in different mouse models of liver cholestasis and fibrosis [bile duct ligation and Mdr2 (Abcb4)-/- mouse] were then assessed. The analysis of liver tissue from cirrhotic and cholestatic patients, as well as from the animal models, showed that miR-873-5p inversely correlated with the expression of GNMT. Importantly, high circulating miR-873-5p was also detected in cholestastic and cirrhotic patients. Preclinical studies with anti-miR-873-5p treatment in bile duct ligation and Mdr2-/- mice recovered GNMT levels in association with ameliorated inflammation and fibrosis mainly by counteracting hepatocyte apoptosis and cholangiocyte proliferation. In conclusion, miR-873-5p emerges as a novel marker for liver fibrosis, cholestasis, and cirrhosis and therapeutic approaches based on anti-miR-873-5p may be effective treatments for liver fibrosis and cholestatic liver disease., SI, This work was supported by grants from NIH (US Department of Health and Human services)- R01AT001576 (S.C.L., J.M.M., and M.L.M.-C.), Ministerio de Economía, Industria y Competitividad: SAF2017-87301-R (M.L.M.-C.), Gobierno Vasco-Departamento de Salud 2013111114 (to M.L.M.-C.), BIOEF (Basque Foundation for Innovation and Health Research: EiTB Maratoia BIO15/CA/016/BD (M.L.M.-C.), ELKARTEK 2016, Departamento de Industria del Gobierno Vasco (to M.L.M.-C.), Asociación Española contra el Cáncer (to T.C.D, P.F.-T. and M.L.M.-C.), Mitotherapeutix (to M.L.M.-C.), Daniel Alagille award from EASL (to T.C.D), Fundación Científica de la Asociación Española Contra el Cancer (AECC Scientific Foundation) Rare Tumor Calls 2017 (to M.L.M, J.M.B., and M.A), La Caixa Foundation Program (to M.L.M, J.M.B.), FIS: PI15/00892 (to M.F.F), FIS: PI15/01132 and FIS PI18/01075 (to J.M.B.), (to J.M.B.), FIS: PI14/00399 and PI17/00022 (to M.J.P.), Miguel Servet Program (CON14/00129 to J.M.B.), Ramon y Cajal Program (RYC-2015-17755 to M.J.P.), GRUPIN14-052 (to M.F.), PI14/00962 Instituto Carlos III (to J.B.), AECC Scientific Foundation (to J.B.), World Wide Cancer Research (to J.B.), Programma di Ricerca Regione-Università 2007-2009 and 2011-2012, Regione Emilia-Romagna (to E.V.), “Diputación Foral Gipuzkoa” (DFG15/010, DFG16/004 to J.M.B.), BIOEF (Basque Foundation for Innovation and Health Research: EiTB Maratoia BIO15/CA/016/BD to J.M.B.), Department of Health of the Basque Country (2013111173 to J.M.B.; 2015111100 to M.J.P.). Ciberehd_ISCIII_MINECO is funded by the Instituto de Salud Carlos III. “Hepacare Project” from Fundación La Caixa, Spain (to M.A.A and C.B.), BiO-Eusko Fundazioa project BIO15/CA/011 (to M.A.A and C.B.). We thank this work produced with the support of a 2017 Leonardo Grant for Researchers and Cultural Creators, BBVA Foundation (to M.V.R.). We thank MINECO for the Severo Ochoa Excellence Accreditation (SEV-2016-0644).
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Residential proximity to industrial pollution sources and colorectal cancer risk: A multicase-control study (MCC-Spain)

  • García Pérez, Javier
  • Fernández de Larrea Baz, Nerea
  • Lope, Virginia
  • Molina de la Torre, Antonio José
  • O’Callaghan Gordo, Cristina
  • Alonso, María Henar
  • Rodríguez Suárez, Marta María
  • Mirón Pozo, Benito
  • Alguacil, Juan
  • Gómez Acebo, Inés
  • Ascunce, Nieves
  • Vanaclocha Espí, Mercedes
  • Amiano, Pilar
  • Chirlaque, María Dolores
  • Simó, Vicente
  • Jiménez Moleon, José Juan
  • Tardón, Adonina
  • Moreno, Víctor
  • Castaño Vinyals, Gemma
  • Martín Sánchez, Vicente
  • Aragonés, Nuria
  • Pérez Gómez, Beatriz
  • Kogevinas, Manolis
  • Pollán, Marina
[EN] Background: Colorectal cancer is the third most frequent tumor in males and the second in females worldwide. In Spain, it is an important and growing health problem, and epidemiologic research focused on potential risk factors, such as environmental exposures, is necessary. Objectives: To analyze the association between colorectal cancer risk and residential proximity to industries, according to pollution discharge route, industrial groups, categories of carcinogens and other toxic substances, and specific pollutants released, in the context of a population-based multicase-control study of incident cancer carried out in Spain (MCC-Spain). Methods: MCC-Spain included 557 colorectal cancer cases and 2948 controls in 11 provinces, frequency matched by sex, age, and region of residence. Distances were computed from subjects’ residences to each of the 134 industries located in the study area. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (95%CIs) for categories of distance (from 1 km to 3 km) to industrial facilities, adjusting for matching variables and other confounders. Results: Excess risk (OR; 95%CI) of colorectal cancer was detected near industries overall for all distances analyzed, from 1 km (2.03; 1.44–2.87) to 3 km (1.26; 1.00–1.59). In general, industries releasing pollutants to air showed higher excess risks than facilities releasing pollution to water. By industrial sector, excess risk (OR; 95%CI) was found near (≤3 km) production of metals (2.66; 1.77–4.00), surface treatment of metals (1.48; 1.08–2.02), glass and mineral fibers (2.06; 1.39–3.07), organic chemical industry (4.80; 3.20–7.20), inorganic chemical industry (6.74; 4.38–10.36), food/beverage sector (3.34; 2.38–4.68), and surface treatment using organic solvents (6.16; 4.06–9.36). By pollutants, the main excess risks (OR; 95%CI) were found near (≤3 km) industries releasing nonylphenol (9.19; 5.91–14.28), antimony (5.30; 3.45–8.15), naphthalene (3.11; 2.16–4.49), organotin compounds (2.64; 1.76–3.98), manganese (2.53; 1.63–3.93), dichloromethane (2.52; 1.74–3.66), and vanadium (2.49; 1.59–3.91). Conclusions: Our results support the hypothesis that residing in the proximity of industries may be a risk factor for colorectal cancer, SI, The authors thank all those who took part in this study providing questionnaire data. This study was funded by: Scientific Foundation of the Spanish Association Against Cancer (Fundación Científica de la Asociación Española Contra el Cáncer (AECC) – EVP-1178/14); “Acción Transversal del Cáncer”, approved on the Spanish Ministry Council on the 11th October 2007; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP); Spain's Health Research Fund (Fondo de Investigación Sanitaria - FIS 12/01416); Carlos III Institute of Health (ISCIII) grants, cofunded by ERDF funds–a way to build Europe– (grants PI08/0533, PI08/1359, PI08/1770, PS09/00773- Cantabria, PS09/01286-Leon, PS09/01662-Granada, PS09/01903- Valencia, PS09/02078-Huelva, PI11/00226, PI11/01403, PI11/01810, PI11/01889-FEDER, PI11/02213, PI12/00150, PI12/00265, PI12/ 00488, PI12/00715, PI12/01270, PI14/00613, PI14/01219, PI15/ 00069, PI15/00914, PI15/01032, PI17-00092); the Fundación Marqués de Valdecilla (API 10/09); the Fundación Caja de Ahorros de Asturias; the University of Oviedo; the Junta de Castilla y León (LE22A10-2); the Regional Government of the Basque Country; the Conselleria de Sanitat of the Generalitat Valenciana (AP_061/10); the Consejería de Salud of the Junta de Andalucía (PI-0571-2009, PI-0306-2011, salud201200057018tra); the Catalan Government DURSI grant 2014SGR647; the European Commission grants FOOD-CT-2006- 036224-HIWATE; the Recercaixa (2010ACUP 00310); Agency for Management of University and Research Grants (AGAUR) of the Catalan Government grant 2017SGR723; and the Spanish Association Against Cancer (AECC) Scientific Foundation. ISGlobal is a member of the CERCA Program, Generalitat de Catalunya
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Lifetime Swimming Pool Attendance and Cancer Risk: Findings from the Multicase-Control Study in Spain (MCC-Spain)

  • Donat Vargas, Carolina
  • Vallbona Vistós, Miquel
  • Castaño Vinyals, Gemma
  • Moreno González, Víctor
  • Aragonés, Nuria
  • Boldo, Elena
  • Molina de la Torre, Antonio José
  • Gómez Acebo, Inés
  • Guevara, Marcela
  • Jiménez Zabala, Ana
  • Amiano, Pilar
  • Molina Barceló, Ana
  • Fernández Tardón, Guillermo
  • Chirlaque, María Dolores
  • Pollán, Marina
  • Kogevinas, Manolis
  • Villanueva, Cristina M.
[EN] Swimming in pools involves inhalation and skin absorption of potential carcinogenic disinfection byproducts (DBPs) as well as physical activity, which is protective for some cancer sites. We evaluated the association between lifetime pool attendance and the risk of breast, colorectal, and prostate cancer in a multicase-control study that recruited 4,941 hospital-based cancer cases (1,724 breast, 2,111 colorectal, 1,106 prostate) and 4,039 population-based controls in Spain (2008–2013). Lifetime swimming pool attendance in summer (as a surrogate of outdoor pools) and the rest of the year (as a surrogate of indoor pools), socio-demographics, and lifestyle were ascertained in face-to-face interviews. Cancer risk associated with pool attendance markers was estimated using linear mixed-effect models, adjusting for covariates with recruitment area as a random effect. Participants reporting lifetime pool attendance compared to those who did not showed lower odds of breast and colorectal cancer (approximately 5% lower risk). Swimming more than 10 times/month did not increase the protective association. For breast and colorectal cancer, only pool attendance outside the summer months was associated with a lower risk, whereas it was associated with increased prostate cancer risk. Findings suggest that lifetime swimming in pools may reduce breast cancer and colorectal cancer risk despite DBP exposure. These novel findings require replication, SI, The study was partially funded by the \u201CAccion Transversal del Cancer\u201D, approved by the Spanish Ministry Council on the 11th October 2007, by the Instituto de Salud Carlos III-FEDER (PI08/1770, PI08/0533, PI08/1359, PS09/00773, PS09/01286, PS09/01903, PS09/02078, PS09/01662, PI11/01889, PI11/00226, PI12/01270, PI12/00715, PI14/0613, PI15/00914, PI17CIII/00034), by the Fundacio\u0301n Marque\u0301s de Valdecilla (API 10/09), by the Conselleria de Sanitat of the Generalitat Valenciana (AP_061/10), by the European Commission grants FOOD-CT-2006-036224-HIWATE, by the Spanish Association Against Cancer (AECC) Scientific Foundation, by the Catalan Government-Agency for Management of University and Research Grants (AGAUR) grants 2017SGR723 and 2014SGR850, and by the Fundacio\u0301n Caja de Ahorros de Asturias and by the University of Oviedo. We acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/10.13039/501100011033 and support from the Generalitat de Catalunya through the CERCA Program
BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Genome-wide interaction analysis of long-term trihalomethane exposure in drinking water and colorectal cancer risk in a Spanish Multicenter Case-Control Study (MCC-Spain)

  • Moratalla Navarro, Ferrán
  • Obón Santacana, Mireia
  • Rius Sansalvador, Blanca
  • Guinó, Elisabet
  • Moragas, Núria
  • Donat Vargas, Carolina
  • Larrea Baz, Nerea Fernández de
  • Molina Barceló, Ana
  • Guevara, Marcela
  • Morón Duran, Francisco D.
  • Dierssen Sotos, Trinidad
  • Tardón, Adonina
  • Castaño Vinyals, Gemma
  • Cabrera Castro, Natalia
  • Molina de la Torre, Antonio José
  • Aizpurua, Amaia
  • Morales Suarez Varela, María M.
  • Martín Sánchez, Vicente
  • Fernández Navarro, Pablo
  • Villanueva, Cristina M.
  • Moreno, Victor
[EN] We conducted a genome-wide interaction analysis between long-term exposure to trihalomethanes in drinking water and colorectal cancer (CRC) risk in a multicenter case-control study in Spain, including 1037 CRC cases and 2100 controls. Exposure categories were estimated based on sex-specific median and quartile values of total trihalomethanes (TTHM), chloroform (CHCl3), and brominated trihalomethanes (Br-THMs) among controls. In addition, TTHM exposure was assessed relative to the WHO guideline thresholds. Gene-environment interaction models were computed with the GxEScanR package. To explore biological plausibility, relevant results were inspected in search of expression quantitative trait loci (eQTLs) in two independent resources: BarcUVaSeq and the Genome Tissue Expression (GTEx) v8. Finally, we searched the Comparative Toxicogenomics Database to identify candidate genes previously linked to trihalomethane exposure, retrieved their eQTLs, and evaluated gene-environment interactions with TTHM levels. We found three variants that modulated CRC risk in relation to CHCl3 and TTHM exposure: rs77985109 near LRRC8B, chr15:28997737 near WHAMMP2, and rs7890183 near MAGEB2. Two additional variants were specifically found for women and one for rectal cancer. Functional assessment suggested a regulatory role of rs77985109 in LRRC8B expression. Moreover, eQTL analysis of candidate genes revealed an additional variant associated with CCL2 which could modulate CRC risk under different TTHM exposure levels. The present study identified novel loci potentially influencing CRC susceptibility under THM exposure, highlighting the importance of integrating environmental and genetic data to better understand environmental driven cancer risks. Further research is needed to confirm these results and clarify underlying mechanisms., SI, Funding This work was partially supported by Programa FORTALECE del Ministerio de Ciencia e Innovacion´ ”, through the project number FORT23/00032; Spanish Association Against Cancer (AECC) Scientific Foundation grant GCTRA18022MORE; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) action Genrisk; DISCERN HORIZON-MISS-2021-CANCER-02–03 101096888; Instituto de Salud Carlos III–FEDER [PI08/1770, PI08/0533, PI08/1359, PI09/00773-Cantabria, PI09/01286-Leon, ´ PI09/01903-Valencia, PI09/ 02078-Huelva, PI09/01662-Granada, PI11/01403, PI11/01889-FEDER, PI11/00226, PI11/01810, PI11/02213, PI12/00488, PI12/00265, PI12/01270, PI12/00715, PI12/00150, PI14/01219, PI14/0613, PI15/ 00069, PI15/00914, PI15/01032, PI17CIII/00034]; CIBERESP [CB06/ 02/0073]; Fundacion ´ Marqu´es de Valdecilla [API 10/09]; the Junta de Castilla y Leon ´ [LE22A10-2]; Conselleria de Sanitat of the Generalitat Valenciana [AP_061/10]; Recercaixa [2010ACUP 00310]; Regional Government of the Basque Country; Consejería de Sanidad of the Regi´ on de Murcia; the European Commission [FOOD-CT-2006–036224-HIWATE]; Fundacion ´ Caja de Ahorros de Asturias; and the University of Oviedo;. BR-S received a pre-doctoral grant from Instituto de Salud Carlos III − grant PFIS FI21/00056 (co-founded by the European Union). Sample collection of this work was supported by the Plataforma Biobancos (PT17/0015/0024) and ICOBIOBANC, sponsored by the Catalan Institute of Oncology. We thank CERCA Programme, Generalitat de Catalunya for institutional support.
Docta Complutense
Publication Artículo científico (JournalArticle)

Prodromic Inflammatory–Oxidative Stress in Peritoneal Leukocytes of Triple-Transgenic Mice for Alzheimer’s Disease

  • Ceprián, Noemí
  • Martínez De Toda Cabeza, Irene
  • Maté, Ianire
  • Garrido, Antonio
  • Giménez Llort, Lydia
  • Fuente Del Rey, María Mónica De La
Inflammatory–oxidative stress is known to be pivotal in the pathobiology of Alzheimer’s disease (AD), but the involvement of this stress at the peripheral level in the disease’s onset has been scarcely studied. This study investigated the pro-inflammatory profile and oxidative stress parameters in peritoneal leukocytes from female triple-transgenic mice for AD (3xTgAD) and non-transgenic mice (NTg). Peritoneal leukocytes were obtained at 2, 4, 6, 12, and 15 months of age. The concentrations of TNFα, INFγ, IL-1β, IL-2, IL-6, IL-17, and IL-10 released in cultures without stimuli and mitogen concanavalin A and lipopolysaccharide presence were measured. The concentrations of reduced glutathione (GSH), oxidized glutathione (GSSG), lipid peroxidation, and Hsp70 were also analyzed in the peritoneal cells. Our results showed that although there was a lower release of pro-inflammatory cytokines by 3xTgAD mice, this response was uncontrolled and overstimulated, especially at a prodromal stage at 2 months of age. In addition, there were lower concentrations of GSH in leukocytes from 3xTgAD and higher amounts of lipid peroxides at 2 and 4 months, as well as, at 6 months, a lower concentration of Hsp70. In conclusion, 3xTgAD mice show a worse pro-inflammatory response and higher oxidative stress than NTg mice during the prodromal stages, potentially supporting the idea that Alzheimer’s disease could be a consequence of peripheral alteration in the leukocyte inflammation–oxidation state.
Docta Complutense
Publication Artículo científico (JournalArticle)

CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition

  • Quijada Álamo, Miguel
  • Hernández Sánchez, María
  • Alonso Pérez, Verónica
  • Rodríguez Vicente, Ana E.
  • García Tuñón, Ignacio
  • Martín Izquierdo, Marta
  • Hernández Sánchez, Jesús María
  • Herrero, Ana B.
  • Bastida, José María
  • San Segundo, Laura
  • Gruber, Michaela
  • García, Juan Luis
  • Yin, Shanye
  • Hacken, Elisa ten
  • Benito, Rocío
  • Ordóñez, José Luis
  • Wu, Catherine J.
  • Hernández-Rivas, Jesús María
The deletion of 11q (del(11q)) invariably comprises ATM gene in chronic lymphocytic leukemia (CLL). Concomitant mutations in this gene in the remaining allele have been identified in 1/3 of CLL cases harboring del(11q), being the biallelic loss of ATM associated with adverse prognosis. Although the introduction of targeted BCR inhibition has significantly favored the outcomes of del(11q) patients, responses of patients harboring ATM functional loss through biallelic inactivation are unexplored, and the development of resistances to targeted therapies have been increasingly reported, urging the need to explore novel therapeutic approaches. Here, we generated isogenic CLL cell lines harboring del(11q) and ATM mutations through CRISPR/Cas9-based gene-editing. With these models, we uncovered a novel therapeutic vulnerability of del(11q)/ ATM-mutated cells to dual BCR and PARP inhibition. Ex vivo studies in the presence of stromal stimulation on 38 CLL primary samples confirmed a synergistic action of the combination of olaparib and ibrutinib in del(11q)/ATM-mutated CLL patients. In addition, we showed that ibrutinib produced a homologous recombination repair impairment through RAD51 dysregulation, finding a synergistic link of both drugs in the DNA damage repair pathway. Our data provide a preclinical rationale for the use of this combination in CLL patients with this high-risk cytogenetic abnormality
Docta Complutense
Publication Artículo científico (JournalArticle)

Power transmission and workload balancing policies in eHealth mobile cloud computing scenarios

  • Pagán Ortiz, Josué
  • Zapater, Marina
  • Ayala Rodrigo, José Luis
The Internet of Things (IoT) holds big promises for healthcare, especially in proactive personal eHealth. Prediction of symptomatic crises in chronic diseases in the IoT scenario leads to the deployment of ambulatory monitoring systems. These systems place a major concern in the amount of data to be processed and the intelligent management of the energy consumption. The huge amount of data generated for these systems require high computing capabilities only available in Data Centers. This paper presents a real case of prediction in the eHealth scenario, devoted to neurological disorders. The presented case study focuses on the migraine headache, a disease that affects around 15% of the European population. This paper extrapolates results from real data and simulations in a study where migraine patients are monitored using an unobtrusive Wireless Body Sensor Network. Low-power techniques are applied in monitorization nodes. Techniques such us: on-node signal processing and radio policies to make node’s autonomy longer and save energy, have been applied. Workload balancing policies are carried out in the coordinator nodes and Data Centers to reduce the computational burden in these facilities and minimize its energy consumption. Our results draw average savings of € 288 million in this eHealth scenario applied only to 2% of European migraine sufferers; in addition to savings of € 1272 million due to the benefits of the migraine prediction.
Docta Complutense
Publication Artículo científico (JournalArticle)

Protective Effect of Placental Mesenchymal Stromal Cells in an In Vitro Model of Parkinson's Disease Using Differentiated Neuroblastoma Cells

  • Almudena Coto-Vilcapoma
  • Laura Sánchez-Carretero
  • Daniel Arenas-Gonzalez
  • José A Molina
  • María José Morán-Jiménez
  • Paz de la Torre
  • Ana I Flores
  • Merino Martín, José Joaquín
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder. It is characterized by the accumulation of misfolded α-synuclein (α-syn) and progressive loss of dopaminergic neurons in the substantia nigra. Due to the limitations of current therapies, mesenchymal stromal cell (MSC) transplantation has emerged as a promising neuroprotective strategy. This study evaluated the neuroprotective potential of decidua-derived mesenchymal stromal cells (DMSCs) in vitro using a human neuroblastoma cell line (NB69) exposed to the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) as a PD model. The NB69 cells were differentiated into a mature dopaminergic phenotype using dibutyryl cyclic adenosine monophosphate (dbcAMP) and then exposed to MPP+. In proliferative NB69 cells, the effect of DMSCs was masked by their inherent antitumor activity against the neuroblastoma phenotype. Conversely, in the differentiated NB69 model, DMSCs demonstrated a significant protective role against MPP+-induced cytotoxicity. Interestingly, the mechanism by which DMSCs might exert a neuroprotective effect against MPP+ damage in differentiated NB69 cells appears to involve improving mitochondrial function by reducing free radicals. In summary, these findings suggest that DMSCs exert a neuroprotective effect in a dopaminergic-like context and highlight the importance of using differentiated cell models to accurately evaluate cell-based therapies for PD in the striatum.
Docta Complutense
Publication Artículo científico (JournalArticle)

Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide

  • López-Valero, Israel
  • Saiz-Ladera, Cristina
  • Torres, Sofía
  • Hernández-Tiedra, Sonia
  • García-Taboada, Elena
  • Rodríguez-Fornés, Fátima
  • Barba, Marina
  • Dávila, David
  • Salvador-Tormo, Nélida
  • Guzmán Pastor, Manuel
  • Sepúlveda, Juan Manuel
  • Sánchez-Gómez, Pilar
  • Lorente Pérez, María Del Mar
  • Velasco Díez, Guillermo
Glioblastoma multiforme (GBM) is the most frequent and aggressive type of brain tumor due, at least in part, to its poor response to current anticancer treatments. These features could be explained, at least partially, by the presence within the tumor mass of a small population of cells termed Glioma Initiating Cells (GICs) that has been proposed to be responsible for the relapses occurring in this disease. Thus, the development of novel therapeutic approaches (and specifically those targeting the population of GICs) is urgently needed to improve the survival of the patients suffering this devastating disease. Previous observations by our group and others have shown that Δ9-Tetrahydrocannabinol (THC, the main active ingredient of marijuana) and other cannabinoids including cannabidiol (CBD) exert antitumoral actions in several animal models of cancer, including gliomas. We also found that the administration of THC (or of THC + CBD at a 1:1 ratio) in combination with temozolomide (TMZ), the benchmark agent for the treatment of GBM, synergistically reduces the growth of glioma xenografts. In this work we investigated the effect of the combination of TMZ and THC:CBD mixtures containing different ratios of the two cannabinoids in preclinical glioma models, including those derived from GICs. Our findings show that TMZ + THC:CBD combinations containing a higher proportion of CDB (but not TMZ + CBD alone) produce a similar antitumoral effect as the administration of TMZ together with THC and CBD at a 1:1 ratio in xenografts generated with glioma cell lines. In addition, we also found that the administration of TMZ + THC:CBD at a 1:1 ratio reduced the growth of orthotopic xenografts generated with GICs derived from GBM patients and enhanced the survival of the animals bearing these intracranial xenografts. Remarkably, the antitumoral effect observed in GICs-derived xenografts was stronger when TMZ was administered together with cannabinoid combinations containing a higher proportion of CBD. These findings support the notion that the administration of TMZ together with THC:CBD combinations – and specifically those containing a higher proportion of CBD – may be therapeutically explored to target the population of GICs in GBM.
Docta Complutense
Publication Artículo científico (JournalArticle)

Clinical, cognitive, and neuroimaging evidence of a neurodevelopmental continuum in offspring of probands with schizophrenia and bipolar disorder

  • Sugranyes, Gisela
  • Serna, Elena de la
  • Borras, Roger
  • Sanchez Gistau, Vanessa
  • Pariente, Jose C.
  • Romero, Soledad
  • Baeza, Inmaculada
  • Martínez Díaz-Caneja, María Covadonga
  • Rodríguez Toscano, Elisa
  • Moreno Ruiz, María del Carmen
  • Bernardo, Miguel
  • Moreno Pardillo, Dolores María
  • Vieta, Eduard
  • Castro Fornieles, Josefina
Background: Studies in child and adolescent offspring of patients with schizophrenia or bipolar disorders may help understand the influence of neurodevelopmental factors on the premorbid phenotype of these disorders. Aims: To assess whether a combination of neurodevelopmental factors discriminates between young offspring of patients with schizophrenia (SzO) or bipolar disorder (BpO) and community controls (CcO). To assess the association between these factors and rates of psychiatric diagnoses in high risk (HR) youth. Methods: One hundred thirty-three HR offspring (47 SzO and 86 BpO) and 84 CcO, aged 6–17, underwent cross-sectional clinical, neurocognitive, and structural neuroimaging assessment. Information on perinatal events and early childhood development was also obtained. General linear mixed models were performed to assess group discrimination and association with lifetime axis I psychiatric disorders. Results: Multivariate analyses revealed that greater neurological soft signs (NSS), less total grey matter volume (GMV) and a higher frequency of obstetric complications discriminated HR offspring from CcO. When comparing each group individually, greater NSS and a higher frequency of obstetric complications discriminated SzO from CcO, and BpO from CcO, while lower intelligence also discriminated SzO from CcO and from BpO. Within HR offspring, lower intelligence and less total GMV were associated with lifetime incidence of psychiatric disorders. Conclusions: Both SzO and BpO showed evidence of neurodevelopmental insult, although this may have a greater impact in SzO. Lower intelligence and less total GMV hold potential as biomarkers of risk for psychiatric disorders in HR youth.
Docta Complutense
Publication Artículo científico (JournalArticle)

Endothelial vascular markers in coronary surgery

  • Valencia Nuñez, Diana M.
  • Kreutler, Willy
  • Moya González, Javier
  • Alados Arboledas, Pedro
  • Muñoz Carvajal, Ignacio
  • Carmona, Andrés
  • Ramírez Chamond, Rafael
  • Carracedo Añón, Julia María
Coronary heart disease is associated with high morbidity and mortality. Endothelial dysfunction in affected patients is linked to long-term atherosclerotic disease progression and cardiovascular event rates. The present paper reports on changes in the levels of endothelial progenitor cells (VEGFR2/CD133/CD34), essential for endothelial repair, and of endothelial microvesicles (CD31/annexin V) as indicators of endothelial lesion, in patients undergoing coronary bypass surgery with respect both to baseline levels and to counts in healthy subjects. In an observational descriptive study, 31 patients scheduled for coronary revascularization surgery were compared with those of 25 healthy controls. In a subsequent longitudinal study, patients undergoing surgery were monitored at 5 timepoints up until 48 h after surgery. Endothelial progenitor cell (VEGFR2/CD133/CD34) and endothelial microvesicle (CD31/annexin V) levels were quantified by flow cytometry. Baseline endothelial progenitor cell counts in coronary patients were significantly lower than those of healthy controls (p < 0.001); however, after surgery, levels rose steadily over all 5 timepoints to 48 h with statistically significant differences (p < 0.001) between intra-operative and 48 h after surgery (T5). Endothelial microvesicle levels were significantly higher in coronary patients prior to surgery than in healthy controls (p < 0.001), and despite declining at 48 h remained significantly higher than those of controls (p < 0.001). Coronary surgery has had a positive impact on the endothelium in the patients, prompting a decrease in signs of endothelial dysfunction and a considerable improvement in the endothelial repair mechanisms involved in angiogenesis, playing an important role in the inflammatory response and the remodelling process of ischemic myocardium in postoperative period.
Docta Complutense
Publication Artículo científico (JournalArticle)

Benefits of exercise and immunotherapy in a murine model of human non-small-cell lung carcinoma.

  • Martín Ruiz Valdepeñas, María Asunción
  • Fiuza Luces, C.
  • Rincón Castanedo, C.
  • Fernández Moreno, D.
  • González Gálvez, Beatriz
  • Martínez Martínez, Ernesto
  • Martín Acosta, P.
  • Coronado, M. J.
  • Franco Luzón, L.
  • González Murillo, A.
  • Ramírez, M.
  • Provencio, M.
  • Lucia, A.
Background: Lung cancer has the highest incidence and mortality rate in the world. One of the most promising new cancer therapies in recent years is immunotherapy, which is based on the blockade of immune checkpoints such as programmed cell death protein 1 (PD-1). Exercise training is beneficial to maintain and improve the quality of life of cancer patients, and it might also modulate the anti-tumoral efficiency of some chemotherapeutic agents. However, the potential of exercise combined with immunotherapy as a cancer therapy remains to be elucidated. Here, we examined the effects of exercise on tumor growth and its possible adjuvant effects when combined with anti-PD-1 immunotherapy (nivolumab) in a patient derived xenograft (PDX) model of non-small-cell lung carcinoma (NSCLC). Methods: We generated a PDX model using NOD-SCID gamma mice with subcutaneous grafts from tumor tissue of a patient with NSCLC. Animals were randomly assigned to one of four groups: non-exercise + isotype control (n=5), exercise + isotype control (n=5), non-exercise + nivolumab (n=6) or exercise + nivolumab (n=6). The animals undertook an 8- week moderate-intensity training regimen (treadmill aerobic exercise and strength training). Immunotherapy (nivolumab) or an isotype control was administered 2 days/week, for 6 weeks. Several tumor growth and microenvironment parameters were measured after the intervention. Results: Improvements in aerobic capacity and muscle strength (p=0.027 and p=0.005) were noted in exercised animals. Exercise alone reduced the tumor growth rate with respect to non-exercised mice (p=0.050). The double intervention (exercise + nivolumab) increased tumor necrosis and reduced apoptosis with respect to controls (p=0.026; p=0.030). All interventions achieved a reduction in proliferation compared with the control group (p=0.015, p=0.011, and p=0.011). Exercise alone increased myeloid tumor infiltrates (mostly neutrophils) with respect to the nivolumab only group (p=0.018). Finally, Vegf-a expression was higher in the nivolumab groups (in combination or not with exercise) than in exercise + isotype control group (p=0.045 and p=0.047, respectively). No other significant effects were found. Conclusions: Our results would suggest that aerobic and strength training should be studied as an adjuvant to cancer immunotherapy treatment.
Docta Complutense
Publication Artículo científico (JournalArticle)

Human Milk Composition and Nutritional Status of Omnivore Human Milk Donors Compared with Vegetarian/Vegan Lactating Mothers

  • Ureta Velasco, Noelia
  • Keller, Kristin
  • Escuder Vieco, Diana
  • Fontecha, Javier
  • Calvo, María V.
  • Megino-Tello, Javier
  • Serrano, José C. E.
  • Romero Ferreiro, Carmen
  • García Lara, Nadia Raquel
  • Pallas Alonso, Carmen Rosa
Women of childbearing age in Western societies are increasingly adopting vegetarian diets. These women are sometimes rejected as milk donors, but little about the composition of their milk is known. The present study aimed to compare the intake, nutritional status, and nutritional composition of human milk from omnivore human milk donors (Donors) and vegetarian/vegan lactating mothers (Veg). Milk, blood, and urine samples from 92 Donors and 20 Veg were used to determine their fatty acid profiles, as well as vitamins and minerals. In a representative sample of both groups, we also determined the lipid class profile as a distribution of neutral and polar lipids, the molecular species of triacylglycerols, and the relative composition of phospholipids in their milk. A dietary assessment was conducted with a five-day dietary record (while considering the intake of supplements). We highlight the following results, expressed as the mean (SE), for the Veg vs. Donors: (1) Their docosahexaenoic acid (DHA) intake was 0.11 (0.03) vs. 0.38 (0.03) g/day; the plasma DHA was 0.37 (0.07) vs. 0.83 (0.06)%; and the milk DHA was 0.15 (0.04) vs. 0.33 (0.02)%. (2) Their milk B12 levels were 545.69 (20.49) vs. 482.89 (4.11) pM; 85% of the Veg reported taking B12 supplements (mean dose: 312.1 mcg/day); and the Veg group showed no differences with Donors in terms of total daily intake or plasma B12. (3) Their milk phosphatidylcholine levels were 26.88 (0.67) vs. 30.55 (1.10)%. (4) Their milk iodine levels were 126.42 (13.37) vs. 159.22 (5.13) mcg/L. In conclusion, the Vegs’ milk was shown to be different from the Donors’ milk, mainly due to its low DHA content, which is concerning. However, raising awareness and ensuring proper supplementation could bridge this gap, as has already been achieved for cobalamin.
Docta Complutense
Publication Artículo científico (JournalArticle)

Successful aging: insights from proteome analyses of healthy centenarians

  • Santos-Lozano, Alejandro
  • Valenzuela, Pedro L.
  • Llavero, Francisco
  • Lista, Simone
  • Carrera-Bastos, Pedro
  • Hampel, Harald
  • Pareja-Galeano, Helios
  • González Gálvez, Beatriz
  • López, Juan Antonio
  • Vázquez, Jesús
  • Emanuele, Enzo
  • Zugaza, José L.
  • Lucia, Alejandro
Healthy aging depends on a complex gene-environment network that is ultimately reflected in the expression of different proteins. We aimed to perform a comparative analysis of the plasma proteome of healthy centenarians (n=9, 5 women, age range 100-103 years) with a notably preserved ambulatory capacity (as a paradigm of 'successful' aging), and control individuals who died from a major age-related disease before the expected life expectancy (n=9, 5 women, age range: 67-81 years), and while having impaired ambulatory capacity (as a paradigm of 'unsuccessful' aging). We found that the expression of 49 proteins and 86 pathways differed between the two groups. Overall, healthy centenarians presented with distinct expression of proteins/pathways that reflect a healthy immune function, including a lower pro-inflammatory status (less 'inflammaging' and autoimmunity) and a preserved humoral immune response (increased B cell-mediated immune response). Compared with controls, healthy centenarians also presented with a higher expression of proteins involved in angiogenesis and related to enhanced intercellular junctions, as well as a lower expression of proteins involved in cardiovascular abnormalities. The identification of these proteins/pathways might provide new insights into the biological mechanisms underlying the paradigm of healthy aging.
Docta Complutense
Publication Artículo científico (JournalArticle)

Associations of Dietary Intake and Nutrient Status with Micronutrient and Lipid Composition in Breast Milk of Donor Women

  • Ureta-Velasco, Noelia
  • Montealegre-Pomar, Adriana
  • Keller, Kristin
  • Escuder Vieco, Diana
  • Fontecha, Javier
  • Calvo, María V.
  • Megino-Tello, Javier
  • Serrano, José C. E.
  • García-Lara, Nadia Raquel
  • Pallas Alonso, Carmen Rosa
The influence of the diet and nutritional status of milk donors on the nutritional composition of donor human milk (DHM) is unknown. The present study aimed to determine the nutritional profile of DHM and the associations between donors’ dietary intake and nutritional status and the micronutrient and lipid composition in DHM. For this purpose, 113 donors completed a food frequency questionnaire, provided a five-day weighed dietary record, and collected milk for five consecutive days. Nutrient determinations in donors’ erythrocytes, plasma, urine, and milk were performed. Multiple linear regressions were conducted for the evaluation of the associations. We highlight the following results: DHM docosahexaenoic acid (DHA) was positively associated with donors’ plasma DHA content and donors’ DHA intake (R2 0.45, p < 0.001). For every 1 g/day DHA intake, an increase of 0.38% in DHA content and 0.78% in total omega-3 content was observed in DHM (R2 0.29, p < 0.001). DHM saturated fatty acids were positively associated with erythrocyte dimethyl acetals, plasma stearic acid, trans fatty acids intake, and breastfeeding duration and negatively associated with erythrocyte margaroleic acid (R2 0.34, p < 0.01). DHM cholecalciferol was associated with plasma cholecalciferol levels and dairy intake (R2 0.57, p < 0.01). Other weaker associations were found for free thiamin, free riboflavin, pyridoxal, dehydroascorbic acid, and the lipid profile in DHM. In conclusion, the diet and nutritional status of donors influence the fatty acid profile and micronutrient content of DHM.
Docta Complutense
Publication Artículo científico (JournalArticle)

Exercise Intolerance in McArdle Disease: A Role for Cardiac Impairment? A Preliminary Study in Humans and Mice.

  • Santos Lozano, Alejandro
  • Boraita, Araceli
  • Valenzuela, Pedro L.
  • Santalla, Alfredo
  • Villareal Salazar, Mónica
  • Bustos, Asunción
  • Brea Alejo, Lidia
  • Barranco Gil, David
  • Millán Parlanti, Daniela
  • López Ortiz, Susana
  • Peñín Grandes, Saúl
  • Naranjo Orellana, José
  • Fiuza Luces, Carmen
  • González Gálvez, Beatriz
  • García Fernández, Miguel Ángel
  • Pinós, Tomàs
  • Lucia, Alejandro
INTRODUCTION: Whether cardiac impairment can be fully discarded in McArdle disease-the paradigm of "exercise intolerance," caused by inherited deficiency of the skeletal muscle-specific glycogen phosphorylase isoform ("myophosphorylase")-remains to be determined. METHODS: Eight patients with McArdle disease and seven age/sex-matched controls performed a 15-min moderate, constant-load cycle-ergometer exercise bout followed by a maximal ramp test. Electrocardiographic and two-dimensional transthoracic (for cardiac dimension's assessment) and speckle tracking (for left ventricular global longitudinal strain (GLS) assessments) echocardiographic evaluations were performed at baseline. Electrocardiographic and GLS assessments were also performed during constant-load exercise and immediately upon maximal exertion. Four human heart biopsies were obtained in individuals without McArdle disease, and in-depth histological/molecular analyses were performed in McArdle and wild-type mouse hearts. RESULTS: Exercise intolerance was confirmed in patients ("second wind" during constant-load exercise, -55% peak power output vs controls). As opposed to controls, patients showed a decrease in GLS during constant-load exercise, especially upon second wind occurrence, but with no other between-group difference in cardiac structure/function. Human cardiac biopsies showed that all three glycogen phosphorylase-myophosphorylase, but also liver and especially brain-isoforms are expressed in the normal adult heart, thereby theoretically compensating for eventual myophosphorylase deficiency. No overall histological (including glycogen depots), cytoskeleton, metabolic, or mitochondrial (morphology/network/distribution) differences were found between McArdle and wild-type mouse hearts, except for lower levels of pyruvate kinase M2 and translocase of outer-membrane 20-kDa subunit in the former. CONCLUSIONS: This study provides preliminary evidence that cardiac structure and function seem to be preserved in patients with McArdle disease. However, the role for an impaired cardiac contractility associated with the second wind phenomenon should be further explored.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Multiple health behaviour change primary care intervention for smoking cessation, physical activity and healthy diet in adults 45 to 75 years old (EIRA study), a hybrid effectiveness-implementation cluster randomised trial

  • Zabaleta del Olmo, Edurne|||0000-0002-5072-8548
  • Casajuana Closas, Marc|||0000-0001-5653-996X
  • López Jiménez, Tomàs|||0000-0001-8255-4936
  • Pombo, Haizea
  • Pons-Vigués, Mariona|||0000-0002-7929-3701
  • Pujol Ribera, Enriqueta|||0000-0002-9475-0755
  • Cabezas Peña, Carmen|||0000-0002-4291-0454
  • Llobera, Joan
  • Martí-Lluch, Ruth|||0000-0002-7320-9521
  • Vicens, Caterina
  • Motrico, Emma|||0000-0002-0720-567X
  • Gómez-Gómez, Irene|||0000-0001-8014-6955
  • Maderuelo-Fernandez, Jose-Angel|||0000-0001-7544-8684
  • Recio Rodríguez, José I.|||0000-0002-3772-8746
  • Masluk, Barbara
  • Contreras-Martos, Sara
  • Jacques-Aviñó, Constanza|||0000-0001-8506-780X
  • Aznar-Lou, Ignacio|||0000-0002-6780-5968
  • Gil-Girbau, Montserrat|||0000-0002-4396-6492
  • Clavería, Ana|||0000-0001-9552-1260
  • Magallon Botaya, Rosa|||0000-0002-5494-6550
  • Bellón Saameño, Juan Ángel|||0000-0002-4268-4979
  • Ramos, Rafel|||0000-0001-7970-5537
  • Sánchez Pérez, Álvaro
  • Moreno-Peral, Patricia|||0000-0003-4130-9090
  • Leiva, Alfonso|||0000-0001-5306-8533
  • González-Formoso, Clara
  • Bolíbar, Bonaventura|||0000-0003-4653-9805
This study aimed to evaluate the effectiveness of a) a Multiple Health Behaviour Change (MHBC) intervention on reducing smoking, increasing physical activity and adherence to a Mediterranean dietary pattern in people aged 45-75 years compared to usual care; and b) an implementation strategy. A cluster randomised effectiveness-implementation hybrid trial-type 2 with two parallel groups was conducted in 25 Spanish Primary Health Care (PHC) centres (3062 participants): 12 centres (1481 participants) were randomised to the intervention and 13 (1581 participants) to the control group (usual care). The intervention was based on the Transtheoretical Model and focused on all target behaviours using individual, group and community approaches. PHC professionals made it during routine care. The implementation strategy was based on the Consolidated Framework for Implementation Research (CFIR). Data were analysed using generalised linear mixed models, accounting for clustering. A mixed-methods data analysis was used to evaluate implementation outcomes (adoption, acceptability, appropriateness, feasibility and fidelity) and determinants of implementation success. 14.5% of participants in the intervention group and 8.9% in the usual care group showed a positive change in two or all the target behaviours. Intervention was more effective in promoting dietary behaviour change (31.9% vs 21.4%). The overall adoption rate by professionals was 48.7%. Early and final appropriateness were perceived by professionals as moderate. Early acceptability was high, whereas final acceptability was only moderate. Initial and final acceptability as perceived by the participants was high, and appropriateness moderate. Consent and recruitment rates were 82.0% and 65.5%, respectively, intervention uptake was 89.5% and completion rate 74.7%. The global value of the percentage of approaches with fidelity ≥50% was 16.7%. Eight CFIR constructs distinguished between high and low implementation, five corresponding to the Inner Setting domain. Compared to usual care, the EIRA intervention was more effective in promoting MHBC and dietary behaviour change. Implementation outcomes were satisfactory except for the fidelity to the planned intervention, which was low. The organisational and structural contexts of the centres proved to be significant determinants of implementation effectiveness. , . Registered 2 May 2017, "retrospectively registered". The online version contains supplementary material available at 10.1186/s12889-021-11982-4.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Video conference vs face-to-face group psychotherapy for distressed cancer survivors, A randomized controlled trial

  • Lleras, María|||0000-0002-7767-1625
  • Medina, Joan Carles|||0000-0002-4550-2157
  • Vives Brosa, Jaume|||0000-0001-5412-7275
  • Casellas-Grau, Anna|||0000-0003-2919-0509
  • Marzo, Jose Luis
  • Borras, Josep M|||0000-0001-7330-6308
  • Ochoa, Cristian|||0000-0002-4508-0951
Objective: This study assesses the effectiveness of face-to-face group positive psychotherapy for cancer survivors (PPC) compared to its online adaptation, online group positive psychotherapy for cancer survivors (OPPC), which is held via videoconference. A two-arm, pragmatic randomized controlled trial was conducted to examine the effects of both interventions on emotional distress, post-traumatic stress symptoms (PTSS), and post-traumatic growth (PTG) among cancer survivors and analyze attrition to treatment. Methods: Adult women with a range of cancer diagnoses were invited to participate if they experienced emotional distress at the end of their primary oncological treatment. Emotional distress, PTSS, and PTG were assessed at baseline, immediately after treatment, and 3 months after treatment. Intention-to-treat analyses were carried out using general linear mixed models to test the effect of the interventions overtime. Logistic regressions were performed to test differential adherence to treatment and retention to follow-up. Results: A total of 269 individuals participated. The observed treatment effect was significant in both modalities, PPC and OPPC. Emotional distress (b = -2.24, 95% confidence interval [CI] = -3.15 to -1.33) and PTSS (b = -3.25, 95% CI = -4.97 to -1.53) decreased significantly over time, and PTG (b = 3.08, 95% CI = 0.38-5.78) increased significantly. Treatment gains were sustained across outcomes and over time. Analyses revealed no significant differences between modalities of treatment, after adjusting for baseline differences, finding that OPPC is as effective and engaging as PPC. Conclusions: The OPPC treatment was found to be effective and engaging for female cancer early survivors. These results open the door for psycho-oncology interventions via videoconference, which are likely to lead to greater accessibility and availability of psychotherapy.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Widespread intra-axonal signal fraction abnormalities in bipolar disorder from multicompartment diffusion, Sensitivity to diagnosis, association with clinical features and pharmacologic treatment

  • Canales-Rodriguez, Erick Jorge|||0000-0001-6421-2633
  • Verdolini, Norma|||0000-0001-9488-2881
  • Alonso-Lana, Silvia|||0000-0002-3063-6929
  • Torres, María Llanos
  • Panicalli, Francesco
  • Argila-Plaza, Isabel|||0000-0002-1604-4708
  • Rodriguez-Cano, Elena
  • Montoro, Irene
  • Garcia-Ruiz, Beatriz
  • Jimenez, Esther|||0000-0001-6929-6207
  • Varo, Cristina|||0000-0002-8859-3052
  • Lluch, Anna
  • del Mar Bonnin, Caterina
  • Maluf, Silvana
  • Pujol, Marc
  • Jaurrieta Guarner, Núria
  • Sarró, Salvador|||0000-0003-1835-2189
  • Vieta, Eduard|||0000-0002-0548-0053
  • Vilella, Elisabet|||0000-0002-1887-5919
  • Salvador, Raymond|||0000-0001-5557-1562
  • Pomarol-Clotet, Edith|||0000-0002-8159-8563
Despite diffusion tensor imaging (DTI) evidence for widespread fractional anisotropy (FA) reductions in the brain white matter of patients with bipolar disorder, questions remain regarding the specificity and sensitivity of FA abnormalities as opposed to other diffusion metrics in the disorder. We conducted a whole-brain voxel-based multicompartment diffusion MRI study on 316 participants (i.e., 158 patients and 158 matched healthy controls) employing four diffusion metrics: the mean diffusivity (MD) and FA estimated from DTI, and the intra-axonal signal fraction (IASF) and microscopic axonal parallel diffusivity (Dpar) derived from the spherical mean technique. Our findings provide novel evidence about widespread abnormalities in other diffusion metrics in BD. An extensive overlap between the FA and IASF results suggests that the lower FA in patients may be caused by a reduced intra-axonal volume fraction or a higher macromolecular content in the intra-axonal water. We also found a diffuse alteration in MD involving white and grey matter tissue and more localised changes in Dpar. A Machine Learning analysis revealed that FA, followed by IASF, were the most helpful metric for the automatic diagnosis of BD patients, reaching an accuracy of 72%. Number of mood episodes, age of onset/duration of illness, psychotic symptoms, and current treatment with lithium, antipsychotics, antidepressants, and antiepileptics were all significantly associated with microstructure abnormalities. Lithium treatment was associated with less microstructure abnormality. A whole-brain voxel-based approach combining DTI and SMT diffusion-derived metrics to reveal specific brain tissue microstructure abnormalities in bipolar disorder (BD) was carried out. We also evaluate the sensitivity of various diffusion metrics for the automatic diagnosis of BD through machine learning algorithms and cross-validation. Finally, we look for differences between BD subtypes and the possible effect of duration of illness, age at onset, history of psychosis, and pharmacological treatment with lithium, antidepressant, antipsychotic, and antiepileptic drugs.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Effectiveness of a Post-discharge Phone-Based Smoking Cessation Intervention for Patients with Severe Mental Health Disorders, The 061 Quitmental Randomized Controlled Clinical Trial

  • Martínez, Cristina|||0000-0002-9368-1356
  • Feliu, Ariadna|||0000-0002-0033-9026
  • Saura Sanchez, Judit Antonia
  • Nieva, Gemma|||0000-0003-2630-1218
  • Pinet, Cristina|||0000-0003-1356-2670
  • Raich, Antònia|||0000-0002-8346-864X
  • Mondon, Silvia|||0000-0002-9213-5759
  • Barrio, Pablo
  • Andreu, Magalí|||0000-0003-2535-0042
  • Hernández-Ribas, R.
  • Costa, Silvia|||0000-0003-1087-752X
  • Suelves, Josep M.|||0000-0002-7716-6944
  • Vilaplana, Jordi|||0000-0002-8188-4914
  • Enríquez, Marta
  • Alaustre, Laura
  • Vilalta, E.
  • Alvarez, J.B.
  • Guydish, Joseph|||0000-0003-2115-3340
  • Fernández, Esteve|||0000-0003-4239-723X
  • Ballbè, Montse|||0000-0002-0747-0924
A pragmatic double-blind randomized controlled trial was conducted in Barcelona to assess a telephone-based smoking cessation intervention's effectiveness for individuals with mental health disorders post-discharge. Participants were divided into an intervention group (IG) and control group (CG) with a 2:1 allocation ratio. The IG received proactive motivational assistance, while the CG received brief advice. Biochemically validated past 7-day abstinence was the main outcome measure. Of 530 screened individuals, 294 were enrolled (200 IG, 94 CG). During follow-up, participants reported 97 episodes of ≥ 7-day abstinence (IG, 51; CG, 26). Overall abstinence probability was 30-35%, with no difference between groups at 1-year follow-up. However, intervention participants were more likely to report abstinence if they quit during hospitalization or were considering quitting. The intervention effectively supported smoking abstinence in motivated individuals. Combining this with clinical and community-based interventions holds promise for aiding smoking cessation in those with mental disorders. ClinicalTrials.gov Identifier: NCT03230955.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Burden of postmenopausal breast cancer attributable to excess body weight, comparative study of body mass index and CUN-BAE in MCC-Spain study

  • Cubelos-Fernández, Naiara
  • Davila-Batista, Veronica|||0000-0001-8888-395X
  • Fernández-Villa, Tania|||0000-0002-9049-3026
  • Castaño-Vinyals, Gemma|||0000-0003-4468-1816
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Amiano, Pilar
  • Ardanaz, Eva
  • Delgado Sillero, Irene
  • Llorca, Javier|||0000-0001-8569-861X
  • Tardón, Guillermo Fernández
  • Alguacil, Juan|||0000-0003-2703-9725
  • Vanaclocha Espí, Mercedes|||0000-0002-7202-2861
  • Marcos-Gragera, Rafael|||0000-0001-9824-3657
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Aragonés, Nuria
  • Dorronsoro, Ane
  • Guevara, Marcela|||0000-0001-9242-6364
  • Reguero Celada, Sofía
  • Pollán, Marina|||0000-0002-4328-1565
  • Martín, Vicente|||0000-0003-0552-2804
10% of postmenopausal breast cancer cases are attributed to a high body mass index (BMI). BMI underestimates body fat, particularly in older women, and therefore the cancer burden attributable to obesity may be even higher. However, this is not clear. CUN-BAE (Clínica Universidad de Navarra-Body Adiposity Estimator) is an accurate validated estimator of body fat, taking into account sex and age. The objective of this study was to compare the burden of postmenopausal breast cancer attributable to excess body fat calculated using BMI and CUN-BAE. This case-control study included 1033 cases of breast cancer and 1143 postmenopausal population controls from the multicase-control MCC-Spain study. Logistic regression models were used to calculate odds ratios (ORs). The population attributable fraction (PAF) of excess weight related to breast cancer was estimated with both anthropometric measures. Stratified analyses were carried out for hormone receptor type. Excess body weight attributable to the risk of breast cancer was 23.0% when assessed using a BMI value ≥30 kg/m 2 and 38.0% when assessed using a CUN-BAE value of ≥40% body fat. Hormone receptor stratification showed that these differences in PAFs were only observed in hormone receptor positive cases, with an estimated burden of 19.9% for BMI and 41.9% for CUN-BAE. These findings suggest that the significance of excess body fat in postmenopausal hormone receptor positive breast cancer could be underestimated when assessed using only BMI. Accurate estimation of the cancer burden attributable to obesity is crucial for planning effective prevention initiatives.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Two Novel Variants in YARS2 Gene Are Responsible for an Extended MLASA Phenotype with Pancreatic Insufficiency

  • Carreño Gago, Lidia
  • Juarez-Flores, Diana Luz|||0000-0003-3615-7803
  • Grau, Josep M.|||0000-0001-7560-224X
  • Ramón, Javier|||0000-0002-0673-9338
  • Lozano, Ester|||0000-0002-6307-9807
  • Vila-Julià, Ferran
  • Martí, Ramon A.|||0000-0002-8273-9540
  • Garrabou, Glòria|||0000-0001-8973-9933
  • García Arumí, Elena|||0000-0003-1848-005X
Pathogenic variants in the mitochondrial tyrosyl-tRNA synthetase gene (YARS2) were associated with myopathy, lactic acidosis, and sideroblastic anemia (MLASA). However, patients can present mitochondrial myopathy, with exercise intolerance and muscle weakness, leading from mild to lethal phenotypes. Genes implicated in mtDNA replication were studied by Next Generation Sequencing (NGS) and whole exome sequence with the TruSeq Rapid Exome kit (Illumina, San Diego, CA, USA). Mitochondrial protein translation was studied following the Sasarman and Shoubridge protocol and oxygen consumption rates with Agilent Seahorse XF24 Analyzer Mitostress Test, (Agilent, Santa Clara, CA, USA). We report two siblings with two novel compound heterozygous pathogenic variants in YARS2 gene: a single nucleotide deletion in exon 1, c.314delG (p.(Gly105Alafs*4)), which creates a premature stop codon in the amino acid 109, and a single nucleotide change in exon 5 c.1391T.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Increased grey matter volumes in the temporal lobe and its relationship with cognitive functioning in euthymic patients with bipolar disorder

  • Porta-Casteràs, Daniel|||0000-0002-3921-3607
  • Vicent Gil, Muriel|||0000-0001-7534-5095
  • Serra Blasco, Maria|||0000-0001-5793-9906
  • Navarra-Ventura, Guillem|||0000-0001-9839-7357
  • Solé, Brisa|||0000-0003-1673-8248
  • Montejo, Laura|||0000-0003-4407-9454
  • Torrent, Carla|||0000-0003-0335-582X
  • Martínez-Àran, Anabel|||0000-0002-0623-6263
  • De la Peña-Arteaga, Víctor|||0000-0001-8627-2653
  • Palao, Diego|||0000-0002-3323-6568
  • Vieta, Eduard|||0000-0002-0548-0053
  • Cardoner, Narcís|||0000-0001-9633-0888
  • Cano, Marta|||0000-0003-0675-9483
Bipolar disorder (BD) is characterized by episodic mood dysregulation, although a significant portion of patients suffer persistent cognitive impairment during euthymia. Previous magnetic resonance imaging (MRI) research suggests BD patients may have accelerated brain aging, observed as lower grey matter volumes. How these neurostructural alterations are related to the cognitive profile of BD is unclear. We aim to explore this relationship in euthymic BD patients with multimodal structural neuroimaging. A sample of 27 euthymic BD patients and 24 healthy controls (HC) underwent structural grey matter MRI and diffusion-weighted imaging (DWI). BD patient's cognition was also assessed. FreeSurfer algorithms were used to obtain estimations of regional grey matter volumes. White matter pathways were reconstructed using TRACULA, and four diffusion metrics were extracted. ANCOVA models were performed to compare BD patients and HC values of regional grey matter volume and diffusion metrics. Global brain measures were also compared. Bivariate Pearson correlations were explored between significant brain results and five cognitive domains. Euthymic BD patients showed higher ventricular volume (F(1, 46) = 6.04; p = 0.018) and regional grey matter volumes in the left fusiform (F(1, 46) = 15.03; pFDR = 0.015) and bilateral parahippocampal gyri compared to HC (L: F(1, 46) = 12.79, pFDR = 0.025/ R: F(1, 46) = 15.25, pFDR = 0.015). Higher grey matter volumes were correlated with greater executive function (r = 0.53, p = 0.008). We evaluated a modest sample size with concurrent pharmacological treatment. Higher medial temporal volumes in euthymic BD patients may be a potential signature of brain resilience and cognitive adaptation to a putative illness neuroprogression. This knowledge should be integrated into further efforts to implement imaging into BD clinical management.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

GPCRmd uncovers the dynamics of the 3D-GPCRome

  • Rodríguez-Espigares, Ismael|||0000-0002-1602-8679
  • Torrens-Fontanals, Mariona|||0000-0001-6233-8945
  • Tiemann, Johanna K. S|||0000-0001-7551-6245
  • Aranda-García, David|||0000-0002-5476-2903
  • Ramírez-Anguita, Juan Manuel|||0000-0002-8509-0927
  • Stepniewski, Tomasz Maciej|||0000-0002-6828-9192
  • Worp, Nathalie
  • Varela-Rial, Alejandro|||0000-0002-6918-1765
  • Morales-Pastor, Adrián
  • Medel-Lacruz, Brian|||0000-0003-2831-7731
  • Pándy-Szekeres, Gáspár|||0000-0002-7697-2696
  • Mayol, Eduardo|||0000-0003-3120-8667
  • Giorgino, Toni|||0000-0001-6449-0596
  • Carlsson, Jens|||0000-0003-4623-2977
  • Deupi, Xavier|||0000-0003-4572-9316
  • Filipek, Slawomir|||0000-0003-3147-3858
  • Filizola, Marta|||0000-0002-4382-8276
  • Gómez-Tamayo, José Carlos|||0000-0003-4709-6030
  • Gonzalez, Angel|||0000-0002-2284-8307
  • Gutiérrez-de-Terán, Hugo|||0000-0003-0459-3491
  • Jiménez-Rosés, Mireia|||0000-0002-4049-8670
  • Jespers, Willem|||0000-0002-4951-9220
  • Kapla, Jon|||0000-0003-3328-1921
  • Khelashvili, George
  • Kolb, Peter|||0000-0003-4089-614X
  • Latek, Dorota|||0000-0002-0429-0637
  • Marti-Solano, Maria|||0000-0003-0373-8927
  • Matricon, Pierre
  • Matsoukas, Minos-Timotheos|||0000-0002-4642-8163
  • Miszta, Przemyslaw
  • Olivella, Mireia|||0000-0002-6035-3399
  • Pérez-Benito, Laura|||0000-0001-9607-9048
  • Provasi, Davide|||0000-0002-2868-303X
  • Ríos, Santiago
  • Rodríguez Torrecillas, Iván
  • Sallander, Jessica
  • Sztyler, Agnieszka|||0009-0008-9459-0078
  • Vasile, Silvana|||0000-0001-5578-7996
  • Weinstein, Harel|||0000-0003-3473-9818
  • Zachariae, Ulrich|||0000-0003-3287-8494
  • Hildebrand, Peter Werner|||0000-0003-0063-1104
  • De Fabritiis, Gianni|||0000-0003-3913-4877
  • Sanz, Ferran|||0000-0002-7534-7661
  • Gloriam, David E.|||0000-0002-4299-7561
  • Cordomí Montoya, Arnau|||0000-0002-3848-2928
  • Guixà González, Ramon|||0000-0003-0397-9800
  • Selent, Jana|||0000-0002-1844-4449
G-protein-coupled receptors (GPCRs) are involved in numerous physiological processes and are the most frequent targets of approved drugs. The explosion in the number of new three-dimensional (3D) molecular structures of GPCRs (3D-GPCRome) over the last decade has greatly advanced the mechanistic understanding and drug design opportunities for this protein family. Molecular dynamics (MD) simulations have become a widely established technique for exploring the conformational landscape of proteins at an atomic level. However, the analysis and visualization of MD simulations require efficient storage resources and specialized software. Here we present GPCRmd (http://gpcrmd.org/), an online platform that incorporates web-based visualization capabilities as well as a comprehensive and user-friendly analysis toolbox that allows scientists from different disciplines to visualize, analyze and share GPCR MD data. GPCRmd originates from a community-driven effort to create an open, interactive and standardized database of GPCR MD simulations.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Prodromic Inflammatory-Oxidative Stress in Peritoneal Leukocytes of Triple-Transgenic Mice for Alzheimer's Disease

  • Ceprián, Noemí|||0000-0001-7028-3083
  • Martínez de Toda, Irene|||0000-0002-1707-487X
  • Maté, Ianire|||0000-0003-0566-2508
  • Garrido, Antonio|||0000-0003-3026-3330
  • Gimenez-Llort, Lydia|||0000-0002-4091-489X
  • De la Fuente, Mónica
Inflammatory-oxidative stress is known to be pivotal in the pathobiology of Alzheimer's disease (AD), but the involvement of this stress at the peripheral level in the disease's onset has been scarcely studied. This study investigated the pro-inflammatory profile and oxidative stress parameters in peritoneal leukocytes from female triple-transgenic mice for AD (3xTgAD) and non-transgenic mice (NTg). Peritoneal leukocytes were obtained at 2, 4, 6, 12, and 15 months of age. The concentrations of TNFα, INFγ, IL-1β, IL-2, IL-6, IL-17, and IL-10 released in cultures without stimuli and mitogen concanavalin A and lipopolysaccharide presence were measured. The concentrations of reduced glutathione (GSH), oxidized glutathione (GSSG), lipid peroxidation, and Hsp70 were also analyzed in the peritoneal cells. Our results showed that although there was a lower release of pro-inflammatory cytokines by 3xTgAD mice, this response was uncontrolled and overstimulated, especially at a prodromal stage at 2 months of age. In addition, there were lower concentrations of GSH in leukocytes from 3xTgAD and higher amounts of lipid peroxides at 2 and 4 months, as well as, at 6 months, a lower concentration of Hsp70. In conclusion, 3xTgAD mice show a worse pro-inflammatory response and higher oxidative stress than NTg mice during the prodromal stages, potentially supporting the idea that Alzheimer's disease could be a consequence of peripheral alteration in the leukocyte inflammation-oxidation state.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Alfabetización en salud mental en adolescentes españoles y su relación con las características sociodemográficas, Mental health literacy in spanish adolescents and its relationship with sociodemographic characteristics

  • Amado Rodríguez, Isaac Daniel|||0000-0001-9863-9256
  • Casañas, Rocio|||0000-0003-2783-8818
  • Mas-Expósito, Laia
  • Lalucat-Jo, Lluís
  • Roldán Merino, Juan Francisco|||0000-0002-7895-6083
  • Fernández San Martín, María Isabel|||0000-0001-9190-7182
FUNDAMENTOS: Diferentes estudios identifican la alfabetización en salud y/o salud mental (ASM) como factores protectores contra el desarrollo de un problema de salud mental. El objetivo de este trabajo fue determinar el grado de alfabetización en salud mental de la población adolescente de Barcelona, así como su relación con variables sociodemográficas y educativas. MÉTODOS: Se realizó un estudio transversal en Barcelona durante el curso 2017-2018. Participaron 1.032 jóvenes entre trece y diecisiete años. Se recogieron las siguientes variables: sexo; edad; nacionalidad; nivel socioeconómico (RDHpc); y nota media escolar. La ASM se midió mediante los test de conocimientos EMHL (reconocimiento de problemas mentales y conocimientos en salud mental; rango 0-10 cada parte), estigma (CAMI: rango 10-50, y RIBS: rango 4-20) y búsqueda de ayuda (GHSQ: rango de 1 a 7). Se realizó análisis de regresión lineal múltiple ajustando el efecto de variables sociodemográficas sobre la puntuación de cada escala. RESULTADOS: La puntuación media (desviación típica) del EMHL test fue de 7,28 (1,27) y 4,24 (1,14), respectivamente, obteniendo mayor puntuación las chicas, RDHpc altas, nota excelente y con nacionalidad española. La mayor diferencia de puntuación en EMHL, ajustando por el resto de variables, correspondió a los adolescentes con nota media excelente y con índice RDHpc elevado (respecto a la categoría basal, beta=0,72 y 0,52, respectivamente). La puntuación media del estigma fue 27,6 (4,47) para CAMI y 8,83 (3,36) para RIBS. Las variables relacionadas con una mayor diferencia de puntuación respecto a la categoría basal y ajustado por el resto de variables fueron: sexo (chico=1,54) y nota académica (excelente=-2,38) para CAMI, y nacionalidad (extranjera=0,82) y nota académica (excelente=-1,30) para RIBS. La puntuación media de RIBS fue 8,83 (3,36), siendo la mayor diferencia de puntuación respecto a la categoría basal la nacionalidad extranjera (beta=0,82) y tener una nota de excelente (1,30). La búsqueda de ayuda fue mayor en padres/madres y amigos, con diferencias según sexo y nacionalidad. CONCLUSIONES: El nivel de alfabetización de salud mental es medio-bajo. Mientras que género, nacionalidad y resultados académicos son los factores que se relacionan con conocimientos y estigma, el nivel socioeconómico se relaciona únicamente con conocimientos en salud mental., BACKGROUND: Different studies identify mental health literacy as a protective factor for developing a mental health problem. The aim of this paper was to determine the degree of mental health literacy of the adolescent population of Barcelona, and its relationship with socio-demographic and educational variables. METHODS: A cross-sectional study was carried out in Barcelona during the 2017-2018 academic year. A total of 1,032 young people between thirteen and seventeen years of age participated. The following variables were collected: sex, age, nationality, socioeconomic status (RDHpc) and average school grade. The aim was to determine the degree of mental health literacy (knowledge, stigma and help-seeking) of the adolescent population of Barcelona, and its relationship with socio-demographic and educational variables. Multiple linear regression analysis was performed adjusting for the effect of sociodemographic variables on the score of each scale. RESULTS: The mean score (standard deviation) of the EMHL test was 7.28 (1.27) and 4.24 (1.14) respectively, with higher scores obtained by girls, high RDHpc, excellent score and Spanish nationality. The greatest difference in EMHL scores, adjusting for the rest of the variables, corresponded to adolescents with an excellent mean score and a high RDHpc index (with respect to the baseline category, beta=0.72 and 0.52 respectively). The mean stigma score was 27.6 (4.47) for CAMI and 8.83 (3.36) for RIBS. The variables related to a greater difference in score with respect to the baseline category and adjusted for the rest of the variables were: gender (boy=1.54) and academic grade (excellent=-2.38) for CAMI, and nationality (foreign=0.82) and academic grade (excellent=-1.30) for RIBS. The mean RIBS score was 8.83 (3.36) with the largest difference in score from baseline being foreign nationality (beta=0.82) and having a grade of excellent (1.30). Help-seeking was higher in parents and friends, with differences according to gender and nationality. CONCLUSIONS: The level of mental health literacy is medium-low. While gender, nationality and educational attainment are the factors that are related to knowledge and stigma, socio-economic status is only related to mental health literacy.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Characterization of Immune Cell Populations and Acid-Sensing Receptors in the Human Esophagus

  • Fortea, Marina|||0000-0001-8885-7495
  • Hacour, Leen
  • Sancho, Francesc
  • Boada, Carlos
  • Sevillano-Aguilera, Cesar
  • González Castro, Ana Maria|||0000-0003-3955-3318
  • Salvo-Romero, Eloisa|||0000-0002-7187-8131
  • Lobo Álvarez, Beatriz|||0000-0003-3391-7125
  • Guagnozzi, Danila|||0000-0002-6171-1901
  • Ceulemans, Laurens J.
  • Pirenne, Jacques
  • Alonso Cotoner, Carmen|||0000-0002-3483-2919
  • Santos, Javier|||0000-0002-4798-5033
  • Farré, Ricard|||0000-0001-7158-171X
  • Vicario Perez, Maria|||0000-0001-9622-3185
Introduction: Esophageal inflammatory diseases are frequent diagnoses in clinical practice and have diverse etiologies, the most common being those associated with the exposure to gastric content, drugs and allergens. In diseases, the immunological component is well identified in endoscopic biopsies, which mainly contain the epithelium and the lamina propria; however, deeper layers are less studied. Moreover, the esophageal capacity of sensing luminal compounds is poorly understood. Methods: In transmural sections from proximal, middle and distal esophagus obtained from deceased patients, we performed a phenotypic analysis of the main immune cell populations and acid-sensing receptors by immunohistochemistry and immunofluorescence methods. Results: A total of nine donors were studied (absence of pathology, optimal tissue preservation and orientation). We found the following: (1) the vascular papillae and the lamina propria are the most infiltrated layers by the lymphoid lineage (T and B lymphocytes), followed by the epithelium, while the smooth muscular layers are mainly populated by the myeloid lineage (macrophages and mast cells); (2) intraepithelial macrophages are consistently found along the esophagus; and (3) eosinophils are absent in all the esophageal layers. The acid-sensing receptors ASIC-1, ASIC-2 and δENAC are expressed in the esophageal epithelium and in the lamina propria, yet only ASIC-2 is expressed in the muscularis mucosae. Conclusions: The human esophagus contains a differential distribution of immune cells and acid-sensing receptors across its layers. This study extends the esophageal histological knowledge previously described and reinforces its role as a defensive and sensing organ.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Semen sEV tRF-Based Models Increase Non-Invasive Prediction Accuracy of Clinically Significant Prostate Cancer among Patients with Moderately Altered PSA Levels

  • Ferre-Giraldo, Adriana
  • Castells-Esteve, Manel|||0000-0003-2370-2008
  • Sánchez Herrero, José Francisco|||0000-0001-6771-4807
  • López-Rodrigo, O.
  • De Rocco Ponce, Maurizio|||0000-0002-0821-3591
  • Bassas, Lluís|||0000-0002-3473-3611
  • Vigués, Francesc|||0000-0003-3717-6301
  • Sumoy, Lauro|||0000-0003-0005-4618
  • Larriba, Sara|||0000-0003-4579-5452
PSA screening has led to an over-diagnosis of prostate cancer (PCa) and unnecessary biopsies of benign conditions due to its low cancer specificity. Consequently, more accurate, preferentially non-invasive, tests are needed. We aim to evaluate the potential of semen sEV (small extracellular vesicles) tsRNAs (tRNA-derived small RNAs) as PCa indicators. Initially, following a literature review in the OncotRF database and high-throughput small RNA-sequencing studies in PCa tissue together with the sncRNA profile in semen sEVs, we selected four candidate 5'tRF tsRNAs for validation as PCa biomarkers. RT-qPCR analysis in semen sEVs from men with moderately elevated serum PSA levels successfully shows that the differential expression of the four tRFs between PCa and healthy control groups can be detected in a non-invasive manner. The combined model incorporating PSA and specific tRFs (5'-tRNA-Glu-TTC-9-1_L30 and 5'-tRNA-Val-CAC-3-1_L30) achieved high predictive accuracy in identifying samples with a Gleason score ≥ 7 and staging disease beyond IIA, supporting that the 5'tRF fingerprint in semen sEV can improve the PSA predictive value to discriminate between malignant and indolent prostate conditions. The in silico study allowed us to map target genes for the four 5'tRFs possibly involved in PCa. Our findings highlight the synergistic use of multiple biomarkers as an efficient approach to improve PCa screening and prognosis.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission, a randomised placebo-controlled clinical trial of GETECCU

  • P. Gisbert, Javier|||0000-0003-2090-3445
  • Donday, María G.
  • Riestra, Sabino|||0000-0002-9383-3698
  • Lucendo, Alfredo J.|||0000-0003-1183-1072
  • Benítez, José Manuel|||0000-0001-8898-3141
  • Navarro-Llavat, Mercè|||0000-0002-1132-0427
  • Barrio, Jesús|||0000-0001-7087-3921
  • Morales-Alvarado, Víctor J.
  • Rivero, Montserrat|||0000-0002-5834-1559
  • Busquets, David|||0000-0002-9385-1415
  • Leo Carnerero, Eduardo|||0000-0002-1267-5211
  • Merino, Olga|||0000-0002-1362-4475
  • Nantes Castillejo, Óscar|||0000-0002-3587-1039
  • Navarro, Pablo|||0000-0001-6228-3462
  • Van Domselaar, Manuel|||0000-0002-9950-2216
  • Gutiérrez Casbas, Ana|||0000-0002-5460-4139
  • Alonso-Abreu, Inmaculada|||0000-0003-0406-029X
  • Mejuto, Rafael
  • Fernández-Salazar, Luis|||0000-0002-9951-7979
  • Iborra, Marisa|||0000-0001-7360-7581
  • Martín-Arranz, María Dolores|||0000-0002-1872-0917
  • Pineda, Juan Ramón
  • Sampedro, Manuela Josefa
  • Serra Nilsson, Katja
  • Bouhmidi, Abdel
  • Batista, Lissette
  • Muñoz-Villafranca, Carmen|||0000-0002-8060-8889
  • Rodríguez-Lago, Iago|||0000-0003-1133-4578
  • Ceballos, Daniel
  • Guerra, Iván|||0000-0002-5175-2515
  • Mañosa i Ciria, Míriam|||0000-0002-9051-2581
  • Marín Jiménez, Ignacio|||0000-0001-5424-2484
  • Torrella, Emilio
  • Vera Mendoza, Maribel
  • Casanova, María José|||0000-0001-8233-9638
  • de Francisco, Ruth|||0000-0001-8476-1672
  • Arias-González, Laura|||0000-0003-2132-9350
  • Marín Pedrosa, Sandra
  • García-Bosch, Orlando
  • García Alonso, Francisco Javier
  • Delgado-Guillena, Pedro|||0000-0002-5798-5491
  • García García, María José|||0000-0002-6517-7005
  • Torrealba, Leyanira|||0000-0002-3144-3408
  • Núñez Ortiz, Andrea
  • Vicuña Arregui, Miren
  • Bosca-Watts, Marta Maia|||0000-0001-7495-8797
  • Blázquez, Isabel|||0000-0003-2429-8174
  • Acosta, Diana|||0000-0001-8347-6642
  • Garre, Ana
  • Baldán, Montse|||0000-0003-0848-8154
  • Martínez, Concepción
  • Barreiro de-Acosta, Manuel|||0000-0001-5915-1477
  • Domènech, Eugeni|||0000-0002-2315-7196
  • Esteve, Maria|||0000-0001-7716-0027
  • García-Sánchez, Valle
  • Nos, Pilar|||0000-0002-6619-1511
  • Panés, Julián|||0000-0002-4971-6902
  • Chaparro, María|||0000-0002-9275-4242
  • Ramírez, Esther
  • Alvarez-Manceñido, Felipe
  • Sánchez-Casanueva, Tomás
  • Cárdenas Aranzana, Manuel J.
  • Gracia García, Berta
  • Caro-Patón, Tomás
  • Seguí Solanes, Carlos
  • Giménez Poderós, Teresa|||0000-0002-7611-7358
  • Castelló Nòria, Àngela
  • Villalba Moreno, Angela|||0000-0002-8658-120X
  • Bustinza Txertudi, Alazne
  • Aranda Alcántara, María
  • Guillot Yacyszyn, Verónica
  • Morales Martínez, Lorena
  • Gracia, Ángel
  • Virgós Aller, Tirso
  • Espino Paisán, Esther
  • Hernando Verdugo, Mercedes
  • Tordera, María
  • Cárdenas, Cristina
  • Sánchez Ulayar, Azhara
  • Ferrer-Artola, Anna|||0000-0003-0424-7353
  • Ventura López, Purificación
  • Loizaga Diaz, Irunne
  • Santos, Amaya
  • Amat López, Mireya
  • Hernández Musiesa, Belén
  • Quiñones Ribas, Carles|||0000-0003-2974-2086
  • Mur Mur, Ana
  • García Motos, Consuelo
  • Sánchez Guerrero, Amelia
Background and objectives: Primary objectives: to compare the rates of sustained clinical remission at 12 months in patients treated with antitumour necrosis factor (anti-TNF) and immunomodulators who withdraw anti-TNF treatment versus those who maintain it. Secondary objectives: to evaluate the effect of anti-TNF withdrawal on relapse-free time, endoscopic and radiological activity, safety, quality of life and work productivity; and to identify predictive factors for relapse. Design: Prospective, quadruple-blind, multicentre, randomised, controlled trial. Patients with ulcerative colitis or Crohn's disease in clinical remission for.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Association between different diet quality scores and depression risk, the REGICOR population-based cohort study

  • Lugon, Gabriela
  • Hernáez, Álvaro|||0000-0001-8593-1477
  • Jacka, F.N.|||0000-0002-9825-0328
  • Marrugat, Jaume|||0000-0003-3320-554X
  • Ramos, Rafel|||0000-0001-7970-5537
  • Garre-Olmo, Josep|||0000-0002-7817-0814
  • Elosua, Roberto|||0000-0001-8235-0095
  • Lassale, Camille|||0000-0002-9340-2708
Our aim was to determine the association between diet quality and depression incidence in the population-based REGICOR cohort study, Catalonia, Spain. Methods: Prospective observational study using participants' baseline (2003-2006), follow-up (2007-2013) and clinical records data. Five diet quality scores were derived from a food frequency questionnaire (FFQ) at baseline: the relative Mediterranean Diet Score (rMED), the Modified Mediterranean Diet Score (ModMDS), a Dietary Approaches to Stop Hypertension (DASH) score, a Healthful Plant-based Diet Index (HPDI) and the World Health Organization Healthy Diet Indicator (WHO-HDI). Participants using pharmacological antidepressant treatment were excluded as a proxy for presence of depression at baseline. At follow-up, the Patient Health Questionnaire (PHQ-9) was applied to assess depressive symptoms (≥ 10 defining depressive disorder). A secondary outcome was depression diagnosis assessed through clinical records. Logistic regression and Cox proportional hazards models were used. Results: Main analysis included 3046 adults (50.3% women) with a mean age of 54.7 (SD = 11.6) years. After 6-years follow-up, 184 (6.04%) cases of depressive disorder were identified. There was 16% lower odds of depressive disorder per 1SD increase of rMED (OR = 0.84; 95%CI = 0.71-0.98). Secondary outcome analysis (n = 4789) identified 261 (5.45%) incident cases of clinical depression diagnosis over 12 years follow-up, and 19% lower risk of clinical depression was observed with the WHO-HDI (HR = 0.81; 95%CI = 0.70-0.93). Adjusting for BMI did not attenuate the findings. Conclusions: A significant inverse association between diet quality and depression incidence was found in this population-based cohort study, independent of sociodemographic, health and lifestyle. Adherence to a healthy diet could be a complementary intervention for the prevention of depression.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Impact of Mental Health Literacy on Improving Quality of Life Among Adolescents in Barcelona

  • Amado Rodríguez, Isaac Daniel|||0000-0001-9863-9256
  • Casañas, Rocio|||0000-0003-2783-8818
  • Juan-Parra, Jaume
  • Roldán Merino, Juan Francisco|||0000-0002-7895-6083
  • Lalucat-Jo, Lluís
  • Fernández San Martín, María Isabel|||0000-0001-9190-7182
Background/Objectives : We aim to assess the effect of the Espaijove.net mental health literacy program on adolescents' quality of life (QOL). Additionally, we aim to describe their QOL and mental well-being. Methods : A multicenter, randomized, controlled trial was conducted, with pre- and post-intervention assessments and 6- and 12-month follow-ups. A total of 1032 students aged 13-14 from 18 schools in Barcelona participated in one of the three following mental health literacy (MHL) programs or were placed in a control group (CG): (1) a 1 h awareness session (G1h); (2) a 6 h MHL program (G6h); (3) a 7 h MHL program with stigma reduction (G7h). Measures: (1) Mental well-being: Strengths and Difficulties Questionnaire (SDQ); (2) QOL: EuroQol 5D-5L with its two parts: the EuroQol 5D-5L Index (0-1) and EuroQol 5D-5L visual analog scale (EQ-VAS) (0-100). Analyses were conducted on an intention-to-treat basis, using data imputation methods for missing data. Intervention effects were assessed using multilevel models. Results : Baseline EQ-VAS and EQ-5D-5L index scores were 77.84 (CI = 76.77-78.91) and 0.91 (CI = 0.90-0.92), respectively. Boys reported higher QOL and SDQ scores (p < 0.001), whereas participants of foreign nationality showed lower scores in QOL (EQ-VAS; p = 0.039) and mental well-being (p < 0.001). Post-intervention, all groups (intervention and control), except G6h, showed QOL improvements. However, in the 6-month follow-up, the CG outperformed the other groups. At 12 months, G7h achieved the highest EQ-VAS scores compared to the other groups. Conclusions : MHL-based interventions improved short-term QOL but failed to sustain these improvements over time. Groups with lower QOL and SDQ scores included girls and adolescents of foreign nationality.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

New Insights into the Exosome-Induced Migration of Uveal Melanoma Cells and the Pre-Metastatic Niche Formation in the Liver

  • Ramos, Raquel
  • Vinyals, Antònia|||0000-0003-3925-0050
  • Campos-Martin, Rafael|||0000-0002-1395-8571
  • Cabré i Gelada, Eduard|||0000-0002-1807-6981
  • Bech-Serra, Joan-Josep|||0000-0003-3486-781X
  • Vaquero, Javier
  • Gonzalez-Sanchez, Ester|||0000-0002-9636-9624
  • Bertran Rodríguez, Esther|||0000-0001-9356-7409
  • Ferreres, Josep Ramon
  • Lorenzo, Daniel|||0000-0001-7545-7257
  • De La Torre, Carolina G.
  • Fabregat, Isabel|||0000-0003-0136-8440
  • Caminal, J.M.|||0000-0001-9563-0344
  • Fabra Fres, Àngels
UM is an aggressive intraocular tumor characterized by high plasticity and a propensity to metastasize in the liver. However, the underlying mechanisms governing liver tropism remain poorly understood. Given the emerging significance of exosomes, we sought to investigate the contribution of UM-derived exosomes to specific steps of the metastatic process. Firstly, we isolated exosomes from UM cells sharing a common genetic background and different metastatic properties. A comparison of protein cargo reveals an overrepresentation of proteins related to cytoskeleton remodeling and actin filament-based movement in exosomes derived from the parental cells that may favor the detachment of cells from the primary site. Secondly, we assessed the role of macrophages in reprogramming the HHSCs by exosomes. The activation of HHSCs triggered a pro-inflammatory and pro-fibrotic environment through cytokine production, upregulation of extracellular matrix molecules, and the activation of signaling pathways. Finally, we found that activated HHSCs promote increased adhesion and migration of UM cells. Our findings shed light on the pivotal role of exosomes in pre-metastatic niche construction in the liver.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Correction, ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer (BMC Cancer, (2024), 24, 1, (876), 10.1186/s12885-024-12501-5)

  • Leary, Alexandra
  • Estévez-García, Purificación
  • Sabatier, Renaud
  • Ray-Coquard, Isabelle|||0000-0003-2472-8306
  • Romeo, Margarita|||0000-0003-1725-8115
  • Barretina-Ginesta, Maria-Pilar|||0000-0003-0074-6614
  • Gil-Martin, Marta|||0000-0002-8548-5355
  • Garralda, Elena|||0000-0002-4412-7842
  • Bosch-Barrera, J.|||0000-0002-0893-7821
  • Morán, Teresa
  • Martin-Martorell, Paloma
  • Nadal, Ernest|||0000-0002-9674-5554
  • Gascón, Pere|||0000-0001-9690-9873
  • Rodon Ahnert, Jordi|||0000-0001-6467-3632
  • Lizcano de Vega, José Miguel|||0000-0002-3154-5383
  • Muñoz-Guardiola, Pau|||0000-0002-0741-4463
  • Fierro-Durán, Gemma
  • Pedrós-Gámez, Oriol
  • Pérez-Montoyo, Hector
  • Yeste-Velasco, Marc|||0000-0001-7788-0913
  • Cortal, Marc
  • Perez Campos, Antonio
  • Alfón, José|||0000-0002-1874-0184
  • Domenech, Carles|||0000-0002-2817-3750
  • Pérez-Fidalgo, Alejandro
  • Oaknin, Ana|||0000-0002-3592-7194
Following publication of the original article [1], the authors reported the the equal contribution statement was missing in the original submission. The correct equal contribution statement is: Alejandro Pérez-Fidalgo and Ana Oaknin contributed equally to this work.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer

  • Leary, Alexandra
  • Estévez-García, Purificación
  • Sabatier, Renaud
  • Ray-Coquard, Isabelle|||0000-0003-2472-8306
  • Romeo, Margarita|||0000-0003-1725-8115
  • Barretina-Ginesta, Maria-Pilar|||0000-0003-0074-6614
  • Gil-Martin, Marta|||0000-0002-8548-5355
  • Garralda, Elena|||0000-0002-4412-7842
  • Bosch-Barrera, J.|||0000-0002-0893-7821
  • Morán, Teresa
  • Martin-Martorell, Paloma
  • Nadal, Ernest|||0000-0002-9674-5554
  • Gascón, Pere|||0000-0001-9690-9873
  • Rodon Ahnert, Jordi|||0000-0001-6467-3632
  • Lizcano de Vega, José Miguel|||0000-0002-3154-5383
  • Muñoz-Guardiola, Pau|||0000-0002-0741-4463
  • Fierro-Durán, Gemma
  • Pedrós-Gámez, Oriol
  • Pérez-Montoyo, Hector
  • Yeste-Velasco, Marc|||0000-0001-7788-0913
  • Cortal, Marc
  • Perez Campos, Antonio
  • Alfón, José|||0000-0002-1874-0184
  • Domenech, Carles|||0000-0002-2817-3750
  • Pérez-Fidalgo, Alejandro
  • Oaknin, Ana|||0000-0002-3592-7194
Background: Carboplatin and paclitaxel (CP) have been the standard of care for advanced/recurrent endometrial cancer (EC) for many years. However, this chemotherapy combination shows limited efficacy and recurrences often occur in less than 12 months. ABTL0812 is a novel drug that selectively kill cancer cells by cytotoxic autophagy and has shown anticancer efficacy in preclinical models of EC in combination with CP. Methods: ENDOLUNG was an open-label, phase 1/2 clinical trial designed to determine the safety and efficacy of Ibrilatazar (ABTL0812) with CP in patients with advanced/recurrent EC and non-irradiable stage III and IV squamous non-small cell lung cancer (sq-NSCLC). The phase 1 part consisted of a 3 + 3 de-escalation design followed by an expansion cohort with 12 patients. The primary endpoint was safety. ABTL0812 starting dose was 1300 mg tid combined with carboplatin at area under the curve (AUC) 5 and paclitaxel at 175 mg/m both administered every 21 days for up to 8 cycles. The phase 2 part included a total of 51 patients. The primary endpoint was overall response rate (ORR) and the secondary endpoints included duration of response (DOR), progression-free survival (PFS) and overall survival (OS). Results: During the phase 1 only one dose limiting toxicity (DLT), a grade 4 neutropenia, was observed in 1 out of 6 patients, thus no de-escalation was applied. One additional DLT, a grade 3 febrile neutropenia, was observed in the expansion cohort, thus the recommended phase 2 dose (RP2D) for ABTL0812 was established at 1300 mg tid. Most frequent hematological adverse events (AE) of the combination were neutropenia (52.9%), anemia (37.3%) and thrombocytopenia (19.6%). Nausea (66.7%), asthenia (66.7%), diarrhea (54.9%) and vomiting (54.9%) were the most frequent non-hematological adverse events (AEs). The combination of ABTL0812 plus CP showed an ORR of 65.8% (13.2% complete response and 52.6% partial response) with a median DOR of 7.4 months (95% CI: 6.3-10.8 months). Median PFS was 9.8 months (95% CI: 6.6-10.6) and median OS 23.6 months (95% CI 6.4-ND). Pharmacokinetic parameters were compatible with target engagement observed in preclinical studies, and blood pharmacodynamic biomarkers indicated sustained target regulation during, at least, 28 days after starting the treatment. Conclusions: This study suggests that the combination of ABTL0812 with CP is safe and feasible with an encouraging activity in patients with advanced/recurrent EC. Our data warrant further confirmation in prospective randomized trials. Trial registration: EU Clinical Trial Register, EudraCT number 2016-001352-21 and National Clinical Trials Number, NCT03366480. Registration on 19 September 2016.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Multidisciplinary medication review during older patient hospitalization according to STOPP/START criteria reduces potentially inappropriate prescriptions, MoPIM cohort study

  • Ortonobes, Sara|||0000-0003-4056-2959
  • Herranz, Susana|||0000-0001-7049-8084
  • Lleal Custey, Marina|||0000-0002-0015-0725
  • Sevilla-Sánchez, Daniel|||0000-0003-2993-6200
  • Jordana, Rosa|||0000-0002-2632-7672
  • Mascaró, Oscar
  • Ferrández, Olivia|||0000-0003-0146-6366
  • De Jaime, Elisabet|||0000-0002-3294-8512
  • Estrada, Rafael
  • Nazco, Gloria Julia|||0000-0001-8265-5753
  • Baré i Mañas, Marisa|||0000-0001-8085-2833
Purpose: Multimorbidity and polypharmacy in older adults converts the detection and adequacy of potentially inappropriate drug prescriptions (PIDP) in a healthcare priority. The objectives of this study are to describe the clinical decisions taken after the identification of PIDP by clinical pharmacists, using STOPP/START criteria, and to evaluate the degree of accomplishment of these decisions. Methods: Multicenter, prospective, non-comparative cohort study in patients aged 65 and older, hospitalized because of an exacerbation of their chronic conditions. Each possible PIDP was manually identified by the clinical pharmacist at admission and an initial decision was taken by a multidisciplinary clinical committee. At discharge, criteria were re-applied and final decisions recorded. Results: From all patients (n = 674), 493 (73.1%) presented at least one STOPP criteria at admission, significantly reduced up to 258 (38.3%) at discharge. A similar trend was observed for START criteria (36.7% vs. 15.7%). Regarding the top 10 most prevalent STOPP criteria, the clinical committee initially agreed to withdraw 257 (34.2%) prescriptions and to modify 93 (12.4%) prescriptions. However, the evaluation of final clinical decisions revealed that 503 (67.0%) of those STOPP criteria were ultimately amended. For the top 10 START criteria associated PIDP, the committee decided to initiate 149 (51.7%) prescriptions, while a total of 198 (68.8%) were finally introduced at discharge. Conclusions: The clinical committee, through a pharmacotherapy review, succeeded in identifying and reducing the degree of prescription inadequacy, for both STOPP and START criteria, in older patients with high degree of multimorbidity and polypharmacy. Trial Registration: NCT02830425.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Platelet miRNA Biosignature Discriminates between Dementia with Lewy Bodies and Alzheimer's Disease

  • Gámez-Valero, Ana|||0000-0002-9530-2751
  • Campdelacreu, Jaume|||0000-0001-9196-7601
  • Vilas Rolán, Dolores|||0000-0003-3084-053X
  • Ispierto, Lourdes
  • Gascon Bayarri, Jordi|||0000-0002-9422-937X
  • Reñé, Ramón
  • Álvarez, Ramiro|||0000-0002-8053-7232
  • Armengol, Maria P.
  • Borràs i Serres, Francesc Enric|||0000-0003-4038-1912
  • Beyer, Katrin|||0000-0001-8905-1514
Dementia with Lewy bodies (DLB) is one of the most common causes of degenerative dementia, after Alzheimer's disease (AD), and presents pathological and clinical overlap with both AD and Parkinson's disease (PD). Consequently, only one in three DLB cases is diagnosed correctly. Platelets, previously related to neurodegeneration, contain microRNAs (miRNAs) whose analysis may provide disease biomarkers. Here, we profiled the whole platelet miRNA transcriptome from DLB patients and healthy controls. Differentially expressed miRNAs were further validated in three consecutive studies from 2017 to 2019 enrolling 162 individuals, including DLB, AD, and PD patients, and healthy controls. Results comprised a seven-miRNA biosignature, showing the highest diagnostic potential for the differentiation between DLB and AD. Additionally, compared to controls, two miRNAs were down-regulated in DLB, four miRNAs were up-regulated in AD, and two miRNAs were down-regulated in PD. Predictive target analysis identified three disease-specific clusters of pathways as a result of platelet-miRNA deregulation. Our cross-sectional study assesses the identification of a novel, highly specific and sensitive platelet-associated miRNA-based biosignature, which distinguishes DLB from AD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Longitudinal trajectories of maternal TSH in healthy pregnant women in Catalonia

  • Soldevila i Madorell, Berta|||0000-0002-4582-4201
  • Velasco Lopez, Maria Ines|||0000-0002-6143-6970
  • Muñoz, Carla
  • Díaz, Yesika|||0000-0002-3727-7340
  • Egea Cortés, Laia|||0000-0003-4002-8254
  • Ferrer-Escopiñan, Laura
  • Pérez-Montes de Oca, Alejandra|||0000-0001-8807-1935
  • Martínez-Mondejar, Raquel
  • Casabona-Barbarà, Jordi|||0000-0003-4816-5536
  • Puig Domingo, Manuel|||0000-0002-6744-7195
Longitudinal evaluation of thyroid function throughout pregnancy in the same subject could offer precise information about its dynamics as a physiological mechanism of adaption to the requirements. In this study, we evaluated longitudinal trajectories of maternal thyroid function during pregnancy by a latent class growth analysis and explored their association with maternal-fetal outcomes. A prospective observational study was carried out, including 414 healthy pregnant women, from the first trimester to delivery. Thyroid function and autoimmunity were measured in the three trimesters. Clinical data during pregnancy were obtained. Longitudinal mixed model techniques were performed to explore trajectories of gestational thyroid function. Three different longitudinal trajectories were obtained from maternal thyrotropin (TSH) levels: low-increasing TSH (class 1) in 86% of cases, high-increasing TSH (class 2) in 9.7%, and decreasing TSH (class 3) in 4.3%. No statistical differences in free thyroxine levels were found among the three classes. Differences in maternal age (P = 0.027) and initial maternal weight (P = 0.043) were observed among the groups. In logistic regression analysis, maternal age correlated with longitudinal trajectories. The three longitudinal classes remain when women with thyroid autoimmunity (TAI) are excluded. Multinomial logistic regression showed maternal age correlated with longitudinal trajectories independently of TAI status. Three differentiated TSH trajectories were found in healthy pregnant women living in Catalonia, as previously described. No association with obstetric outcomes was observed in these different chronological thyroid pathways, but maternal age might condition the longitudinal mechanism of thyroid function regulation throughout pregnancy.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Emotional intelligence, a comparison between patients after first episode mania and those suffering from chronic bipolar disorder type I

  • Varo, Cristina|||0000-0002-8859-3052
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Sparacino, Giulio
  • Jiménez, Esther
  • Solé, Brisa|||0000-0003-1673-8248
  • Bonnin, Caterina del Mar|||0000-0002-1197-1596
  • Montejo, Laura|||0000-0003-4407-9454
  • Serra-Navarro, Maria|||0000-0002-9736-4630
  • Torrent, Carla|||0000-0003-0335-582X
  • Salagre, Estela|||0000-0001-6352-5179
  • Benabarre, Antoni|||0000-0001-8814-2246
  • Salgado-Pineda, Pilar|||0000-0001-7720-0885
  • Montoro Salvatierra, Irene
  • Sáiz, Pilar A.|||0000-0002-5705-4523
  • García-Portilla, María Paz|||0000-0003-3643-1622
  • Sánchez Gistau, Vanessa|||0000-0002-8635-7144
  • Pomarol-Clotet, Edith|||0000-0002-8159-8563
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Pacchiarotti, Isabella|||0000-0002-7822-0367
  • Garcia Rizo, Clemente|||0000-0002-4855-1608
  • Undurraga, Juan|||0000-0001-6958-2369
  • Reinares, María|||0000-0001-8859-4453
  • Martínez-Àran, Anabel|||0000-0002-0623-6263
  • Vieta, Eduard|||0000-0002-0548-0053
  • Verdolini, Norma|||0000-0001-9488-2881
Deficits in emotional intelligence (EI) were detected in patients with bipolar disorder (BD), but little is known about whether these deficits are already present in patients after presenting a first episode mania (FEM). We sought (i) to compare EI in patients after a FEM, chronic BD and healthy controls (HC); (ii) to examine the effect exerted on EI by socio-demographic, clinical and neurocognitive variables in FEM patients. The Emotional Intelligence Quotient (EIQ) was calculated with the Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT). Performance on MSCEIT was compared among the three groups using generalized linear models. In patients after a FEM, the influence of socio-demographic, clinical and neurocognitive variables on the EIQ was examined using a linear regression model. In total, 184 subjects were included (FEM n = 48, euthymic chronic BD type I n = 75, HC n = 61). BD patients performed significantly worse than HC on the EIQ [mean difference (MD) = 10.09, standard error ( = 3.14, p = 0.004] and on the understanding emotions branch (MD = 7.46, = 2.53, p = 0.010). FEM patients did not differ from HC and BD on other measures of MSCEIT. In patients after a FEM, EIQ was positively associated with female sex (β = -0.293, p = 0.034) and verbal memory performance (β = 0.374, p = 0.008). FEM patients performed worse than HC but better than BD on few neurocognitive domains. Patients after a FEM showed preserved EI, while patients in later stages of BD presented lower EIQ, suggesting that impairments in EI might result from the burden of disease and neurocognitive decline, associated with the chronicity of the illness.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Role of Tips in Acute Variceal Bleeding

  • Huerta, Anna|||0000-0002-2524-770X
  • García-Guix, Marta
  • Villanueva, Càndid|||0000-0002-3674-914X
Purpose of review: We aimed to review the role of TIPS in acute variceal bleeding (AVB), focusing on preemptive-TIPS (p-TIPS) as discrepant data suggest room for refinement. Recent findings: Salvage-TIPS can effectively control ongoing AVB despite first-line therapy, but mortality is high. Placing a p-TIPS to prevent failure in high-risk patients may improve survival. This is related to its effect decreasing the overall risk of a further decompensation (FD), not just rebleeding but also ascites and derived complications. Summary: FD is closely related to death risk after AVB. The risk of FD and death concentrates in patients presenting with ascites ± HE in addition to AVB. p-TIPS improve survival, not only by decreasing rebleeding risk, but mainly FD overall. This review suggests potential improvements to optimize p-TIPS, such as improving risk stratification, restricting the indication to patients with AVB and ascites ± HE, or selectively identifying those at high-risk of failure (10%-15% cases) for an early placement. Research on these issues is warranted.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Acute stress triggers sex-dependent rapid alterations in the human small intestine microbiota composition

  • Rodiño-Janeiro, Bruno K.|||0000-0002-0633-6774
  • Khannous-Lleiffe, Olfat
  • Pigrau Pastor, Marc|||0000-0001-6801-3017
  • Willis, Jesse R.
  • Salvo-Romero, Eloísa
  • Nieto Ruiz, Adoración|||0000-0002-3421-2840
  • Expósito, Elba|||0000-0001-6088-3149
  • Fortea, Marina|||0000-0001-8885-7495
  • Pardo-Camacho, Cristina
  • Albert-Bayo, Mercé|||0000-0002-9726-8083
  • González Castro, Ana Maria|||0000-0003-3955-3318
  • Guagnozzi, Danila|||0000-0002-6171-1901
  • Martínez, Cristina|||0000-0002-9368-1356
  • Lobo Álvarez, Beatriz|||0000-0003-3391-7125
  • Vicario Perez, Maria|||0000-0001-9622-3185
  • Santos, Javier|||0000-0002-4798-5033
  • Gabaldón, Toni|||0000-0003-0019-1735
  • Alonso Cotoner, Carmen|||0000-0002-3483-2919
Digestive disorders of gut-brain interaction (DGBI) are very common, predominant in females, and usually associated with intestinal barrier dysfunction, dysbiosis, and stress. We previously found that females have increased susceptibility to intestinal barrier dysfunction in response to acute stress. However, whether this is associated with changes in the small bowel microbiota remains unknown. We have evaluated changes in the small intestinal microbiota in response to acute stress to better understand stress-induced intestinal barrier dysfunction. Jejunal biopsies were obtained at baseline and 90 min after cold pain or sham stress. Autonomic (blood pressure and heart rate), hormonal (plasma cortisol and adrenocorticotropic hormone) and psychological (Subjective Stress Rating Scale) responses to cold pain and sham stress were monitored. Microbial DNA from the biopsies was analyzed using a 16S metabarcoding approach before and after cold pain stress and sham stress. Differences in diversity and relative abundance of microbial taxa were examined. Cold pain stress was associated with a significant decrease in alpha diversity (P = 0.015), which was more pronounced in females, along with significant sex differences in the abundance of specific taxa and the overall microbiota composition. Microbiota alterations significantly correlated with changes in psychological responses, hormones, and gene expression in the intestinal mucosal. Cold pain stress was also associated with activation of autonomic, hormonal and psychological response, with no differences between sexes. Acute stress elicits rapid alterations in bacterial composition in the jejunum of healthy subjects and these changes are more pronounced in females. Our results may contribute to the understanding of female predominance in DGBI.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Risk of Treatment Failure and Death after Ablation in Hepatocellular Carcinoma Patients-A Multiparametric Prediction

  • Muñoz-Martínez, S.|||0000-0003-0663-0575
  • Sapena, Victor|||0000-0003-4379-6486
  • García Criado, Ángeles|||0000-0003-3536-4288
  • Darnell, Anna
  • Forner, Alejandro|||0000-0002-9014-4950
  • Belmonte, Ernest|||0000-0003-3572-9769
  • Sanduzzi Zamparelli, Marco|||0000-0003-3795-3705
  • Rimola, Jordi|||0000-0002-1814-4198
  • Soler-Perromat, Alexandre|||0000-0003-2531-2484
  • Llarch, Neus|||0000-0003-3209-0453
  • Iserte, Gemma|||0000-0003-3908-8743
  • Mauro, Ezequiel|||0000-0002-0757-7676
  • Ayuso, Carmen|||0000-0002-9606-6957
  • Ríos, José|||0000-0002-0716-8784
  • Bruix, Jordi|||0000-0002-9826-0753
  • Vilana, Ramon|||0000-0002-2249-1926
  • Reig, María|||0000-0002-5711-9534
Background: Ablation is a first-line treatment for Barcelona Clinic Liver Cancer (BCLC)-0/A hepatocellular carcinoma (HCC). However, there are scarce data about patients' outcomes after recurrence. The present study evaluates the impact of patient and tumor characteristics at baseline and at recurrence on the Clinical Decision-Making process. Methods: We evaluated BCLC-0/A patients treated with percutaneous ablation from January 2010 to November 2018. Clinical and radiological data such as age, tumor location at ablation, pattern of recurrence/progression, and comorbidities during follow-up were registered. Tumor location was divided into 'suboptimal' vs. 'optimal' locations for ablation. The Clinical Decision-Making was based on tumor burden, liver dysfunction, or comorbidities. The statistical analysis included the time-to-recurrence/progression, censoring at time of death, date of last follow-up or liver transplantation, and time-to-event was estimated by the Kaplan-Meier method and Cox regression models to evaluate the risk of an event of death and change of treatment strategy. Results: A total of 225 patients [39.1% BCLC-0 and 60.9% BCLC-A] were included, 190 had unifocal HCC and 82.6% were ≤3 cm. The complete response rate and median overall survival were 96% and 60.7 months. The HCC nodules number (Hazard Ratio-HR 3.1), Child-Pugh (HR 2.4), and Albumin-Bilirubin score (HR 3.2) were associated with increased risk of death during follow-up. HCC in 'suboptimal location' presented a shorter time to recurrence. When comorbidities prevented further loco-regional or systemic treatment, the risk of death was significantly increased (HR 2.0, p = 0.0369) in comparison to those who received treatment. Conclusions: These results expose the impact of non-liver comorbidities when considering treatment for recurrence after ablation in the real-world setting and in research trials. Ultimately, we identified an orphan population for which effective interventions are needed.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Fecal Short-Chain Fatty Acids to Predict Prediabetes and Type 2 Diabetes Risk: An Exploratory Cross-Sectional Study

  • Puig, Rocío
  • Rojo López, Marina Idalia|||0000-0001-6748-3156
  • Julve i Gil, Josep|||0000-0002-6531-2246
  • Castelblanco, Esmeralda|||0000-0002-2061-6270
  • Ponomarenko, Julia|||0000-0002-1477-9444
  • Amézqueta, Susana
  • Vendrell, Joan|||0000-0002-6994-6115
  • Franch-Nadal, Josep|||0000-0002-5175-1555
  • Torres, Josep Lluís|||0000-0002-5072-8265
  • Mauricio, Didac|||0000-0002-2868-0250
  • Ramos-Romero, Sara|||0000-0002-9293-4454
Background/Objectives: Gut microbiota is profoundly influenced by dysglycemic states, including prediabetes (preDM) and type 2 diabetes (T2D). Although short-chain fatty acids (SCFAs) may serve as proxies reflecting these microbial changes, their predictive role remains elusive. This study aimed to evaluate the association between fecal SCFA concentrations and glycemic status (preDM and T2D), using individuals with normoglycemia (NonDM) as the reference group in a Mediterranean adult population. Methods: This study included a total of 88 participants from the Di@bet.es study who were classified into three groups according to the American Diabetes Association criteria: NonDM (45%), preDM (27%), and T2D (28%), respectively. We evaluated gut microbiota populations through massive sequencing and determined SCFAs concentration using gas chromatography-mass spectrometry. Adjusted multiple logistic regression models were used to estimate associations between SCFAs and metabolic status. Results: The mean age of subjects with preDM and T2D was approximately 68 years, older than that of NonDM participants (about 60 years). About 50% of the subjects in the NonDM and preDM groups were female, whereas in the T2D group, females represented about 25%. The analysis revealed that only fecal acetic acid was significantly reduced in T2D compared to NonDM (p = 0.036) and preDM (p = 0.018) groups. Remarkably, fecal acetic acid was negatively associated with T2D risk when taking preDM as the reference state (OR = 0.561 [95% CI: 0.371-0.846], p = 0.009). Intriguingly, fecal acetic acid was identified as a significant positive predictor of preDM risk, taking the NonDM group as reference (OR = 1.422; p = 0.028), while propionic acid was inversely associated with preDM (OR = 0.714; p = 0.028). Conclusions: Our analysis showed that fecal acetic acid levels were associated with a reduced risk of T2D but also with an increased risk of preDM; however, the biological relevance of these findings remains uncertain.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The Association Between the Mediterranean Diet and Fatty Acids in Red Blood Cells of Spanish Adolescents

  • Ayala-Aldana, Nicolas|||0000-0002-3530-6734
  • Lafuente, David
  • Lázaro, Iolanda|||0000-0002-6172-9845
  • Pinar-Martí, Ariadna|||0000-0002-2602-3396
  • Manidis, Alexios
  • Bernardo-Castro, Sara|||0000-0001-8809-5101
  • Fernández-Barrés, Sílvia|||0000-0002-9977-2291
  • Healy, Darren|||0000-0002-0084-2289
  • Vrijheid, Martine|||0000-0002-7090-1758
  • Contreras Rodríguez, Oren|||0000-0001-8922-8084
  • Sala-Vila, Aleix|||0000-0002-5038-2794
  • Júlvez, Jordi|||0000-0003-0818-4003
Objective: The Mediterranean diet (MedDiet) is characterized by its emphasis on plant-based foods, olive oil, and fish products, and has been associated with providing relevant fatty acids (FAs) for adolescent physiology. This study aims to investigate the relationship between adherence to the MedDiet and the FA composition of red blood cell (RBC) membranes in an adolescent population. Methods: The current research examines the relationship between MedDiet adherence, assessed using the KIDMED questionnaire, and the composition of RBC membranes, specifically measuring 22 FAs in a cross-sectional analysis of adolescents from two cohorts (mean age = 14.55). Baseline data from 552 participants with complete dietary adherence and FA information were analyzed using multivariable regression models and principal component analysis (PCA) as confirmatory analysis. All regression models were adjusted by age, sex, body mass index, physical activity, maternal education and cohort enrollment. Results: Main results shown that "Good adherence" to the MedDiet was positively associated with omega-3 FAs, including eicosapentaenoic acid (β = 0.34; 95% CI: 0.17, 0.52; p -value < 0.001) and docosahexaenoic acid (β = 0.29; 95% CI: 0.11, 0.46; p -value = 0.001), and inversely associated with specific omega-6 FAs, such as arachidonic acid (β = -0.28; 95% CI: -0.46, -0.11; p -value = 0.002) and adrenic acid (β = -0.19; 95% CI: -0.30, -0.08; p -value < 0.001). PCA identified distinct FA patterns, with "Good adherence" to the MedDiet being associated with an increase in the omega-3 FAs pattern (β = 0.32; 95% CI: 0.14, 0.49; p -value < 0.001). These findings remained robust after multiple test comparisons. Conclusions: This study underscores the potential of the MedDiet to promote optimal RBC FA composition in healthy adolescents, characterized by high levels of omega-3 FAs and reduced levels of arachidonic acid and adrenic acid in RBC membranes.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Therapeutic alliance in a stepped digital psychosocial intervention for breast cancer patients, findings from a multicentre randomised controlled trial

  • Flix-Valle, Aida|||0000-0002-1962-330X
  • Medina, Joan Carles|||0000-0002-4550-2157
  • Souto-Sampera, Arnau|||0000-0001-5299-3065
  • Arizu-Onassis, Alejandra|||0000-0001-8497-0263
  • Juan Linares, Eva|||0000-0003-3167-9717
  • Serra Blasco, Maria|||0000-0001-5793-9906
  • Ciria Suarez, Laura|||0000-0002-1388-6686
  • Feixas i Viaplana, Guillem|||0000-0002-6288-6009
  • Ochoa, Cristian|||0000-0002-4508-0951
Background Action mechanisms of therapeutic alliance in stepped and digital interventions remain unclear. Aims (a) To compare the development of therapeutic alliance between psychosocial treatment as usual (PTAU) and a stepped digital intervention designed to prevent distress in cancer patients; (b) to analyse the level of agreement between patients' and therapists' therapeutic alliance ratings; and (c) to explore variables associated with therapeutic alliance in the digital intervention. Method A multicentre randomised controlled trial with 184 newly diagnosed breast cancer women was conducted. Patients were assigned to digital intervention or PTAU. Therapeutic alliance was assessed at 3, 6 and 12 months after inclusion using the working alliance inventory for patients and therapists. Age, usability (system usability scale), satisfaction (visual analogue scale), type and amount of patient-therapist communication were analysed as associated variables. Results Patients and therapists established high therapeutic alliance in the digital intervention, although significantly lower compared with PTAU. The development of patients' therapeutic alliance did not differ between interventions, unlike that of the therapists. No agreement was found between patients' and therapists' therapeutic alliance ratings. Patients' therapeutic alliance was associated with usability and satisfaction with app, whereas therapists' therapeutic alliance was associated with satisfaction with monitoring platform. Conclusions A stepped digital intervention for cancer patients could develop and maintain strong therapeutic alliance. Neither the type nor amount of communication affected patients' therapeutic alliance, suggesting that flexible and available digital communication fosters a sense of care and connection. The association between usability and satisfaction with digital tools highlights their importance as key therapeutic alliance components in digital settings.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Early structural brain abnormalities in borderline personality disorder

  • Salgado-Pineda, Pilar|||0000-0001-7720-0885
  • Ferrer Vinardel, Marc|||0000-0002-1283-8578
  • Calvo, Natalia|||0000-0002-6888-3781
  • Costa, Xavier|||0000-0002-8899-9079
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Tarragona, Brenda
  • Duque-Yemail, Juan|||0000-0002-1346-5996
  • Vaciana-Verdaguer, Cristina
  • Rué, Àlex|||0000-0002-3879-0170
  • Fuentes-Claramonte, Paola|||0000-0002-1428-7976
  • Ferrer, Silvia
  • Salvador, Raymond|||0000-0001-5557-1562
  • McKenna, Peter J.
  • Pomarol-Clotet, Edith|||0000-0002-8159-8563
Structural imaging studies of borderline personality disorder (BPD) have identified regions of reduced and increased cortical volume, as well as volume reductions in the hippocampus and amygdala, although with considerable variability across studies. Examining adolescent patients with the disorder can reduce potential confounding effects such as later development of affective and other comorbid disorders. Fifty-one adolescents (48 females, 3 males) with BPD and without comorbid disorders and with 43 matched healthy controls underwent whole-brain voxel-based morphometry (VBM). Hippocampus and amygdala volumes were also measured using conventional volumetric techniques. At a threshold of p = 0.05 corrected, the BPD patients exhibited a cluster of grey matter volume reduction in the left temporo-parietal junction (TPJ). No evidence of volume reductions in the hippocampus or amygdala was found. Comparison between the female-only subsamples (48 BPD patients and 37 controls) yielded similar findings. The cluster of volume reduction in the left TPJ continued to be seen in 37 drug-naïve patients. According to this study, the initial stage of BPD is characterized by decreased grey matter volume in the left TPJ, a region that is implicated in various aspects of social cognition. Given that the volume loss was detected prior to adulthood, in individuals without comorbidities, and among patients who were drug naïve, this finding could be significant for understanding the developmental trajectory of the disease.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Evaluating topological and graph-theoretical approaches to extract complex multimodal brain connectivity patterns in multiple sclerosis

  • Lozano Bagén, Toni|||0000-0002-6245-3545
  • Martinez-Heras, Eloy|||0000-0001-9937-3162
  • Pontillo, Giuseppe|||0000-0001-5425-1890
  • Solana, Elisabeth|||0000-0001-7973-2439
  • Vivó Pascual, Francesc|||0000-0002-6409-1197
  • Petracca, Maria|||0000-0001-9429-2769
  • Calvi, Alberto|||0000-0002-1953-2803
  • Garrido Romero, Sandra
  • Solé-Ribalta, Albert|||0000-0002-2953-5338
  • Llufriu, Sara|||0000-0003-4273-9121
  • Prados Carrasco, Ferran|||0000-0002-7872-0142
  • Casas Roma, Jordi|||0000-0002-0617-3303
Brain networks, or graphs, derived from magnetic resonance imaging (MRI) offer a powerful framework for representing the structural, morphological, and functional organization of the brain. Graph-theoretical metrics have been widely employed to characterize properties such as efficiency, integration, and communication within these networks. More recently, topological data analysis techniques, such as persistent homology and Betti curves, have emerged as complementary approaches for capturing higher-order network patterns. In this study, we present a comparative analysis of these feature-generation methodologies in the context of neurodegenerative disease. Specifically, we evaluate the effectiveness of Betti curves and graph-theoretical metrics in extracting features for distinguishing people with multiple sclerosis (PwMS) from healthy volunteers (HV). Features are derived from structural connectivity, morphological gray matter, and resting-state functional networks, using both single layer and multilayer graph architectures. Our experiments, conducted on a cohort of PwMS and HV, demonstrate that features extracted using Betti curves generally outperform those based on graph-theoretical metrics. Furthermore, we show that multimodal data in terms of feature concatenation and multilayer graph architectures provide a more comprehensive representation of alterations in complex brain mechanisms associated with MS, leading to improved classification performance. These findings highlight the potential of topological features and multimodal integration for enhancing the understanding and diagnosis of neurodegenerative disorders. PI15/00587, PI18/01030 and PI21/01189.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

From Genetics to Psychosocial Functioning, Unraveling the Mediating Roles of Cognitive Reserve, Cognition, and Negative Symptoms in First-Episode Psychosis

  • Forte, Maria Florencia|||0000-0001-5930-5501
  • Clougher, Derek|||0000-0001-7631-3845
  • González-Segura, Àlex|||0000-0002-9398-2183
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Sánchez Torres, Ana Maria|||0000-0002-9505-2406
  • Vieta, Eduard|||0000-0002-0548-0053
  • Garriga, Marina|||0000-0001-7312-4969
  • Lobo, Antonio|||0000-0002-9098-655X
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Diaz-Caneja, C.M.
  • Roldan-Bejarano, Alexandra|||0000-0001-9905-3943
  • Martínez-Àran, Anabel|||0000-0002-0623-6263
  • de la Serna, Elena|||0000-0002-7869-9881
  • Mané, Anna|||0000-0003-2127-349X
  • Mas, Sergi|||0000-0003-3336-6298
  • Torrent, Carla|||0000-0003-0335-582X
  • Allot, K.|||0000-0002-0640-4634
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Pérez, Antonio|||0000-0001-5528-1143
  • Meseguer, A.
  • Cámara, Concepción de la|||0000-0003-2284-7862
  • Ruiz-Lazaro, P.M.
  • Calvo, L.
  • Estébanez, M.J.
  • Ferrer, Marta
  • Echevarría, A.
  • Escarti, M.J.
  • Rivero, O.
  • Trabsa, Amira|||0000-0002-8669-0676
  • Legido, Teresa|||0000-0002-1175-2641
  • Serra, M.
  • Baeza, Inmaculada|||0000-0003-2611-5781
  • Castro Gutiérrez, Jorge
  • Parra, S.M.
  • Santo, F.D.
  • García-Portilla, María Paz
  • Echevarría, R.S.
  • Rabadán, A.Z.
  • Martínez-Gras, I.
  • Rodriguez-Jimenez, Roberto|||0000-0003-2251-7249
  • Usall, J.
  • Butjosa Molines, Anna|||0000-0001-5317-9508
  • Clotet, E.P.
  • Salvador, R.
  • Ibañez, Angela|||0000-0003-2751-0150
  • Cuesta, M.J.
  • Balanzá-Martínez, Vicent|||0000-0001-7772-7396
Background: Studies have shown associations between polygenic risk scores for educational attainment (PRS), cognitive reserve (CR), cognition, negative symptoms (NS), and psychosocial functioning in first-episode psychosis (FEP). However, their specific interactions remain unclear. This study aimed to investigate the mediating roles of CR, cognition, and NS in the relationship between PRS and psychosocial functioning one year after a FEP. Additionally, we sought to explore the impact of two NS subtypes on this relationship: diminished Expression (EXP-NS) and Motivation and Pleasure (MAP-NS). Methods: A total of 138 FEP participants, predominantly male (70%), with a mean age of 24.77 years (SD = 5.29), underwent genetic, clinical, and cognitive assessments two months after study enrollment. Functioning evaluation followed at one-year follow-up. To investigate the mediating role of CR, cognition, and NS in the relationship between PRS and functioning, a serial mediation model was employed. Two further mediation models were tested to explore the differential impact of EXP-NS and MAP-NS. Mediation analysis was performed using the PROCESS macro version 4.1 within SPSS version 26. Results: The serial mediation model revealed a causal chain for PRS.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Red Blood Cell Fatty Acid Patterns and Cognitive Functions in Adolescents, A Pooled Analyses with Two Cohort Study Data Sets

  • Ayala-Aldana, Nicolas|||0000-0002-3530-6734
  • Pinar-Martí, Ariadna|||0000-0002-2602-3396
  • Ruiz-Rivera, Marina|||0009-0004-4537-8944
  • Lázaro, Iolanda|||0000-0002-6172-9845
  • Sala-Vila, Aleix|||0000-0002-5038-2794
  • Healy, Darren|||0000-0002-0084-2289
  • Contreras Rodríguez, Oren|||0000-0001-8922-8084
  • Casanova, Jordi
  • Sola-Valls, Nuria
  • Vrijheid, Martine|||0000-0002-7090-1758
  • Júlvez, Jordi|||0000-0003-0818-4003
Objective: Fatty acids (FAs) play a pivotal role in brain development and cognitive functions during adolescence. We aimed to investigate the association of red blood cell (RBC) FA patterns and several high order neuropsychological functions in adolescents. Methods: The study followed a cross-sectional design. Principal component analysis was applied to 22 FA species previously measured in RBC membranes (exposure variable) to identify FA principal components (PCs) from two cohorts of adolescents in Catalonia, Spain (mean age = 14.53 years). Multiple linear regression was then used to examine associations between PC FAs and cognitive outcomes-working memory, fluid intelligence, and risky decision-making (gain and loss domains). Regression models were adjusted for child sex, age, body mass index, maternal education, and cohort enrollment. Results: Three FA PCs (eigenvalues.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Difficulties during delivery, brain ventricle enlargement and cognitive impairment in first episode psychosis

  • Verdolini, Norma|||0000-0001-9488-2881
  • Garcia Rizo, Clemente|||0000-0002-4855-1608
  • Mezquida, Gisela|||0000-0002-6080-2203
  • Janssen, Joost|||0000-0001-7613-2067
  • Corripio, Iluminada|||0000-0003-2562-711X
  • Bioque, Miquel|||0000-0001-6887-7149
  • Lobo, Antonio|||0000-0002-9098-655X
  • Vieta, Eduard|||0000-0002-0548-0053
  • Mané, Anna|||0000-0003-2127-349X
  • Roldan-Bejarano, Alexandra|||0000-0001-9905-3943
  • Cuesta, M.J.
  • Parellada, Mara|||0000-0001-7977-3601
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Costas-Carrera, A.
  • Valli, Isabel|||0000-0003-3052-7383
  • Sánchez Torres, Ana Maria|||0000-0002-9505-2406
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Rapado-Castro, M.
  • de la Serna, Elena|||0000-0002-7869-9881
  • Crossley, N.
  • Penadés, R.
Background Patients with a first episode of psychosis (FEP) display clinical, cognitive, and structural brain abnormalities at illness onset. Ventricular enlargement has been identified in schizophrenia since the initial development of neuroimaging techniques. Obstetric abnormalities have been associated with an increased risk of developing psychosis but also with cognitive impairment and brain structure abnormalities. Difficulties during delivery are associated with a higher risk of birth asphyxia leading to brain structural abnormalities, such as ventriculomegaly, which has been related to cognitive disturbances. Methods We examined differences in ventricular size between 142 FEP patients and 123 healthy control participants using magnetic resonance imaging. Obstetric complications were evaluated using the Lewis-Murray scale. We examined the impact of obstetric difficulties during delivery on ventricle size as well as the possible relationship between ventricle size and cognitive impairment in both groups. Results FEP patients displayed significantly larger third ventricle size compared with healthy controls. Third ventricle enlargement was associated with diagnosis (higher volume in patients), with difficulties during delivery (higher volume in subjects with difficulties), and was highest in patients with difficulties during delivery. Verbal memory was significantly associated with third ventricle to brain ratio. Conclusions Our results suggest that difficulties during delivery might be significant contributors to the ventricular enlargement historically described in schizophrenia. Thus, obstetric complications may contribute to the development of psychosis through changes in brain architecture.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Development of amyloid-negative neuropsychological norms using GAMLSS

  • Rubio Guerra, Sara|||0000-0001-7652-8029
  • Sánchez-Saudinós, María Belén|||0000-0003-1795-1833
  • Sala Matavera, Isabel|||0000-0002-9886-4792
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Bejanin, Alexandre|||0000-0002-9958-0951
  • Estanga, Ainara|||0000-0002-6616-314X
  • Ecay-Torres, Mirian|||0000-0001-7170-6180
  • de Luis, C.L.
  • Rami Gonzalez, Lorena|||0000-0002-7411-1921
  • Tort-Merino, Adrià|||0000-0002-5646-0482
  • Castellví, Magdalena|||0000-0001-8769-9288
  • Pozueta, A.
  • García-Martínez, M.
  • Gómez-Andrés, David|||0000-0001-5654-7791
  • Lage, Carmen|||0000-0003-1703-121X
  • López-Garcia, Sara
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
  • Balasa, Mircea|||0000-0002-1795-4228
  • Llado Plarrumani, Albert|||0000-0002-5066-4150
  • Altuna-Azkargorta, Miren|||0000-0001-9709-5314
  • Tainta, Mikel|||0000-0003-0624-1211
  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Zhu, Nuole|||0000-0002-0015-9455
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Lleó, Alberto|||0000-0002-2568-5478
  • Fortea, Juan|||0000-0002-1340-638X
  • Rodríguez-Rodríguez, Eloy|||0000-0001-7742-677X
  • Sánchez Valle, Raquel|||0000-0001-7750-896X
  • Martinez-Lage, Pablo|||0000-0001-5404-9967
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
INTRODUCTION: Recent research has suggested increased sensitivity of Alzheimer's disease (AD)-negative neuropsychological norms; concurrently, generalized additive models for location, scale, and shape (GAMLSS) have emerged as a promising alternative to traditional norming approaches. Here, we developed amyloid β-negative (Aβ-) next-generation norms (NGN) for a comprehensive neuropsychological battery using GAMLSS. METHODS: We included N = 987 cognitively normal (CN) individuals from a Spanish multicenter study with extensive neuropsychological data and cerebrospinal fluid AD biomarker assessment. NGN were developed using GAMLSS based on the performance of n = 774 Aβ- CN individuals aged 30-90 years. RESULTS: Age-, education-, and sex-adjusted z-scores were obtained for 14 measures covering the main cognitive domains (memory, language, attention/executive, and visuospatial functions). A user-friendly calculator for the z-scores was made available in an open-access ShinyApp to facilitate their application. DISCUSSION: NGN may improve the detection of objective cognitive impairment in clinical and research settings. Highlights: Brain amyloid β (Aβ) is associated with poorer performance in cognitively normal individuals. We provide GAMLSS-based Aβ-negative norms for 14 neuropsychological measures. Age, education, and often sex significantly influence cognitive performance. An online calculator for the demographically adjusted z-scores is freely available.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Genome-Wide Search for Nonadditive Allele Effects Identifies PSKH2 as Involved in the Variability of Factor V Activity

  • Gendre, B.
  • Martinez-Perez, Angel|||0000-0002-5934-1454
  • Vlieg, A.v.H.|||0000-0001-7386-1168
  • Boland, Anne|||0000-0001-8789-5676
  • Germain, M.|||0000-0002-8489-8916
  • Munsch, G.|||0000-0003-1564-9825
  • Moissl, Angela Patricia|||0000-0003-0302-2136
  • Suchon, P.
  • Souto, Juan Carlos|||0000-0003-2092-5142
  • Soria Fernández, José Manuel|||0000-0002-6226-4293
  • Deleuze, J.F.|||0000-0002-5358-4463
  • Rosendaal, Frits|||0000-0003-2558-7496
  • Sabater-Lleal, Maria|||0000-0002-0128-379X
  • Morange, Pierre-Emmanuel|||0000-0002-9065-722X
  • Trégouët, David-Alexandre|||0000-0001-9084-7800
  • Kleber, M.E.
  • Olaso, R.
  • März, W.
BACKGROUND: Factor V (FV) is a key molecular player in the coagulation cascade. FV plasma levels have been associated with several human diseases, including thrombosis, bleeding, and diabetic complications. So far, 2 genes have been robustly found through genome-wide association analyses to contribute to the inter-individual variability of plasma FV levels: structural F5 gene and PLXDC2. METHODS AND RESULTS: The authors used the underestimated Brown-Forsythe methodology implemented in the QuickTest software to search for non-additive genetic effects that could contribute to the inter-individual variability of FV plasma activity. QUICKTEST was applied to 4 independent genome-wide association studies studies (LURIC [Ludwigshafen RIsk and Cardiovascular Health Study], MARTHA [Marseille Thrombosis Association], MEGA [Multiple Environmental and Genetic Assessment], and RETROVE [Riesgo de Enfermedad Tromboembolica Venosa]) totaling 4505 participants of European ancestry with measured FV plasma levels. Results obtained in the 4 cohorts were meta-analyzed using a fixed-effect model. Additional analyses involved exploring haplotype and gene×gene interactions in downstream investigations. A genome-wide significant signal at the PSKH2 locus on chr8q21.3 with lead variant rs75463553 with no evidence for heterogeneity across cohorts was observed (P=0.518). Although rs75463553 did not show an association with mean FV levels (P=0.49), it demonstrated a robust significant (P=3.38x10) association with the variance of FV plasma levels. Further analyses confirmed the reported association of PSKH2 with neutrophil biology and revealed that rs75463553 likely interacts with two loci, GRIN2A and POM121L12, known for their involvement in smoking biology. CONCLUSIONS: This comprehensive approach identifies the role of PSKH2 as a novel molecular player in the genetic regulation of FV, shedding light on the contribution of neutrophils to FV biology.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Morphine Use in the ED and Outcomes of Patients With Acute Heart Failure, A Propensity Score-Matching Analysis Based on the EAHFE Registry

  • Miró, Oscar|||0000-0002-7924-9751
  • Gil, Víctor
  • Martín-Sánchez, Francisco Javier|||0000-0002-5970-725X
  • Herrero-Puente, Pablo|||0000-0002-5529-5008
  • Jacob, Javier|||0000-0003-1101-1066
  • Mebazaa, Alexandre|||0000-0001-8715-7753
  • Harjola, Veli-Pekka
  • Ríos, José|||0000-0002-0716-8784
  • Hollander, Judd E.
  • Peacock, W. Frank
  • Llorens Soriano, Pere|||0000-0002-9291-7179
Objective The objective was to determine the relationship between short-term mortality and intravenous morphine use in ED patients who received a diagnosis of acute heart failure (AHF). Methods Consecutive patients with AHF presenting to 34 Spanish EDs from 2011 to 2014 were eligible for inclusion. The subjects were divided into those with (M) or without IV morphine treatment (WOM) groups during ED stay. The primary outcome was 30-day all-cause mortality, and secondary outcomes were mortality at different intermediate time points, in-hospital mortality, and length of hospital stay. We generated a propensity score to match the M and WOM groups that were 1:1 according to 46 different epidemiological, baseline, clinical, and therapeutic factors. We investigated independent risk factors for 30-day mortality in patients receiving morphine. Results We included 6,516 patients (mean age, 81 [SD, 10] years; 56% women): 416 (6.4%) in the M and 6,100 (93.6%) in the WOM group. Overall, 635 (9.7%; M, 26.7%; WOM, 8.6%) died by day 30. After propensity score matching, 275 paired patients constituted each group. Patients receiving morphine had a higher 30-day mortality (55 [20.0%] vs 35 [12.7%] deaths; hazard ratio, 1.66; 95% CI, 1.09-2.54; P =.017). In patients receiving morphine, death was directly related to glycemia (P =.013) and inversely related to the baseline Barthel index and systolic BP (P =.021) at ED arrival (P =.021). Mortality was increased at every intermediate time point, although the greatest risk was at the shortest time (at 3 days: 22 [8.0%] vs 7 [2.5%] deaths; OR, 3.33; 95% CI, 1.40-7.93; P =.014). In-hospital mortality did not increase (39 [14.2%] vs 26 [9.1%] deaths; OR, 1.65; 95% CI, 0.97-2.82; P =.083) and LOS did not differ between groups (median [interquartile range] in M, 8 [7]; WOM, 8 [6]; P =.79). Conclusions This propensity score-matched analysis suggests that the use of IV morphine in AHF could be associated with increased 30-day mortality.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Mammographic density and breast cancer pathological subtypes by menopausal status and body mass index

  • Fernández-Morata, Julia
  • Pollán, Marina|||0000-0002-4328-1565
  • Fernández de Larrea-Baza-Baz, Nerea
  • Pachón Olmos, Vanessa|||0000-0001-5139-9398
  • García-Pérez, Javier|||0000-0003-0300-1810
  • Castelló, Adela|||0000-0002-1308-9927
  • Sierra, María Ángeles
  • Lucas, Pilar
  • Llobet, Rafael
  • Stradella, Agostina|||0000-0002-2307-8869
  • Cantos, Blanca|||0000-0003-2105-1213
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Santisteban, Marta|||0000-0003-0625-686X
  • Seguí Palmer, Miguel Ángel|||0000-0002-5103-6746
  • Santaballa Bertrán, Ana
  • Granja, Mónica
  • Camps-Herrero, Julia|||0000-0002-8061-6272
  • Recalde, Sabela
  • Nuñez-García, Beatriz
  • Calvo Verges, Nuria
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Pastor-Barriuso, Roberto
  • Lope, Virginia
Mammographic density (MD) is an established biomarker of breast cancer (BC) risk. However, its relationship to BC pathological subtypes remains unclear. This study aimed to investigate this association and assess whether it differs by body mass index (BMI) and menopausal status. MD percentage was assessed in the diagnostic mammograms of the contralateral breast of 714 BC patients recruited from eight Spanish hospitals. Participants completed an epidemiological questionnaire, and hospital researchers collected clinical and pathological data. Standardized prevalences (SPs) and standardized prevalence ratios (SPRs) for each BC pathological subtype across MD categories were estimated based on multinomial logistic regression models, both overall and stratified by BMI and menopausal status. Mean MD was 26.1% (SD = 17.3). Although no statistically significant differences were detected, women with MD ≥ 50% had a 13% lower SP of hormone receptor positive tumors (SPR = 0.87; 95% CI 0.67-1.13), a 36% higher SP of human epidermal growth factor receptor 2 positive (HER2+) tumors (SPR = 1.36; 95% CI 0.72-2.58), and a 23% higher SP of triple negative (TN) tumors (SPR = 1.23; 95% CI 0.47-3.22), compared to those with MD < 10%. These patterns were mainly observed in pre/perimenopausal women and in those with BMI ≥ 25 kg/m2. High MD might be mainly associated with the development of more aggressive and non-hormone-dependent cancers, such as HER2+ and TN BC, especially among pre/perimenopausal an overweight women.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Timing of previous heart failure hospitalization as a prognostic factor for emergency department heart failure patients

  • Romero, Carlos|||0009-0002-1803-6303
  • Alquézar-Arbé, A.|||0000-0003-4164-274X
  • Herrera, Sergio|||0000-0001-6134-0402
  • Llorens, Pere
  • Gil, Víctor
  • Curtelin, David
  • Jacob, Javier|||0000-0003-1101-1066
  • Herrero-Puente, Pablo|||0000-0002-5529-5008
  • María Pilar Lopez Díez
  • Llauger, Lluis
  • Luisa López Grima, M.
  • Gil, Cristina
  • Tost, Josep|||0000-0003-3846-9616
  • Agüera Urbano, Carmen
  • Espinosa, Begoña
  • Campos-Meneses, Maria
  • Fernandez, G
  • Torres, A.
  • Escoda, Rosa
  • Martín, Enrique
  • Garrido, Jose Manuel
  • Lucas-Imbernon, Francisco Javier
  • Rodríguez-Adrada, Esther
  • Torres Gárate, Raquel|||0000-0002-8731-9350
  • Andueza, Juan Antonio
  • Peacock, W. Frank
  • Miró, Oscar|||0000-0002-7924-9751
To investigate whether the timing of a previous hospital admission for acute heart failure (AHF) is a prognostic factor for AHF patients revisiting the emergency department (ED) in the subsequent 12-month follow-up. All ED AHF patients enrolled in the previously described EAHFE registry were stratified by the presence or absence of an AHF hospitalization admission in the prior 12 months. The primary outcome was 12-month all-cause mortality post ED visit. Secondary end points were hospital admission, prolonged hospitalization (> 7 days), mortality during hospitalization and a 90-day post-discharge adverse composite event (ACE) rate, defined as ED revisits due to AHF, hospitalizations due to AHF, or all-cause mortality. Outcomes were adjusted for baseline and AHF episode characteristics.Of 5,757 patients included, the median age was 84 years (IQR 77-88); 57% were women, and 3,759 (65.3%) had an AHF hospitalization in the previous 12 months. The 12-month mortality was 37% (41.7% vs. 28.3% p < 0.001), hospital admission was 76.1% (78.8% vs. 71.1% p < 0.001) ACE was 60.2% (65.1% vs. 50.5% p < 0.001). In the adjusted analysis, patients with AHF hospitalization in the prior 12 months had a higher mortality (HR = 1.41; 95% CI 1.27-1.56), 90-day ACE rate (HR = 1.45: 95% CI 1.32-1.59), and more hospital admissions (OR = 1.32; 95% CI 1.16-1.51), with shorter times since the previous hospitalization being related to the outcomes analyzed. One-year mortality, adverse events at 90 days, and readmission rates are increased in ED AHF patients previously admitted within the last 12 months.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Association between dietary niacin intake and diabetic retinopathy in a Catalonian population, a cross-sectional study

  • Torres-Méndez, Jeimy Katherine|||0000-0001-6299-8222
  • Rojo López, Marina Idalia|||0000-0001-6748-3156
  • Antentas Peraile, María|||0009-0005-8140-203X
  • Vendrell Tito, Pau|||0009-0003-2020-5126
  • Ortega, Emilio|||0000-0002-2217-8905
  • Alonso Pedrol, Núria|||0000-0001-9687-8050
  • Castelblanco, Esmeralda|||0000-0002-2061-6270
  • Muscarà, Andrea
  • Rubinat, Esther|||0000-0003-0232-9777
  • Alcubierre, Nuria|||0000-0001-6245-3599
  • Hernández García, Marta|||0000-0003-1237-298X
  • Rossell, Joana|||0000-0003-1500-6379
  • Granado-Casas, Minerva|||0000-0003-3447-5728
  • Mauricio, Didac|||0000-0002-2868-0250
  • Julve i Gil, Josep|||0000-0002-6531-2246
Background: Accumulating evidence suggests that niacin interventions may have a beneficial role in preventing ophthalmological microangiopathic remodeling. This study aimed to assess the impact of niacin intake on the presence of diabetic retinopathy (DR) in two independent Mediterranean cohorts of individuals with type 1 diabetes (T1D) and type 2 diabetes (T2D). Methods: Cross-sectional, population-based epidemiologic study. A total of 243 individuals with T1D, and 291 individuals with T2D. All participants underwent an eye examination. Dietary niacin intake was analyzed using a validated Spanish 101-items food frequency questionnaire consumption. The association between niacin intake and DR was assessed using a multivariate logistic regression, with potential non-linear associations further explored through restricted cubic spline regression. DR diagnostic was established via multifield stereoscopic retinal photography, in accordance with the international consensus on DR. Results: DR was identified in 103 out of 243 individuals with T1D and 144 out of 291 with T2D. Dietary niacin intake did not differ within the study groups according to DR status. Multivariate logistic regression models also revealed no association between dietary niacin intake and DR. As previously described, the duration of diabetes for T1D and T2D, [OR (95%CI), 1.02 (1.01-1.03), and 1.02 (1.02-1.03), respectively] and glycated hemoglobin (HbA1c) [OR (95%CI), 1.16 (1.09-1.24), and 1.14 (1.09-1.18), respectively] were identified as the main determinant variables for DR in both groups. Conclusions: We found that dietary niacin intake was not associated with the presence of RD in subjects with either T1D or T2D. Further research is needed to better understand the potential role of niacin in the development or prevention of DR.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Correction, Mammographic density and breast cancer pathological subtypes by menopausal status and body mass index

  • Fernández-Morata, Julia
  • Pollán, Marina|||0000-0002-4328-1565
  • Fernández de Larrea, Nerea
  • Pachón Olmos, Vanessa|||0000-0001-5139-9398
  • García-Pérez, Javier|||0000-0003-0300-1810
  • Castelló, Adela|||0000-0002-1308-9927
  • Sierra, María Ángeles
  • Lucas, Pilar
  • Llobet, Rafael
  • Stradella, Agostina|||0000-0002-2307-8869
  • Cantos, Blanca|||0000-0003-2105-1213
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Santisteban, Marta|||0000-0003-0625-686X
  • Seguí Palmer, Miguel Ángel|||0000-0002-5103-6746
  • Santaballa Bertrán, Ana
  • Granja, Mónica
  • Camps-Herrero, Julia|||0000-0002-8061-6272
  • Recalde, Sabela
  • Nuñez-García, Beatriz
  • Calvo Verges, Nuria
  • Pérez-Gómez, Beatriz|||0000-0002-4299-8214
  • Pastor-Barriuso, Roberto
  • Lope, Virginia
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Brain functional abnormality in drug naïve adolescents with borderline personality disorder during self- and other-reflection

  • Salgado-Pineda, Pilar|||0000-0001-7720-0885
  • Ferrer Massot, Marc|||0000-0003-0046-1301
  • Duque-Yemail, Juan|||0000-0002-1346-5996
  • Costa, Xavier|||0000-0002-8899-9079
  • Rué, Àlex|||0000-0002-3879-0170
  • Pérez-Rodríguez, Violeta|||0000-0002-2485-3054
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Fuentes-Claramonte, Paola|||0000-0002-1428-7976
  • Salvador, Raymond|||0000-0001-5557-1562
  • McKenna, Peter J.
  • Pomarol-Clotet, Edith|||0000-0002-8159-8563
  • Calvo, Natalia|||0000-0002-6888-3781
  • Veciana-Verdaguer, Cristina
A disturbed sense of identity is one of the major features of borderline personality disorder (BPD), which manifests early in the course of the disorder, and is potentially examinable using functional imaging during tasks involving self-reflection. Twenty-seven medication-naïve adolescent female patients with BPD, who had no psychiatric comorbidities, and 28 matched healthy female controls underwent fMRI while answering questions either about themselves or acquaintances. Control conditions consisted of answering questions involving factual knowledge and a low-level baseline (cross fixation). When self-reflection was compared to fact processing, BPD patients exhibited reduced activation in the right dorsolateral prefrontal cortex (DLPFC), as well as in the left parietal and calcarine cortex and the right precuneus. In contrast, other-reflection was associated with relatively lower activation in the medial frontal cortex in BPD patients, with further analysis revealing that this change reflected a failure of de-activation during the fact processing condition. There were no differences between the BPD patients and controls when self- and other-processing was examined against low-level baseline. This study provides evidence of reduced DLPFC activation during self-reflection in adolescent females with BPD, which may reflect diminished top-down cognitive control of this process, but not other-reflection in the disorder.
RIUMA. Repositorio Institucional de la Universidad de Málaga
Publication Artículo científico (JournalArticle)

Effectiveness of exercise-based interventions in reducing depressive symptoms in people without clinical depression: systematic review and meta-analysis of randomised controlled trials

  • Bellón-Saameño, Juan Ángel
  • Conejo-Cerón, Sonia
  • Sánchez-Calderón, Almudena
  • Rodríguez-Martín , Beatriz
  • Bellón, Dario
  • Rodríguez-Sánchez, Emiliano
  • Mendive, Juan Manuel
  • Ara, Ignacio
  • Moreno Peral, Patricia
Background In most trials and systematic reviews that evaluate exercise-based interventions in reducing depressive symptoms, it is difficult to separate treatment from prevention. Aims To evaluate the effectiveness of exercise-based interventions in reducing depressive symptoms in people without clinical depression. Method We searched PubMed, PsycINFO, Embase, WOS, SPORTDiscus, CENTRAL, OpenGrey and other sources up to 25 May 2020. We selected randomised controlled trials (RCTs) that compared exclusively exercise-based interventions with control groups, enrolling participants without clinical depression, as measured using validated instruments, and whose outcome was reduction of depressive symptoms and/or incidence of new cases of people with depression. Pooled standardised mean differences (SMDs) were calculated using random-effect models (registration at PROSPERO: CRD42017055726). Results A total of 14 RCTs (18 comparisons) evaluated 1737 adults without clinical depression from eight countries and four continents. The pooled SMD was −0.34 (95% CI −0.51 to −0.17; P < 0.001) and sensitivity analyses confirmed the robustness of this result. We found no statistical evidence of publication bias and heterogeneity was moderate (I2 = 54%; 95% CI 22–73%). Only two RCTs had an overall low risk of bias and three had long-term follow-up. Multivariate meta-regression found that a larger sample size, country (Asia) and selective prevention (i.e. people exposed to risk factors for depression) were associated with lower effectiveness, although only sample size remained significant when adjustment for multiple tests was considered. According to the Grading of Recommendations Assessment, Development and Evaluation tool, the quality of evidence was low. Conclusions Exercise-based interventions have a small effect on the reduction of depressive symptoms in people without clinical depression. It could be an alternative to or complement psychological programmes, although further higher-quality trials with larger samples and long-term follow-up are needed.
Repisalud
Publication Artículo científico (JournalArticle)

Multicohort Epigenome-Wide Association Study of All-Cause Cardiovascular Disease and Cancer Incidence: A Cardio-Oncology Approach

  • Domingo-Relloso, Arce
  • Riffo-Campos, Angela L
  • Zhao, Naisi
  • Ayala, Guillermo
  • Haack, Karin
  • Manterola, Carlos
  • Rhoades, Dorothy A
  • Umans, Jason G
  • Fallin, M Daniele
  • Herreros-Martinez, Miguel
  • Pollan-Santamaria, Marina
  • Boerwinkle, Eric
  • Platz, Elizabeth A
  • Jones, Miranda R
  • Bressler, Jan
  • Joehanes, Roby
  • Ryan, Calen P
  • Gonzalez, Juan R
  • Levy, Daniel
  • Belsky, Daniel W
  • Cole, Shelley A
  • Michaud, Dominique S
  • Tellez-Plaza, Maria
  • Navas-Acien, Ana
Background: Emerging evidence reveals a complex relationship between cardiovascular disease (CVD) and cancer, which share common risk factors and biological pathways. Objectives: The aim of this study was to evaluate common epigenetic signatures for CVD and cancer incidence in 3 ethnically diverse cohorts: Native Americans from the SHS (Strong Heart Study), European Americans from the FHS (Framingham Heart Study), and European Americans and African Americans from the ARIC (Atherosclerosis Risk In Communities) study. Methods: A 2-stage strategy was used that included first conducting untargeted epigenome-wide association studies for each cohort and then running targeted models in the union set of identified differentially methylated positions (DMPs). We also explored potential molecular pathways by conducting a bioinformatics analysis. Results: Common DMPs were identified across all populations. In a subsequent meta-analysis, 3 and 1 of those DMPs were statistically significant for CVD only and both cancer and CVD, respectively. No meta-analyzed DMPs were statistically significant for cancer only. The enrichment analysis pointed to interconnected biological pathways involved in cancer and CVD. In the DrugBank database, elements related to 1-carbon metabolism and cancer and CVD medications were identified as potential drugs for target gene products. In an additional analysis restricted to the 950 SHS participants who developed incident CVD, the C index for incident cancer increased from 0.618 (95% CI: 0.570-0.672) to 0.971 (95% CI: 0.963-0.978) when adjusting the models for the combined cancer and CVD DMPs identified in the other cohorts. Conclusions: These results point to molecular pathways and potential treatments for precision prevention of CVD and cancer. Screening based on common epigenetic signatures of incident CVD and cancer may help identify patients with newly diagnosed CVD at increased cancer risk.
Repisalud
Publication Artículo científico (JournalArticle)

Burden of postmenopausal breast cancer attributable to excess body weight: comparative study of body mass index and CUN-BAE in MCC-Spain study

  • Cubelos-Fernández, Naiara
  • Dávila-Batista, Verónica
  • Fernández-Villa, Tania
  • Castaño-Vinyals, Gemma
  • Perez-Gomez, Beatriz
  • Amiano, Pilar
  • Ardanaz, Eva
  • Delgado Sillero, Irene
  • Llorca, Javier
  • Tardón, Guillermo Fernández
  • Alguacil, Juan
  • Vanaclocha-Espi, Mercedes
  • Marcos-Gragera, Rafael
  • Moreno, Victor
  • Aragones, Nuria
  • Dorronsoro, Ane
  • Guevara, Marcela
  • Reguero Celada, Sofía
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Martín, Vicente
Background: 10% of postmenopausal breast cancer cases are attributed to a high body mass index (BMI). BMI underestimates body fat, particularly in older women, and therefore the cancer burden attributable to obesity may be even higher. However, this is not clear. CUN-BAE (Clínica Universidad de Navarra-Body Adiposity Estimator) is an accurate validated estimator of body fat, taking into account sex and age. The objective of this study was to compare the burden of postmenopausal breast cancer attributable to excess body fat calculated using BMI and CUN-BAE. Methods: This case-control study included 1033 cases of breast cancer and 1143 postmenopausal population controls from the multicase-control MCC-Spain study. Logistic regression models were used to calculate odds ratios (ORs). The population attributable fraction (PAF) of excess weight related to breast cancer was estimated with both anthropometric measures. Stratified analyses were carried out for hormone receptor type. Results: Excess body weight attributable to the risk of breast cancer was 23.0% when assessed using a BMI value ≥30 kg/m2 and 38.0% when assessed using a CUN-BAE value of ≥40% body fat. Hormone receptor stratification showed that these differences in PAFs were only observed in hormone receptor positive cases, with an estimated burden of 19.9% for BMI and 41.9% for CUN-BAE. Conclusion: These findings suggest that the significance of excess body fat in postmenopausal hormone receptor positive breast cancer could be underestimated when assessed using only BMI. Accurate estimation of the cancer burden attributable to obesity is crucial for planning effective prevention initiatives.
Repisalud
Publication Artículo científico (JournalArticle)

Gain-of-function mutations in DNMT3A in patients with paraganglioma.

  • Remacha, Laura
  • Currás-Freixes, Maria
  • Torres-Ruiz, Raúl
  • Schiavi, Francesca
  • Torres-Pérez, Rafael
  • Calsina, Bruna
  • Letón, Rocío
  • Comino-Méndez, Iñaki
  • Roldán-Romero, Juan M
  • Montero-Conde, Cristina
  • Santos, María
  • Pérez, Lucía Inglada
  • Pita, Guillermo
  • Alonso, María R
  • Honrado, Emiliano
  • Pedrinaci, Susana
  • Crespo-Facorro, Benedicto
  • Percesepe, Antonio
  • Falcioni, Maurizio
  • Rodríguez-Perales, Sandra
  • Korpershoek, Esther
  • Ramón-Maiques, Santiago
  • Opocher, Giuseppe
  • Rodríguez-Antona, Cristina
  • Robledo Batanero, Mercedes
  • Cascon Soriano, Alberto
The high percentage of patients carrying germline mutations makes pheochromocytomas/paragangliomas the most heritable of all tumors. However, there are still cases unexplained by mutations in the known genes. We aimed to identify the genetic cause of disease in patients strongly suspected of having hereditary tumors.
Repisalud
Publication Artículo científico (JournalArticle)

Health-Related Quality of Life in Long-Term Colorectal Cancer Survivors

  • Marcos-Delgado, Alba
  • Martín-Sánchez, Vicente
  • Molina-Barceló, Ana
  • Alonso-Molero, Jéssica
  • Perez-Gomez, Beatriz
  • Pollán, Marina
  • Aragones, Nuria
  • Ederra-Sanz, María
  • Fernández-Tardón, Guillermo
  • Binefa, Gemma
  • Moreno, Victor
  • Barrios-Rodríguez, Rocío
  • Amiano, Pilar
  • Huerta, José María
  • Teso, Enrique Pastor
  • Alguacil, Juan
  • Castaño-Vinyals, Gemma
  • Kogevinas, Manolis
  • Molina de la Torre, Antonio José
The aim of our study is to evaluate the relationship between sociodemographic and clinical characteristics of individuals with Colorectal Cancer (CRC), tumour-intrinsic characteristics and treatment received with health-related quality of life (HRQoL). Methods: Cross-sectional analysis of data from 805 survivors from the MCC study was conducted. HRQoL was assessed through a general and specific questionnaire, SF-12 and FCSI (Colorectal Symptom Index). Statistical analyses were performed with linear regression with adjustment for sociodemographic variables, stage at diagnosis and histological grade. Results: Participants had survived a median of 7.9 years from diagnosis (IQR 7.1-8.5 years). Age at diagnosis, sex and area showed a clear association with HRQoL in both physical and mental dimensions of the SF-12 questionnaire. A direct association between CRC recurrence was also found in the PCS-12 and MCS-12 dimensions and radical surgery in the PCS-12. Regarding the scores in FCSI questionnaire, statistically significant differences were observed by sex, age and area, with older women being the most impaired (p < 0.001). Conclusions: Age, sex and area was associated with lower scores of HRQoL among CRC survivors. Knowing the determinants related to HRQoL would allow us to lay the groundwork to develop strategies that help reduce morbidity and mortality, relapses and increase HRQoL.
Repisalud
Publication Artículo científico (JournalArticle)

Risk of prostate cancer in the proximity of industrial installations: A multicase-control study in Spain (MCC-Spain).

  • García-Pérez, Javier
  • Fernandez de Larrea-Baz, Nerea
  • Lope Carvajal, Virginia
  • Domínguez-Castillo, Alejandro
  • Espinosa, Ana
  • Dierssen-Sotos, Trinidad
  • Contreras-Llanes, Manuel
  • Sierra, Maria Angeles
  • Castaño-Vinyals, Gemma
  • Tardón, Adonina
  • Jiménez-Moleón, José J
  • Molina-Barceló, Ana
  • Aragonés, Nuria
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Perez-Gomez, Beatriz
Background: Prostate cancer (PC) is the second most frequent tumor in men worldwide; however, its etiology remains largely unknown, with the exception of age and family history. The wide variability in incidence/mortality across countries suggests a certain role for environmental exposures that has not yet been clarified. Objective: To evaluate the association between risk of PC (by clinical profile) and residential proximity to pollutant industrial installations (by industrial groups, groups of carcinogens, and specific pollutants released), within the context of a Spanish population-based multicase-control study of incident cancer (MCC-Spain). Methods: This study included 1186 controls and 234 PC cases, frequency matched by age and province of residence. Distances from participants' residences to the 58 industries located in the study area were calculated and categorized into "near" (considering different limits between ≤1 km and ≤ 3 km) or "far" (>3 km). Odds ratios (ORs) and 95 % confidence intervals (95%CIs) were estimated using mixed and multinomial logistic regression models, adjusted for potential confounders and matching variables. Results: No excess risk was detected near the overall industries, with ORs ranging from 0.66 (≤2 km) to 1.11 (≤1 km). However, positive associations (OR; 95%CI) were found, by industrial group, near (≤3 km) industries of ceramic (2.54; 1.28-5.07), food/beverage (2.18; 1.32-3.62), and disposal/recycling of animal waste (2.67; 1.12-6.37); and, by specific pollutant, near plants releasing fluorine (4.65; 1.45-14.91 at ≤1.5 km) and chlorine (5.21; 1.56-17.35 at ≤1 km). In contrast, inverse associations were detected near industries releasing ammonia, methane, dioxins+furans, polycyclic aromatic hydrocarbons, trichloroethylene, and vanadium to air. Conclusions: The results suggest no association between risk of PC and proximity to the overall industrial installations. However, some both positive and inverse associations were detected near certain industrial groups and industries emitting specific pollutants.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Lectin-gated and glycan functionalized mesoporous silica nanocontainers for targeting cancer cells overexpressing Lewis X antigen

  • Bhat, Ravishankar
  • García, I.
  • Arnáiz, B.
  • Liz-Marzán, L.M.
  • Penadés, S.
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Gated mesoporous silica nanoparticles can deliver payload upon the application of a predefined stimulus, and therefore are promising drug delivery systems. Despite their important role, relatively low emphasis has been placed on the design of gating systems that actively target carbohydrate tumor cell membrane receptors. We describe herein a new Lewis X (Le(x)) antigen-targeted delivery system comprising mesoporous silica nanoparticles (MSNs) loaded with ATTO 430LS dye, functionalized with a Le(x) derivative (1) and capped with a fucose-specific carbohydrate-binding protein (Aleuria aurantia lectin (AAL)). This design takes advantage of the affinity of AAL for Le(x) overexpressed receptors in certain cancer cells. In the proximity of the cells, AAL is detached from MSNs to bind Le(x), and selectins in the cells bind Le(x) in the gated MSNs, thereby inducing cargo delivery. Gated MSNs are nontoxic to colon cancer DLD-1 cells, and ATTO 430LS dye delivered correlated with the amount of Le(x) antigen overexpressed at the DLD-1 cell surface. This is one of the few examples of MSNs using biologically relevant glycans for both capping (via interaction with AAL) and targeting (via interaction with overexpressed Le(x) at the cell membrane)., The authors thank the Spanish Government (Projects MAT2015-64139-C4-1-R and MAT2013-46101-R (MINECO/ FEDER)), Fondo de Investigacion Sanitaria (PI15/00480) and Generalitat Valenciana (Project PROMETEOII/2014/047 and project GVA/2014/13) for support. R. B. is thankful to Svagata. Eu (Erasmus Mundus Action-II program) for his fellowship. The authors also thank the Electron Microscopy Service at the UPV for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Residential proximity to industrial pollution and mammographic density

  • Jiménez, Tamara
  • Pollán, Marina
  • Domínguez-Castillo, Alejandro
  • Lucas, Pilar
  • Sierra, María Ángeles
  • Fernández de Larrea-Baz, Nerea
  • González-Sánchez, Mario
  • Salas-Trejo, Dolores
  • Martinez, Inmaculada
  • Pino, María Nieves
  • Martínez-Cortés, Mercedes
  • Pérez-Gómez, Beatriz
  • Lope, Virginia
  • García-Pérez, Javier
  • Llobet Azpitarte, Rafael|||0000-0002-8278-9740
[EN] Background: Mammographic density (MD), expressed as percentage of fibroglandular breast tissue, is an important risk factor for breast cancer. Our objective is to investigate the relationship between MD and residential proximity to pol-lutant industries in premenopausal Spanish women. MeOds: A cross-sectional study was carried out in a sample of 1225 women extracted from the DDM-Madrid study. Multiple linear regression models were used to assess the association of MD percentage (and their 95% confidence in-tervals (95%CIs)) and proximity (between 1 km and 3 km) to industries included in the European Pollutant Release and Transfer Register. Results: Although no association was found between MD and distance to all industries as a whole, several industrial sectors showed significant association for some distances: "surface treatment of metals and plastic" (j3 = 4.98, 95%CI = (0.85; 9.12) at <_1.5 km, and j3 = 3.00, 95%CI = (0.26; 5.73) at <_2.5 km), "organic chemical industry" (j3 = 6.73, 95%CI = (0.50; 12.97) at <_1.5 km), "pharmaceutical products" (j3 = 4.14, 95%CI = (0.58; 7.70) at <_2 km; j3 = 3.55, 95%CI = (0.49; 6.60) at <_2.5 km; and j3 = 3.11, 95%CI = (0.20; 6.01) at <_3 km), and "urban waste-water treatment plants" (j3 = 8.06, 95%CI = (0.82; 15.30) at <_1 km; j3 = 5.28; 95%CI = (0.49; 10.06) at <_1.5 km; j3 = 4.30, 95%CI = (0.03; 8.57) at <_2 km; j3 = 5.26, 95%CI = (1.83; 8.68) at <_2.5 km; and j3 = 3.19, 95%CI = (0.46; 5.92) at <_3 km). Moreover, significant increased MD was observed in women close to industries releasing specific pollutants: ammonia (j3 = 4.55, 95%CI = (0.26; 8.83) at <_1.5 km; and j3 = 3.81, 95%CI = (0.49; 7.14) at <_2 km), dichloromethane (j3 = 3.86, 95%CI = (0.00; 7.71) at <_2 km), ethylbenzene (j3 = 8.96, 95%CI = (0.57; 17.35) at <_3 km), and phenols (j3 = 2.60, 95%CI = (0.21; 5.00) at <_2.5 km). Conclusions: Our results suggest no statistically significant relationship between MD and proximity to industries as a whole, although we detected associations with various industrial sectors and some specific pollutants, which suggests that MD could have a mediating role in breast carcinogenesis., We would like to thank the participants in the DDM-Madrid study for their contribution to breast cancer research. This work was supported by the Carlos III Institute of Health (AESI PI15CIII/0029, AESI PI15CIII/00013, and EPY-505/19-PFIS) . The article presents independent research. The views expressed are those of the authors and not necessarily those of the Carlos III Institute of Health.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Functional Signatures in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Sex-Based Differences in Transcriptomic Studies

  • Pérez-Díez, Irene
  • Hidalgo, Marta R.
  • Malmierca-Merlo, Pablo
  • Andreu, Zoraida
  • Romera-Giner, Sergio
  • Farràs, Rosa
  • Provencio, Mariano
  • Romero, Atocha
  • García-García, Francisco
  • DE LA IGLESIA VAYÁ, MARIA DE LOS DESAMPARADOS
[EN] While studies have established the existence of differences in the epidemiological and clinical patterns of lung adenocarcinoma between male and female patients, we know relatively little regarding the molecular mechanisms underlying such sex-based differences. In this study, we explore said differences through a meta-analysis of transcriptomic data. We performed a meta-analysis of the functional profiling of nine public datasets that included 1366 samples from Gene Expression Omnibus and The Cancer Genome Atlas databases. Meta-analysis results from data merged, normalized, and corrected for batch effect show an enrichment for Gene Ontology terms and Kyoto Encyclopedia of Genes and Genomes pathways related to the immune response, nucleic acid metabolism, and purinergic signaling. We discovered the overrepresentation of terms associated with the immune response, particularly with the acute inflammatory response, and purinergic signaling in female lung adenocarcinoma patients, which could influence reported clinical differences. Further evaluations of the identified differential biological processes and pathways could lead to the discovery of new biomarkers and therapeutic targets. Our findings also emphasize the relevance of sex-specific analyses in biomedicine, which represents a crucial aspect influencing biological variability in disease., This work was supported by Fondo de Investigación Sanitaria (ISCIII PI15-00209), GV/2020/186, and ISCIII PT17/0009/0015 FEDER.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Photomutagenicity of chlorpromazine and its N-demethylated metabolites assessed by NGS

  • Agúndez, Jose A.G.
  • García-Martín, Elena
  • Garcia-Lainez, Guillermo
  • Miranda Alonso, Miguel Ángel
  • Andreu, Inmaculada|||0000-0003-3409-9443
[EN] The human genome is constantly attacked by endogenous and exogenous agents (ultraviolet light, xenobiotics, reactive oxygen species), which can induce chemical transformations leading to DNA lesions. To combat DNA damage, cells have developed several repair mechanisms; however, if the repair is defective, DNA lesions lead to permanent mutations. Single-cell gel electrophoresis (COMET assay) is a sensitive and well-established technique for quantifying DNA damage in individual cells. Nevertheless, this tool lacks relationship with mutagenesis. Therefore, to identify errors that give rise to mutations it would be convenient to test an alternative known procedure, such as next generation sequencing (NGS). Thus, the present work aims to evaluate the photomutagenicity of neuroleptic drug chlorpromazine (CPZ), and its N-demethylated metabolites using COMET assay and to test NGS as an alternative method to assess photomutagenesis. In this context, upon exposure to UVA radiation, COMET assay reveals CPZ-photosensitized DNA damage partially repaired by cells. Conversely with this result, metabolites demethylchlorpromazine (DMCPZ) and didemethylchlorpromazine (DDMCPZ) promote extensive DNA-photodamage, hardly repaired under the same conditions. Parallel assessment of mutagenesis by NGS is consistent with these results with minor discrepancies for DDMCPZ. To our knowledge, this is the first example demonstrating the utility of NGS for evaluating drug-induced photomutagenicity., This study was funded by the Carlos III Institute (ISCIII) of Health (Grants: PI15/00303, PI18/00540, PI16/01877, CPII16/00052, the Thematic Networks and Co-operative Research Centres: ARADyAL RD16/0006/0004 and RD16/0006/0030), IB16170, GR18145 from Junta de Extremadura, Spain, co-funded by European Regional Development Fund and Generalitat Valenciana Prometeo/2017/075. We would also like to thank M. Dolores Coloma for technical assistance in the preliminary experiments.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

NUTRARET: Effect of 2-Year Nutraceutical Supplementation on Redox Status and Visual Function of Patients With Retinitis Pigmentosa: A Randomized, Double-Blind, Placebo-Controlled Trial

  • Olivares-González, Lorena
  • Salom, David
  • González-García, Emilio
  • Mejía-Chiqui, Natalia
  • Melero, Mar
  • Velasco, Sheyla
  • Muresan, Bianca Tabita
  • Campillo, Isabel
  • Vila-Clérigues, Nieves
  • Lopez-Briz, Eduardo
  • Merino-Torres, Juan Francisco
  • Millán, José María
  • Soriano del Castillo, José Miguel
  • Rodrigo, Regina
  • Hervás-Marín, David|||0000-0003-0635-4961
[EN] Oxidative stress plays a major role in the pathogenesis of retinitis pigmentosa (RP). The main goal of this study was to evaluate the effect of 2-year nutritional intervention with antioxidant nutraceuticals on the visual function of RP patients. Secondly, we assessed how nutritional intervention affected ocular and systemic redox status. We carried out a randomized, double-blind, placebo-controlled study. Thirty-one patients with RP participated in the study. RP patients randomly received either a mixture of nutraceuticals (NUT) containing folic acid, vitamin B6, vitamin A, zinc, copper, selenium, lutein, and zeaxanthin or placebo daily for 2 years. At baseline and after 2-year of the nutritional supplementation, visual function, dietetic-nutritional evaluations, serum concentration of nutraceuticals, plasma and aqueous humor concentration of several markers of redox status and inflammation were assessed. Retinal function and structure were assessed by multifocal electroretinogram (mfERG), spectral domain-optical coherence tomography (SD-OCT) and automated visual field (VF) tests. Nutritional status was estimated with validated questionnaires. Total antioxidant capacity, extracellular superoxide dismutase (SOD3), catalase (CAT), and glutathione peroxidase (GPx) activities, protein carbonyl adducts (CAR) content, thiobarbituric acid reactive substances (TBARS) formation (as indicator of lipid peroxidation), metabolites of the nitric oxide (NOX) and cytokine (interleukin 6 and tumor necrosis factor alpha) concentrations were assessed by biochemical and immunological techniques in aqueous humor or/and blood. Bayesian approach was performed to determine the probability of an effect. Region of practical equivalence (ROPE) was used. At baseline, Bayesian analysis revealed a high probability of an altered ocular redox status and to a lesser extent systemic redox status in RP patients compared to controls. Twenty-five patients (10 in the treated arm and 15 in the placebo arm) completed the nutritional intervention. After 2 years of supplementation, patients who received NUT presented better retinal responses (mfERG responses) compared to patients who received placebo. Besides, patients who received NUT showed better ocular antioxidant response (SOD3 activity) and lower oxidative damage (CAR) than those who received placebo. This study suggested that long-term NUT supplementation could slow down visual impairment and ameliorate ocular oxidative stress., This work was supported by the Spanish Ministry of Economy, Industry, and Competitiveness (MINECO) Carlos III Health Institute (ISCIII) (Grant numbers: PI15/00052 and PI18/00252) and co-funded by the European Regional Development Fund (FEDER)/European Social Fund ¿A way to make Europe¿/¿Investing in your future.¿ It was also supported by the IIS La Fe-UV PROGRAMA VLC-BIOMED-I (NUTRARET) and by RETINA COMUNIDAD VALENCIANA. LO-G had an ISCIII CIBERER research contract CB06/07/1030; RR had an ISCIII Spanish National Health System (SNS) Miguel Servet Type II research contract (code: CP15/00019).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Mutant PRPF8 Causes Widespread Splicing Changes in Spliceosome Components in Retinitis Pigmentosa Patient iPSC-Derived RPE Cells

  • Arzalluz-Luque, Ángeles
  • Cabrera, Jose Luis
  • Skottman, Heli
  • Benguria, Alberto
  • Bolinches-Amorós, Arantxa
  • Cuenca, Nicolás
  • Lupo, Vincenzo
  • Dopazo, Ana
  • Delás, Bárbara
  • Carballo, Miguel
  • Pascual, Beatriz
  • Hernán, Imma
  • Erceg, Slaven
  • Lukovic, Dunja
  • Tarazona, Sonia|||0000-0001-5346-1407
[EN] Retinitis pigmentosa (RP) is a rare, progressive disease that affects photoreceptors and retinal pigment epithelial (RPE) cells with blindness as a final outcome. Despite high medical and social impact, there is currently no therapeutic options to slow down the progression of or cure the disease. The development of effective therapies was largely hindered by high genetic heterogeneity, inaccessible disease tissue, and unfaithful model organisms. The fact that components of ubiquitously expressed splicing factors lead to the retina-specific disease is an additional intriguing question. Herein, we sought to correlate the retinal cell-type-specific disease phenotype with the splicing profile shown by a patient with autosomal recessive RP, caused by a mutation in pre-mRNA splicing factor 8 (PRPF8). In order to get insight into the role of PRPF8 in homeostasis and disease, we capitalize on the ability to generate patient-specific RPE cells and reveal differentially expressed genes unique to RPE cells. We found that spliceosomal complex and ribosomal functions are crucial in determining cell-type specificity through differential expression and alternative splicing (AS) and that PRPF8 mutation causes global changes in splice site selection and exon inclusion that particularly affect genes involved in these cellular functions. This finding corroborates the hypothesis that retinal tissue identity is conferred by a specific splicing program and identifies retinal AS events as a framework toward the design of novel therapeutic opportunities., This work was supported by Institute of Health Carlos III/ERDF (European Regional Development Fund), Spain [PI16/00409 (DL), PI20/01119 (DL), CP18/00033 (DL), PI15/00227 (MC), CPII16/00037 (SE), and PI18-00286 (SE)], Platform for Proteomics, Genotyping and Cell Lines; PRB3 of ISCIII (PT17/0019/0024); National Science Foundation GACR 18-04393S and the project "Centre of Reconstructive Neuroscience", registration number CZ.02.1.01/0.0./0.0/15_003/0000419PI15/00227; Spanish Ministry of Economy and Competitiveness grant BES-2016-076994 (AA-L); and Academy of Finland (HS).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Effects of the inhibition of late sodium current by GS967 on stretch-induced changes in cardiac electrophysiology

  • Canto Serrano, Irene Del
  • Santamaría, L.
  • Genovés, P.
  • Such-Miquel, Luis
  • Arias-Mutis, Óscar Julián
  • Zarzoso Muñoz, Manuel
  • Soler, C.
  • Parra-Giraldo, G.
  • Alberola, Antonio
  • Such Belenguer, Luis
  • Chorro, F.J.
  • Tormos Ferrando, Álvaro|||0000-0002-3280-376X
[EN] PurposeMechanical stretch increases sodium and calcium entry into myocytes and activates the late sodium current. GS967, a triazolopyridine derivative, is a sodium channel blocker with preferential effects on the late sodium current. The present study evaluates whether GS967 inhibits or modulates the arrhythmogenic electrophysiological effects of myocardial stretch.MethodsAtrial and ventricular refractoriness and ventricular fibrillation modifications induced by acute stretch were studied in Langendorff-perfused rabbit hearts (n=28) using epicardial multiple electrodes and high-resolution mapping techniques under control conditions and during the perfusion of GS967 at different concentrations (0.03, 0.1, and 0.3M).ResultsOn comparing ventricular refractoriness, conduction velocity and wavelength obtained before stretch had no significant changes under each GS967 concentration while atrial refractoriness increased under GS967 0.3M. Under GS967, the stretch-induced changes were attenuated, and no significant differences were observed between before and during stretch. GS967 0.3M diminished the normal stretch-induced changes resulting in longer (less shortened) atrial refractoriness (13826ms vs 95 +/- 9ms; p<0.01), ventricular refractoriness (155 +/- 18ms vs 124 +/- 16 ms; p<0.01) and increments in spectral concentration (23 +/- 5% vs 17 +/- 2%; p<0.01), the fifth percentile of ventricular activation intervals (46 +/- 8ms vs 31 +/- 3ms; p<0.05), and wavelength of ventricular fibrillation (2.5 +/- 0.5cm vs 1.7 +/- 0.3cm; p<0.05) during stretch. The stretch-induced increments in dominant frequency during ventricular fibrillation (control=38%, 0.03M=33%, 0.1M=33%, 0.3M=14%; p<0.01) and the stretch-induced increments in arrhythmia complexity index (control=62%, 0.03M=41%, 0.1M=32%, 0.3M=16%; p<0.05) progressively decreased on increasing the GS967 concentration.Conclusions GS967 attenuates stretch-induced changes in cardiac electrophysiology., This work was supported by the Spanish Ministry of Economy and Competiveness (Carlos III Health Institute)/European Regional Development Fund (FEDER) (Grants FIS PI12/00407, PI15/01408, PIE15/00013, CB16/11/00486) and by the Generalitat Valenciana (Grant PROMETEO FASE II 2014/037).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Effects of S-Nitrosoglutathione on Electrophysiological Manifestations of Mechanoelectric Feedback

  • Such-Miquel, Luis
  • Canto Serrano, Irene Del
  • Zarzoso Muñoz, Manuel
  • Brines-Ferrando, L.
  • Soler, C.
  • Parra-Giraldo, G.
  • Alberola, Antonio
  • Such Belenguer, Luis
  • Chorro, F.J.
  • Guill Ibáñez, Antonio|||0000-0001-8546-264X
[EN] Electromechanical coupling studies have described the intervention of nitric oxide and S-nitrosylation processes in Ca2+ release induced by stretch, with heterogeneous findings. On the other hand, ion channel function activated by stretch is influenced by nitric oxide, and concentration-dependent biphasic effects upon several cellular functions have been described. The present study uses isolated and perfused rabbit hearts to investigate the changes in mechanoelectric feedback produced by two different concentrations of the nitric oxide carrier S-nitrosoglutathione. Epicardial multielectrodes were used to record myocardial activation at baseline and during and after left ventricular free wall stretch using an intraventricular device. Three experimental series were studied: (a) control (n=10); (b) S-nitrosoglutathione 10 mu M (n=11); and (c) S-nitrosoglutathione 50 mu M (n=11). The changes in ventricular fibrillation (VF) pattern induced by stretch were analyzed and compared. S-nitrosoglutathione 10 mu M did not modify VF at baseline, but attenuated acceleration of the arrhythmia (15.6 +/- 1.7 vs. 21.3 +/- 3.8Hz; p<0.0001) and reduction of percentile 5 of the activation intervals (42 +/- 3 vs. 38 +/- 4ms; p<0.05) induced by stretch. In contrast, at baseline using the 50 mu M concentration, percentile 5 was shortened (38 +/- 6 vs. 52 +/- 10ms; p<0.005) and the complexity index increased (1.77 +/- 0.18 vs. 1.27 +/- 0.13; p<0.0001). The greatest complexity indices (1.84 +/- 0.17; p<0.05) were obtained during stretch in this series. S-nitrosoglutathione 10 mu M attenuates the effects of mechanoelectric feedback, while at a concentration of 50 mu M the drug alters the baseline VF pattern and accentuates the increase in complexity of the arrhythmia induced by myocardial stretch., Carlos III Health Institute/FEDER funds (Spanish Ministry of Economy and Competitiveness): Grants FIS PI12/00407, PI15/01408, PIE15/00013, and RETIC “RIC” RD12/0042/0048. Generalitat Valenciana: Grant PROMETEO FASE II 2014/037.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Arsenic exposure and human blood DNA methylation and hydroxymethylation profiles in two diverse populations from Bangladesh and Spain

  • Domingo-Relloso, Arce
  • Bozack, Anne
  • Kiihl, Samara
  • Rodriguez-Hernandez, Zulema
  • Rentero-Garrido, Pilar
  • Casasnovas, J. Antonio
  • Leon-Latre, Montserrat
  • Garcia-Barrera, Tamara
  • Gomez-Ariza, J. Luis
  • Moreno, Belen
  • Cenarro, Ana
  • De Marco, Griselda
  • Parvez, Faruque
  • Siddique, Abu B.
  • Shahriar, Hasan
  • Uddin, Mohammad N.
  • Islam, Tariqul
  • Navas-Acien, Ana
  • Gamble, Mary
  • Tellez-Plaza, Maria
This work was supported by the Strategic Action for Research in Health sciences (PI15/00071) and CIBERCV, which are initiatives from Instituto de Salud Carlos III and the Spanish Ministry of Science and Innovation and co-funded with European Funds for Regional Development (FEDER) , and the United States National Institute of Health (grants R01 CA133595, P30 ES009089, T32 ES007322, P42 ES010349, and F31 ES029019) . MTP was supported by the Third AstraZeneca Award for Spanish Young Researchers. ADR received the support of a fellowship from "la Caixa" Foundation (ID 100010434, fellowship code "LCF/BQ/DR19/11740016") .
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer

  • García-Foncillas, J.
  • Tabernero, J.
  • Ëlez, E.
  • Aranda, E.
  • Benavides, M.
  • Camps-Herrrero, Carlos
  • Lopez, R.
  • Muinelo-Romay, L.
  • Montagut, C.
  • Antón, A.
  • Lopez, G.
  • Diaz-Rubio, E.
  • Rojo, F.
  • Vivancos, A.
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
[EN] BACKGROUND: Liquid biopsy offers a minimally invasive alternative to tissue-based evaluation of mutational status in cancer. The goal of the present study was to evaluate the aggregate performance of OncoBEAM RAS mutation analysis in plasma of colorectal cancer (CRC) patients at 10 hospital laboratories in Spain where this technology is routinely implemented. METHODS: Circulating cell-free DNA from plasma was examined for RAS mutations using the OncoBEAM platform at each hospital laboratory. Results were then compared to those obtained from DNA extracted from tumour tissue from the same patient. RESULTS: The overall percentage agreement between plasma-based and tissue-based RAS mutation testing of the 236 participants was 89% (210/236; kappa, 0.770 (95% CI: 0.689-0.852)). Re-analysis of tissue from all discordant cases by BEAMing revealed two false negative and five false positive tumour tissue RAS results, with a final concordance of 92%. Plasma false negative results were found more frequently in patients with exclusive lung metastatic disease. CONCLUSIONS: In this first prospective real-world RAS mutation performance comparison study, a high overall agreement was observed between results obtained from plasma and tissue samples. Overall, these findings indicate that the plasma-based BEAMing assay is a viable solution for rapid delivery of RAS mutation status to determine mCRC patient eligibility for anti-EGFR therapy., This work was supported by Sysmex Inostics, Inc as well as the AES Programme [Grant Numbers PI15/00934, PT17/0015/0006]. The funders had no involvement in the writing of this manuscript but did review for medical accuracy prior to submission.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Tesis doctoral (DoctoralThesis)

Characterization of Tumor Cells and Immune Microenvironment Interactions in Non Small Cell Lung Cancer. Translational implications

  • Torres Martínez, Susana
[ES] En esta tesis, buscamos profundizar en el estudio del microambiente inmunitario del tumor (TME), lo que resultaría en una mejor caracterización del contexto inmunológico de los pacientes y la búsqueda de nuevos biomarcadores en el cáncer de pulmón. Se emplearon cultivos derivados de pacientes con cáncer de pulmón, y líneas celulares comerciales para ensayos de formación de tumoresferas y condiciones adherentes como control. Se analizó la expresión génica de diversos factores inmunorreguladores, observándose una mayor expresión de la mayoría de ellos en las tumoresferas en comparación con las células adherentes. Junto con la secreción, la Galectina-3 (GAL3 o LGALS3 cuando se referencian la proteína o el gen, respectivamente) se seleccionó como la molécula que podría tener una fuerte implicación en la modulación del TME. Los análisis proteicos confirmaron que la GAL3 aumentaba en las tumoresferas de cultivos de adenocarcinoma (ADC) y mostraba patrones de localización y expresión diferencial. Las vesículas extracelulares procedentes de tumoresferas exhibieron niveles altos de LGALS3. Además, revelamos que la GAL3 podría desempeñar un papel crucial como molécula inmunomoduladora en el TME, modulando la inmunosupresión a través de las células T reguladoras (TREGS). Esto se confirmó en muestras tumorales de pacientes, dónde los niveles de expresión altos de LGALS3, se correlacionaron con mayores niveles de TREGS, sugiriendo que los tumores pueden reclutar esta población a través de la GAL3. Posteriormente, se evaluaron los roles pronósticos y diagnósticos de la GAL3 soluble (sGAL3) y otros factores inmunorreguladores (sICOSL, sFGL1, sGAL1, sMICA, sMICB, sCD276) en una cohorte de 94 pacientes con cáncer de pulmón en estadios tempranos resecables (cohorte test). sFGL1, sGAL3 y su combinación mostraron una eficacia diagnóstica óptima para nuestros pacientes. El análisis de supervivencia demostró que, en la sub-cohorte de ADC, los pacientes con niveles altos de sGAL3 experimentaron una supervivencia libre de recaída (SLR) (p=0,048) y una supervivencia global (SG) más corta (p=0,021), mientras que no se observó ninguna asociación en la sub-cohorte de pacientes con carcinoma de células escamosas. El análisis multivariante indicó que sGAL3 podría ser un biomarcador pronóstico independiente para SLR y SG. La expresión génica de nuestro panel de factores inmunoreguladores también se analizó en un grupo independiente de 661 pacientes de TCGA (cohorte de validación), confirmando el valor pronóstico independiente de LGALS3 en la sub-cohorte de ADC para SLR (p=0,021) y SG (p=0,004). El papel diagnóstico, predictivo y pronóstico de estos factores se evaluó en muestras de plasma en el momento basal (PRE) y en la evaluación de la primera respuesta (FR) en una cohorte de 52 pacientes con cáncer de pulmón en estadio avanzado tratados en primera línea con pembrolizumab. sFGL1, sGAL3 y su combinación de nuevo ofrecieron una eficacia diagnóstica óptima para esta cohorte de pacientes. Los niveles de sGAL3 en FR y sMICB en PRE y FR se asociaron con un beneficio clínico en toda la cohorte y en la subcohorte de ADC. sCD276 también se asoció con la respuesta global en toda la cohorte y en la sub-cohorte de ADC. sMICB en FR se identificó como un biomarcador independiente para la supervivencia libre de progresión (SLP) en toda la cohorte y para SLP y SG en la sub-cohorte de ADC. Además, sGAL3 en PRE se encontró como un biomarcador independiente para SLP y SG en toda la cohorte y en FR se identificó como biomarcador independiente para SG en la sub-cohorte ADC. Una disminución en los niveles de sGAL3 en los pacientes en tratamiento se asoció con una reducción en la SG en toda la cohorte. En conclusión, nuestros hallazgos proporcionan información diagnóstica, pronóstica y predictiva relevante del rol de la GAL3 y otros factores inmunoreguladores para los pacientes con cáncer de pulmón y sirven como base para el desarrollo de nuevos biomarcadores y terapias., [CA] En aquest estudi, busquem profunditzar en l'estudi del microambient immunològic del tumor (TME), el que resultaria en una millor caracterització del context immunològic dels pacients i la recerca de nous biomarcadors en el càncer de pulmó. S'utilitzaren cultius de llarg termini establits a partir de pacients amb càncer de pulmó en etapa primerenca, i línies cel·lulars comercials per a assajos de formació de tumorsferes per a l'enriquiment de cèl·lules mares canceroses i condicions adherents com a control. S'analitzà l'expressió gènica de diversos factors immunoreguladors, i es va observar una major expressió de la majoria d'ells en les tumorsferes en comparació amb les cèl·lules adherents. Juntament la secreció, la Galectina-3 (GAL3 o LGALS3 quan es fa referència a la proteïna o al gen, respectivament) es va seleccionar com la molècula que podria tindre una forta implicació en la modulación del TME. Els anàlisis proteics van confirmar que la GAL3 augmentava consistentment en les tumorsferes de cultius d'adenocarcinoma de pulmó (ADC) i mostrava patrons de localització i expressió diferencial. Les vesícules extracel·lulars precedents de les tumorspheres també van exhibir nivells alts de LGALS3. Vam revelar que la GAL3 podria jugar un paper crucial com a molècula immunomoduladora expressada i secreta en el TME, modulant la immunosupressió a través de les cèl·lules T reguladores (TREGS). Això es va confirmar en mostres tumorals de pacients amb nivells d'expressió elevats de GAL3, que a més tenien majors nivells de TREGS. Posteriorment, es van avaluar els rols pronòstics i diagnòstics de la GAL3 soluble (sGAL3) i altres factors immunoreguladors (sICOSL, sFGL1, sGAL1, sMICA, sMICB, sCD276) en una cohort de 94 pacients amb càncer de pulmó en estadi primerenc (cohort de test). sFGL1, sGAL3 i la seua combinació van mostrar una eficàcia diagnòstica òptima en la nostra cohort. A més, l'anàlisi de supervivència de Kaplan-Meier va demostrar en la subcohort de ADC en estadi primerenc, que els pacients amb nivells alts de sGAL3 van experimentar una supervivència lliure de recaiguda (SLR) (p=0,048) i una supervivència global (SG) més curta (p=0,021), però no en la de carcinoma de cèl·lules escamoses. L'anàlisi multivariant va indicar que sGAL3 podria ser un biomarcador independent del pronòstic per a SG i SLR. L'expressió gènica de tots aquests factors immunoreguladors també es va analitzar en un grup independent de 661 pacients de TCGA (cohort de validació), confirmant el valor pronòstic independent de LGALS3 en la subcohort de ADC per a SLR (p=0,021) i SG (p=0,004). El paper diagnòstic, predictiu i pronòstic d'aquests factors immunoreguladors també es va avaluar en el moment basal (PRE) i en l'avaluació de la primera resposta (FR) en una cohort de 52 pacients amb cáncer de pulmó en estadi avançat tractats en primera línia amb pembrolizumab. sFGL1, sGAL3 i la seua combinació de nou van oferir una eficàcia diagnòstica òptima per als pacients d'aquesta cohort. Els nivells de sGAL3 en FR i sMICB en PRE i FR estaven associats amb un benefici clínic durador en tota la cohort i en la subcohort de LUAD. sCD276 també es va associar amb la resposta global en tota la cohort i en la subcohort de ADC. Un anàlisi de regressió de Cox va identificar sMICB en FR com a biomarcador independent per a la supervivència lliure de progressió (SLP) en tota la cohort i per a SLP i SG en la subcohort de ADC. sGAL3 en PRE es va trobar com a biomarcador independent per a SLP i SG en tota la cohort, i sGAL3 en FR es va identificar com a biomarcador independent per a SG en la subcohort de ADC. Una disminució en FR dels nivells de sGAL3 es va associar amb una reducció en la SG en tota la cohort. En conclusió, els nostres descobriments proporcionen informació rellevant sobre el rol diagnòstic y el pronòstic de la GAL3 y altres factor inmunoreguladors per als pacients amb càncer de pulmó i serveixen com a base per al desenvolupament de nous biomarcadors i teràpies., [EN] The complex field of immuno-oncology is constantly evolving, driven by cancer heterogeneity and the plasticity of the immune cells participating in this process. In this study we aim to delve deeper into the study of immune tumor microenvironment (TME), which will result in an improved characterization of patient`s immune contexture and the search for new biomarkers in lung cancer. In this thesis, long term patient derived lung cancer cell (PDLCC) and commercial cell lines cultures were employed for sphere-forming assays for cancer stem cells enrichment and adherent conditions for the control counterparts. Gene expression of immune-mediators was analyzed showing that expression levels of most selected genes were higher in tumorspheres compared with the adherent cells counterparts. Together with secretion, Galectin-3 (GAL3 or LGALS3 when protein or gene are referenced, respectively) was selected as the molecule that could have a strong implication in the modulation of TME. Immunoblot, flow cytometry and immunofluorescence analyses confirmed that GAL3 was consistently increased in tumorspheres from lung adenocarcinoma (LUAD) and showed differential localization and expression patterns. Extracelullar vesicles from tumorspheres also exhibited high levels of LGALS3. Next, we revealed that GAL3 could play a crucial role as an immunomodulatory molecule expressed and secreted in the TME, modulating immunosuppression through regulatory T cells (TREGS). This was confirmed in patient's tumor samples, where higher levels of LGALS3 correlated with increased TREGS, suggesting that tumors may be recruiting this population through GAL3. The prognostic and diagnostic roles of soluble GAL3 (sGAL3) and other immune-mediators (sICOSL, sFGL1, sGAL1, sMICA, sMICB, sCD276) were evaluated in a cohort of 94 early-stage lung cancer (test cohort). sFGL1, sGAL3 and its combination yielded optimal diagnostic efficacy in our patient's cohort. A Cox regression analysis revealed an association between sGAL3 and prognosis. Kaplan-Meier plots show that, in the early-stage LUAD subcohort, patients with high levels of sGAL3 experienced shorter relapse-free survival (RFS) (p=0.048) and overall survival (OS) (p=0.021), while no such association was observed in the lung squamous cell carcinoma subcohort. Multivariate analysis indicated that sGAL3 could be an independent biomarker of prognosis for OS and RFS. Gene expression of our panel of immunoregulatory mediators was also analyzed in an independent group of 661 patients from TCGA (validation cohort), confirming the independent prognostic value of LGALS3 in the LUAD subcohort for PFS (p=0.021) and OS (p=0.004). The diagnostic, predictive and prognostic role of these immune-mediators was also evaluated in plasma samples at baseline (PRE) and at first response assessment (FR) in a cohort of 52 advanced-stage lung cancer patients treated in first-line with pembrolizumab. sFGL1, sGAL3 and its combination were also found to have a diagnostic value in this clinical setting. The Mann-Whitney test revealed that sGAL3 at FR and sMICB at PRE and FR were associated with clinical benefit in the entire cohort and in the LUAD subcohort. sCD276 was also associated with objective response in the entire cohort and in the LUAD subcohort. A Cox regression analysis identified sMICB at FR as an independent biomarker for progression-free survival (PFS) in the entire cohort and for PFS and OS in the LUAD subcohort. Furthermore, sGAL3 at PRE was found to be an independent biomarker for PFS and OS in the entire cohort, and sGAL3 at FR was identified as an independent biomarker for OS in the LUAD subcohort. A decreased in the levels of sGAL3 on treatment was associated with reduction of OS in the entire cohort. In conclusion, our findings provide relevant prognostic and predictive information on the role of GAL3 and other immune-mediators for lung cancer patients and served as the basis for developing new biomarkers and therapies., This thesis was supported by the following Spanish institutions: Centro de Investigación Biomédica en Red Cáncer (Project CB16/12/00350); Fondo de Investigación Sanitaria-Fondo Europeo de Desarrollo Regional (Projects PI15/00209, PI15/00753, PI18/00266 and IFEQ21/00194); Fundación Arnal Planelles; Generalitat Valenciana y Fondo Social Europeo (Project ACIF/2018/275): ERA-NET EURONANOMED III (Project METASTARG JTC 2018-045)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A Sonic Hedgehog Pathway Score to Predict the Outcome of Resected Non-Small Cell Lung Cancer Patients

  • Herreros-Pomares, Alejandro|||0000-0003-3838-097X
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Doria, Paula
  • Gallach, Sandra
  • Meri-Abad, Marina
  • Guijarro, Ricardo
  • Calabuig-Fariñas, Silvia
  • Camps, Carlos
[EN] Background Mutations and deregulations in components of the Hedgehog (Hh) pathway have been associated with cancer onset and tumor growth in different malignancies, but their role in non-small cell lung cancer (NSCLC) remains unclear. This study aims to investigate the expression pattern of the main components of the Hh pathway in tumor and adjacent normal tissue biopsies of resected NSCLC patients. Methods The relative expression of GLI1, PTCH1, SHH, and SMO was analyzed by quantitative polymerase chain reaction (PCR) in a cohort of 245 NSCLC patients. Results were validated in an independent cohort of NSCLC patients from The Cancer Genome Atlas (TCGA). Results We found that SMO and GLI1 were overexpressed in the tumor compared with normal-paired tissue, whereas PTCH1 and SHH were underexpressed. In addition, patients with higher expression levels of PTCH1 presented better outcomes. A gene expression score, called the Hedgehog Score, was calculated using a multivariable model including analyzed components of the Hh signaling pathway. NSCLC patients with a high Hedgehog Score had significantly shorter relapse-free survival (RFS) and overall survival (OS) than patients with a low score, especially at stage I of the disease. Similarly, patients in the adenocarcinoma (ADC) subcohort had shorter RFS and OS. Multivariate Cox analysis exhibited that the Hedgehog Score is an independent prognostic biomarker for OS in both the entire training cohort and the ADC subcohort. The Hedgehog Score was validated in an independent cohort of NSCLC patients from TCGA, which confirmed its prognostic value. Conclusions Our results provide relevant prognostic data for NSCLC patients and support further studies on the Hh pathway., This work was supported by grant no. CB16/12/00350 from the Centro de Investigacion Biomedica en Red de Cancer (CIBEROnc) and Grant No. PI18/00266 from the Instituto de Salud Carlos III (ISCIII).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Serum Phospholipid Fatty Acids and Mammographic Density in Premenopausal Women

  • Lope, Virginia
  • del Pilar del Pozo, Maria
  • Criado-Navarro, Inmaculada
  • Pérez-Gómez, Beatriz
  • Pastor-Barriuso, Roberto
  • Ruiz, Emma
  • Castelló, Adela
  • Lucas, Pilar
  • Sierra, Ángeles
  • Salas-Trejo, Dolores
  • Martínez, Inmaculada
  • Romieu, Isabelle
  • Chajès, Véronique
  • Priego-Capote, Feliciano
  • Pollán, Marina
  • Llobet Azpitarte, Rafael|||0000-0002-8278-9740
[EN] Background: The role of fatty acids (FAs) on mammographic density (MD) is unclear, and available studies are based on self-reported dietary intake. Objectives: This study assessed the association between specific serum phospholipid fatty acids (PLFAs) and MD in premenopausal women. Methods: The cross-sectional study DDM-Madrid recruited 1392 Spanish premenopausal women, aged 39-50 y, who attended a screening in a breast radiodiagnosis unit of Madrid City Council. Women completed lifestyle questionnaires and FFQs. Percentage MD was estimated using a validated computer tool (DM-Scan), and serum PLFA percentages were measured by GC-MS. Multivariable linear regression models were used to quantify the association of FA tertiles with MD. Models were adjusted for age, education, BMI, waist circumference, parity, oral contraceptive use, previous breast biopsies, and energy intake, and they were corrected for multiple testing. Results: Women in the third tertile of SFAs showed significantly higher MD compared with those in the first tertile (beta(T3vsT1) = 7.53; 95% CI: 5.44, 9.61). Elevated relative concentrations of palmitoleic (beta(T3vsT1) = 3.12; 95% CI: 0.99, 5.25) and gondoic (beta(T3vsT1) = 2.67; 95% CI: 0.57, 4.77) MUFAs, as well as high relative concentrations of palmitelaidic (beta(T3vsT1) = 5.22; 95% CI: 3.15, 7.29) and elaidic (beta(T3vsT1) = 2.69; 95% CI: 0.59, 4.79) trans FAs, were also associated with higher MD. On the contrary, women with elevated relative concentrations of n-6 (omega-6) linoleic (beta(T3vsT1) = -5.49; 95% CI; -7.62, -3.35) and arachidonic (beta(T3vsT1) = -4.68; 95% CI: -6.79, -2.58) PUFAs showed lower MD. Regarding desaturation indices, an elevated palmitoleic to palmitic ratio and a low ratio of oleic to steric and arachidonic to dihomo. gamma-linolenic acids were associated with higher MD. Conclusions: Spanish premenopausal women with high relative concentrations of most SFAs and some MUFAs and trans FAs showed an increased MD, whereas those with high relative concentrations of some n-6 PUFAs presented lower density. These results, which should be confirmed in further studies, underscore the importance of analyzing serum FAs individually., This study was funded by the Carlos III Institute of Health (AESI PI15CIII/0029). The article presents independent research. The views expressed are those of the authors and not necessarily those of the Carlos III Institute of Health.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small cell lung cancer

  • Herreros-Pomares, Alejandro|||0000-0003-3838-097X
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • de Maya-Gironés, J.D.
  • Calabuig-Fariñas, Silvia
  • Lucas, Rut
  • Martínez-Romero, Alicia
  • Pardo-Sánchez, José Miguel
  • Alonso, Sergio
  • Blasco-Cordellat, Ana
  • Guijarro, Ricardo
  • Martorell, Miguel
  • Escorihuela, Eva
  • Chiara, María Dolores
  • Durendez-Saez, Elena
  • Gandía, Carolina
  • Forteza, Jerónimo
  • Farràs, Rosa
  • Camps-Herrero, Carlos
[EN] The high resistance against current therapies found in non-small-cell lung cancer (NSCLC) has been associated to cancer stem-like cells (CSCs), a population for which the identification of targets and biomarkers is still under development. In this study, primary cultures from early-stage NSCLC patients were established, using sphere-forming assays for CSC enrichment and adherent conditions for the control counterparts. Patient-derived tumorspheres showed self-renewal and unlimited exponential growth potentials, resistance against chemotherapeutic agents, invasion and differentiation capacities in vitro, and superior tumorigenic potential in vivo. Using quantitative PCR, gene expression profiles were analyzed and NANOG, NOTCH3, CD44, CDKN1A, SNAI1, and ITGA6 were selected to distinguish tumorspheres from adherent cells. Immunoblot and immunofluorescence analyses confirmed that proteins encoded by these genes were consistently increased in tumorspheres from adenocarcinoma patients and showed differential localization and expression patterns. The prognostic role of genes significantly overexpressed in tumorspheres was evaluated in a NSCLC cohort (N = 661) from The Cancer Genome Atlas. Based on a Cox regression analysis, CDKN1A, SNAI1, and ITGA6 were found to be associated with prognosis and used to calculate a gene expression score, named CSC score. Kaplan¿Meier survival analysis showed that patients with high CSC score have shorter overall survival (OS) in the entire cohort [37.7 vs. 60.4 months (mo), p = 0.001] and the adenocarcinoma subcohort [36.6 vs. 53.5 mo, p = 0.003], but not in the squamous cell carcinoma one. Multivariate analysis indicated that this gene expression score is an independent biomarker of prognosis for OS in both the entire cohort [hazard ratio (HR): 1.498; 95% confidence interval (CI), 1.167¿1.922; p = 0.001] and the adenocarcinoma subcohort [HR: 1.869; 95% CI, 1.275¿2.738; p = 0.001]. This score was also analyzed in an independent cohort of 114 adenocarcinoma patients, confirming its prognostic value [42.90 vs. not reached (NR) mo, p = 0.020]. In conclusion, our findings provide relevant prognostic information for lung adenocarcinoma patients and the basis for developing novel therapies. Further studies are required to identify suitable markers and targets for lung squamous cell carcinoma patients., This work was supported by Fondo de Investigación Sanitaria, ISCIII (PI12-02838, PI12-00956, PI15-00753, PI15-00209), and Fundación Arnal Planelles. A. H.-P. and J.M.P.-S. are supported by Ministerio de Educación, Cultura y Deporte (FPU14/06911 and FPU13/02755, respectively).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer

  • Moreno-Manuel, Andrea
  • Simoes, Ines
  • Aranda, Fernando
  • Calabuig-Fariñas, Silvia
  • Carreras, Esther
  • Zuñiga, Sheila
  • Saenger, Yvone
  • Rosell, Rafael
  • Camps-Herrero, Carlos
  • Lozano, Francisco
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
[EN] Background: The study of immune surveillance in the tumour microenvironment is leading to the development of new biomarkers and therapies. The present research focuses on the expression of CD5 and CD6¿two lymphocyte surface markers involved in the fine tuning of TCR signaling¿as potential prognostic biomarkers in resectable stages of non-small cell lung cancer (NSCLC). Methods: CD5 and CD6 gene expression was analysed by reverse transcription quantitative polymerase chain reaction (RTqPCR) in 186 paired fresh frozen tumour and normal tissue samples of resected NSCLC. Results: Patients with higher CD5 expression had significantly increased overall survival (OS, 49.63 vs. 99.90 months, P=0.013). CD5 expression levels were correlated to CD4 infiltration and expression levels, and survival analysis showed that patients with a higher CD5/CD4+ ratio had significantly improved prognosis. Multivariate analysis established CD5 expression as an independent prognostic biomarker for OS in early stages of NSCLC (HR=0.554; 95% CI, 0.360¿0.853; P=0.007). Further survival analysis of NSCLC cases (n=97) from The Cancer Genome Atlas (TCGA) database, confirmed the prognostic value of both CD5 and CD6 expression¿ although CD6 expression alone did not reach significant prognostic value in our NSCLC training cohort. Conclusions: Our data support further studies on CD5 and CD6 as novel prognostic markers in resectable NSCLC and other cancer types (i.e., melanoma), as well as a role for these receptors in immune surveillance., This work was supported by Spanish Health Institute Carlos III (ISCII, Fondo de Investigacion Sanitaria; PI15-00753 to RS and P118/00226 to EJ and CC), Spanish Ministry of Economy, Industry and Competitiveness (MINECO, Plan Nacional de I+D+i; SAF2016-80535-R to FL) -co-financed by European Development Regional Fund "A way to achieve Europe" ERDF; Worldwide Cancer Research (14-1275 to FL), Fundacio La Marato TV3 (201319-30-31-32 to FL and YS), and Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) from Generalitat de Catalunya (2017/SGR/1582 to FL). AM is recipient of a PhD scholarship from Asociacion Espanola Contra el Cancer (AECC) Scientific Foundation and Junta Provincial Asociada de Valencia AECC; IS, FA and EC are recipients of fellowships from Fundacao para a Ciencia e a Tecnologia (SFRH/BD/75738/2011), Sara Borrell Program from ISCIII (CD15/00016), and European Community Seventh Framework Program (BIOTRACK, FP7/2007/2013; 229673), respectively.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Allergic Reactions to Metamizole: Immediate and Delayed Responses

  • Blanca-López, Natalia
  • Pérez-Sanchez, Natalia
  • Agúndez, Jose A.G.
  • García-Martín, Elena
  • Torres, Maria José
  • Cornejo-Garcia, José Antonio
  • Perkins, James R.
  • Miranda Alonso, Miguel Ángel
  • Mayorga, Cristobalina
  • Canto, María Gabriela
  • Blanca, Miguel
  • Doña, Inmaculada
  • Andreu, Inmaculada|||0000-0003-3409-9443
[EN] Background: Pyrazolones are the most common causes of selective nonsteroidal anti-inflammatory drug (NSAID) hypersensitivity. We studied a large group of patients with immediate and delayed selective responses to metamizole. Methods: Patients with suspicion of hypersensitivity to metamizole were evaluated. We verified acetylsalicylic acid tolerance and classified patients as immediate or delayed responders if they showed symptoms less or more than 24 h after metamizole administration. Skin tests were performed and if negative, a basophil activation test (BAT) was performed on immediate responders. If it was negative, we performed a drug provocation test (DPT) with metamizole. Results: A total of 137 patients were included: 132 reacted within 24 h (single NSAID-induced urticaria/angioedema/ anaphylaxis; SNIUAA) and 5 after 24 h (single NSAID-induced delayed hypersensitivity reaction; SNIDHR). Most SNIUAA patients developed anaphylaxis (60.60%); for SNIDHR, maculopapular exanthema was the most frequent entity (60%). Skin testing was positive in 62.04% of all cases and BAT in 28% of the SNIUAA patients with negative skin tests. In 5.1% of the cases, DPT with metamizole was needed to establish the diagnosis. In 22.62% of the cases, diagnosis was established by consistent and unequivocal history of repeated allergic episodes in spite of a negative skin test and BAT. Conclusions: SNIUAA to metamizole is the most frequent type of selective NSAID hypersensitivity, with anaphylaxis being the most common clinical entity. It may occur within 1 h after drug intake. SNIDHR occurs in a very low percentage of cases. The low sensitivity of diagnostic tests may be due to incomplete characterization of the chemical structures of metamizole and its metabolites., The present study has been supported by the Institute of Health ‘Carlos III’ of the Ministry of Economy and Competitiveness [grants cofounded by European Regional Development Fund (ERDF), Red de Reacciones Adversas a Alergenos y Farmacos (RD12/0013/0001 and PI15/01317)] and by Consejeria de Salud de la Junta de Andalucía (PI-0463-2013).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Simulating the Influence of Conjugative-Plasmid Kinetic Values on the Multilevel Dynamics of Antimicrobial Resistance in a Membrane Computing Model

  • Campos Frances, Marcelino
  • Sempere Luna, José María|||0000-0003-2393-9224
  • San Millan, Alvaro
  • Lanza, Val F.
  • Coque, Teresa M.
  • Llorens, Carlos
  • Baquero, Fernando
[EN] Bacterial plasmids harboring antibiotic resistance genes are critical in the spread of antibiotic resistance. It is known that plasmids differ in their kinetic values, i.e., conjugation rate, segregation rate by copy number incompatibility with related plasmids, and rate of stochastic loss during replication. They also differ in cost to the cell in terms of reducing fitness and in the frequency of compensatory mutations compensating plasmid cost. However, we do not know how variation in these values influences the success of a plasmid and its resistance genes in complex ecosystems, such as the microbiota. Genes are in plasmids, plasmids are in cells, and cells are in bacterial populations and microbiotas, which are inside hosts, and hosts are in human communities at the hospital or the community under various levels of cross-colonization and antibiotic exposure. Differences in plasmid kinetics might have consequences on the global spread of antibiotic resistance. New membrane computing methods help to predict these consequences. In our simulation, conjugation frequency of at least 10(-3) influences the dominance of a strain with a resistance plasmid. Coexistence of different antibiotic resistances occurs if host strains can maintain two copies of similar plasmids. Plasmid loss rates of 10(-4) or 10(-5) or plasmid fitness costs of >= 0.06 favor plasmids located in the most abundant species. The beneficial effect of compensatory mutations for plasmid fitness cost is proportional to this cost at high mutation frequencies (10(-3) to 10(-5)). The results of this computational model clearly show how changes in plasmid kinetics can modify the entire population ecology of antibiotic resistance in the hospital setting., F. Baquero, M. Campos, and T. M. Coque were supported by EU Joint Programming Initiative JPIAMR2016-AC16/00043 (JPIonAMR-Third call on Transmission, ST131TS project), the Health Institute Carlos III of Spain (grants PI15-00818 and PI18-01942 and CIBER [CIBER in Epidemiology and Public Health, CIBERESP; CB06/02/0053]), and the Regional Government of Madrid (InGEMICS-C; S2017/BMD-3691), all of them cofinanced by the European Development Regional Fund (ERDF) "A Way to Achieve Europe." A. San Millan was supported by the European Research Council under the European Union's Horizon 2020 Research and Innovation Program (ERC grant agreement number 757440-PLASREVOLUTION)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Simulating Multilevel Dynamics of Antimicrobial Resistance in a Membrane Computing Model

  • Campos Frances, Marcelino
  • Sempere Luna, José María|||0000-0003-2393-9224
  • Capilla, Rafael
  • Naya, Fernando
  • Futami, Ricardo
  • Coque, Teresa
  • Moya, Andrés
  • Fernández-Lanza, Val
  • Cantón, Rafael
  • Llorens, Carlos
  • Baquero, Fernando
[EN] Membrane computing is a bio-inspired computing paradigm whose devices are the so-called membrane systems or P systems. The P system designed in this work reproduces complex biological landscapes in the computer world. It uses nested "membrane-surrounded entities" able to divide, propagate, and die; to be transferred into other membranes; to exchange informative material according to flexible rules; and to mutate and be selected by external agents. This allows the exploration of hierarchical interactive dynamics resulting from the probabilistic interaction of genes (phenotypes), clones, species, hosts, environments, and antibiotic challenges. Our model facilitates analysis of several aspects of the rules that govern the multilevel evolutionary biology of antibiotic resistance. We examined a number of selected landscapes where we predict the effects of different rates of patient flow from hospital to the community and vice versa, the cross-transmission rates between patients with bacterial propagules of different sizes, the proportion of patients treated with antibiotics, and the antibiotics and dosing found in the opening spaces in the microbiota where resistant phenotypes multiply. We also evaluated the selective strengths of some drugs and the influence of the time 0 resistance composition of the species and bacterial clones in the evolution of resistance phenotypes. In summary, we provide case studies analyzing the hierarchical dynamics of antibiotic resistance using a novel computing model with reciprocity within and between levels of biological organization, a type of approach that may be expanded in the multilevel analysis of complex microbial landscapes., This work was supported by the European Commission, Seven Framework Program (EVOTAR; FP7-HEALTH-282004) to F. Baquero, T. Coque, V. Fernandez-Lanza, and M. Campos; the Instituto de Salud Carlos III of Spain (Plan Estatal de I+D+i 2013-2016, grant PI15-00818 and FIS18-1942; CIBERESP, grant CB06/02/0053, and the EU Joint Programming Initiative JPIAMR2016-AC16/00036 to F. Baquero; the Regional Government of Madrid (InGEMICS-C; S2017/BMD-3691) to T. Coque and F. Baquero; and SAF2015-65878-R (MINECO, Spain) and PrometeoII/2014/065 (Generalitat Valenciana, Spain) to A. Moya (all cofinanced by the European Development Regional Fund [ERDF] "A Way to Achieve Europe").
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Association of miR-126-3p, miR-1260b and miR-374a-5p with the incidence of heart failure in a population-based cohort: the Hortega Follow-Up Study

  • Grau-Perez, Maria
  • Martinez-Arroyo, Olga
  • Rubia-Martinez, Marta
  • Flores-Chova, Ana
  • Rodríguez-Hernández, Zulema
  • Fernández-Navarro, Pablo
  • Gonzalez-Neira, Anna
  • Alonso, María Rosario
  • Pita, Guillermo
  • Pineda, Silvia
  • Martin-Escudero, Juan C.
  • Redon, Josep
  • Tellez-Plaza, Maria
  • Cortes, Raquel
  • Guasque Ortega, Ana|||0000-0002-2900-8466
[EN] Background: Circulating microRNAs (miRNAs) are emerging markers for cardiovascular prevention and control. miRNAs associated to vascular damage are candidates to play a causal role in the microvascular dysfunction of heart failure (HF). The aim was to evaluate the observational and causal (Mendelian randomization) association of miRNAs related with vascular alterations (miR-126-3p, miR-1260b and miR-374a-5p) with HF incidence in a sample from the general population. Methods: Plasma miRNAs levels were measured in 985 Hortega Study participants using real time quantitative polymerase chain reaction (RT-qPCR). Single nucleotide polymorphisms (SNPs) were genotyped with the TOPMED imputable Illumina GSA array. We identified genetic instrumental variables for miR-126-3p (33 SNPs), miR-1260b (22 SNPs) and miR-374a-5p (35 SNPs) and run several Mendelian randomization approaches. Results: The hazard ratio (95 % confidence interval) of HF by a 10-fold increase in miR-126-3p, miR-1260b and miR-374a-5p was 1.53 (1.09, 2.14), 1.38 (1.03, 1.86), and1.30 (1.09, 1.57), respectively. The corresponding rate differences were 9.7 (-0.1, 19.5), 12.0 (0.4, 23.6) and 9.1 (1.2, 17.1) per 10000 person-years. In flexible dose-response analysis, increased miRNAs levels were associated with higher HF risk, both in the relative and additive scale. In Mendelian randomization analysis, consistently suggestive positive causal associations were found with HF for increased miR-126-3p and miR-1260b levels, but not for miR-374a-5p. Conclusions: In observational analysis, miR-126-3p, miR-1260b and miR-374a-5p levels were positively associ-ated with HF incidence. Mendelian randomization analysis supported a causal role for miR-126-3p and miR-1260b, thus suggesting a potential use as prognostic and therapeutic targets for HF prevention and control., We thank Nuria Alvarez y Belen Herraez, from the Human Genotyping-CEGEN Unit, at the National Center for Cancer Research from the Carlos III Health Institutes, in Madrid (Spain) , for their contribution in the genotyping procedure. This research was funded by health sciences research grants from the Carlos III Health Institute (grant numbers PI19/01796 to J.R.; PI21/00249 and CP22/00069 to R.C.; PI23/01179 to A.O.; FI20/00096 to O.M.-A; and FI22/00032 to A.F.-C.; PI15/00071 and PI22CIII/00029 to M.T.-P.) . This work was also sup-ported by the State Agency for Research (PID2019-108973RB-C21 to M. T.-P.) . Grant IJC2020-045308-I, Juan de la Cierva Incorporacion funded by MCIN/AEI/10.13039/501100011033 and by ESF-Investing in Your Future (to A.O.) ; CNS2022-136175, Research Consolidation Grants, funded by MCIN/AEI/10.13039/501100011033 and European Union "Next Generation EU"/PRTR" (to R.C) .; FP7-HEALTH 11 (grant number no 278249) . It was co-funded by the European Union (the European Regional Development Fund (ERDF) and the European Social Fund (FSE) ) ; CIBER of Obesity and Nutrition Physiopathology (CIBEROBN) (grant numbers CIBER-02-08-2009, CB06/03 and CB12/03/30016) . CIBER of Cardiovascular diseases (CIBERCV) (grant number CB16/11/00261) . CIBEROBN and CIBERCV are co-funded with European Funds for Regional Development (FEDER) , and IDIFEDER/2021/072, CIAICO/2022/181 and INVEST/2023/180 from the Generalitat Valenciana of Spain. Z.R.-H. received a fellowship associated to a Spain National Investigation Agency project (PRE2020-093926) . The genotyping service was carried out at the Genotyping Unit-CEGEN in the Spanish Na-tional Cancer Research Centre (CNIO) , supported by Instituto de Salud Carlos III (ISCIII) , Ministerio de Ciencia e Innovacion. CEGEN is part of the initiative IMPaCT GEN oMICA (IMP/00009) cofunded by ISCIII and the European Regional Development Fund (ERDF)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Analysis of the prognostic role of an immune checkpoint score in resected non-small cell lung cancer patients

  • Usó, Marta
  • Calabuig-Farinas, Silvia
  • Blasco, Ana
  • Garcia del Olmo, Eva
  • Guijarro, Ricardo
  • Martorell, Miguel
  • Camps, Carlos
  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
[EN] Tumors develop mechanisms to recruit tolerogenic immune cells and to induce the expression of molecules that act as immune checkpoints. This regulation of the immune microenvironment favors immune tolerance to the neoplastic cells. In this study, we have investigated the prognostic role of immune-checkpoint expression markers in a cohort of resectable non-small cell lung cancer (NSCLC) patients. RNA was isolated from fresh-frozen lung specimens (tumor and normal lung) (n = 178). RTqPCR was performed to analyze the relative expression of 20 immune-related genes that were normalized by the use of endogenous genes selected by GeNorm algorithm. Patients with higher expression levels of IL23A and LGALS2 presented better outcomes. In the clustering expression patterns, we observed that patients with higher expression of immunoregulatory genes had better survival rates. Additionally, these data were used to develop a gene expression score. Since CTLA4 and PD1 were associated with prognosis based on Cox regression analysis (Z-score > 1.5), a multivariate model including these two genes was created. Absolute regression coefficients from this analysis were used in order to calculate the immunecheckpoint score: (PD1 x 0.116) + (CTLA4 x 0.059) for each case. Kaplan-Meier survival analysis showed that patients with high immune-checkpoint score have longer overall survival (OS) [NR vs. 40.4 mo, p = 0.008] and longer relapse-free survival (RFS) [82.6 vs. 23 mo, p = 0.009]. Multivariate analysis in the entire cohort indicated that the immune-checkpoint score was an independent biomarker of prognosis for OS [HR: 0.308; 95% CI, 0.156-0.609; p = 0.001] and RFS [HR: 0.527; 95% CI, 0.298-0.933; p = 0.028] in early-stage NSCLC patients. In conclusion, this score provides relevant prognostic information for a better characterization of early stage NSCLS patients with strikingly different outcomes and who may be candidates for immune-based therapies., This work was supported by the Red Tematica de Investigacion Cooperativa en Cancer (RD12/0036/0025) and the Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional (PI09/01147, PI09/01149 and PI12/02838)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Mammographic density and exposure to air pollutants in premenopausal women: a cross-sectional study

  • Jiménez, Tamara
  • Domínguez-Castillo, Alejandro
  • Fernández de Larrea-Baz, Nerea
  • Lucas, Pilar
  • Sierra, María Ángeles
  • Maeso, Sergio
  • Pino, Marina Nieves
  • Martínez-Cortés, Mercedes
  • Pérez-Gómez, Beatriz
  • Pollán, Marina
  • Lope, Virginia
  • García-Pérez, Javier
  • Llobet Azpitarte, Rafael|||0000-0002-8278-9740
[EN] Background: Mammographic density (MD) is a well-established risk factor for breast cancer. Air pollution is a major public health concern and a recognized carcinogen. We aim to investigate the association between MD and exposure to specific air pollutants (SO2, CO, NO, NO2, NOx, PM2.5, PM10, and O3) in premenopausal females. Methods: This cross-sectional study, carried out in Spain, included 769 participants who attended their gynecological examinations. Hourly concentrations of the pollutants were extracted from the Air Quality Monitoring System of Madrid City over a 3-year period. Individual long-term exposure to pollutants was assessed by geocoding residential addresses and monitoring stations, and applying ordinary kriging to the 3-year annual mean concentrations of each pollutant to interpolate the surface of Madrid. This exposure variable was categorized into quartiles. In a first analysis, we used multiple linear regression models with the log-transformed percent MD as a continuous variable. In a second analysis, we used MD as a dichotomous variable (¿high¿ density (MD > 50%) vs. ¿low¿ density (MD ¯ 50%)) and applied multiple logistic regression models to estimate odds ratios (ORs). We also analyzed the correlation among the pollutants, and performed a principal component analysis (PCA) to reduce the dimensionality of this set of eight correlated pollutants into a smaller set of uncorrelated variables (principal components (PCs)). Finally, the initial analyses were applied to the PCs to detect underlying patterns of emission sources. Results: The first analysis detected no association between MD and exposure to any of the pollutants. The second analysis showed nonstatistically significant increased risks (ORQ4; IC95%) of high MD were detected in women with higher exposure to SO2 (1.50; 0.90¿ 2.48), and PM2.5 (1.27; 0.77¿2.10). In contrast, non-significant ORs < 1 were found in all exposure quartiles for NO (ORQ2 = 0.72, ORQ3 = 0.68, ORQ4 = 0.78), and PM10 (ORQ2 = 0.69, ORQ3 = 0.82, ORQ4 = 0.72). PCA identified two PCs (PC1: ¿traffic pollution¿ and PC2: ¿natural pollution¿), and no association was detected between MD and proximity to these two PCs. Conclusions: In general, our results show a lack of association between residential exposure to specific air pollutants and MD in premenopausal females. Future research is needed to confirm or refute these findings, This work was supported by the Instituto de Salud Carlos III (ISCIII)/Carlos III Institute of Health (EPY-505/19-PFIS, AESI PI15CIII/00013, and AESI PI15CIII/00029), and the Sociedad Española de Epidemiología (SEE)/ Spanish Society of Epidemiology ( Lola Cuevas Award 2024)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Left ventricular remodeling after myocardial infarction pathophysiology, diagnostic approach and management during Cardiac Rehabilitation

  • Marcos-Garcés, Víctor
  • Bertolín-Boronat, Carlos
  • Merenciano-Gonzalez, Héctor
  • Martínez Mas, Maria Luz
  • Climent Alberola, Josefa Inés
  • Lopez Bueno, Laura
  • Paya Rubio, Alfonso
  • Pérez-Solé, Nerea
  • Rios-Navarro, César
  • De Dios, Elena
  • Rodríguez-Palomares, Jose F.
  • Ortiz-Perez, Jose T.
  • Sanchis, Juan
  • Gavara-Doñate, Josep|||0000-0002-3483-7066
  • Moratal, David|||0000-0002-2825-3646
[EN] Despite the improvement in prognosis in patients with acute myocardial infarction (AMI), a significant proportion of survivors still experience heart failure (HF)-related adverse outcomes. Adverse left ventricular remodeling (LVR), which refers to a progressive dilation of left ventricular (LV) end-diastolic and end-systolic volumes, usually accompanied by a deterioration in LV systolic function, occurs frequently and underlies most cases of HF development after AMI. In this review, we discuss the current definitions of post-AMI LVR, the most appropriate imaging modalities for its detection, and the pathophysiological mechanisms by which Cardiac Rehabilitation (CR) can improve LVR-including exercise interventions, cardiovascular risk factors control, and pharmacological therapy optimization. Finally, we provide up-to-date recommendations for the follow-up and management of LVR in post-AMI patients enrolled in CR and outline future prospects on this topic., This research was funded by the Instituto de Salud Carlos III, Fondos Europeos de Desarrollo Regional FEDER and Fondo Social Europeo Plus (FSE+) (grant numbers PI23/01150, PI15/00531, CB16/11/00486, CB16/11/00420, and CB16/11/00479 and postgraduate contracts CM21/00175 and CM23/00246) and by Conselleria de Educacion of the Generalitat Valenciana (CIPROM/2024/028). Dr. Marcos-Garces acknowledges funding from the Instituto de Salud Carlos III and co-funding from Fondo Social Europeo Plus (FSE+) (grant JR23/00032), as well as a GE 2023 grant from the Conselleria de Innovacion, Universidades, Ciencia y Sociedad Digital of the Generalitat Valenciana (CIGE/2022/26). Dr. Ortiz-Perez acknowledges partial financial support from Fundacio La Marato de TV3 (grant number 20153030-31-32), Siemens Healthcare, and La Caixa Banking Foundation (HR17-00527). Dr. Gavara acknowledges funding from the Conselleria de Educacion-Generalitat Valenciana and co-funding from Fondo Social Europeo Plus (grant number CIAPOS/2023/247). Dr. Moratal has received financial support from the Conselleria d'Educacio, Investigacio, Cultura i Esport, Generalitat Valenciana (grants AEST/2019/037 and AEST/2020/029).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Overeating, caloric restriction and mammographic density in Spanish women. DDM-Spain study

  • del Pozo, Maria del Pilar
  • Castelló, Adela
  • Vidal, Carmen
  • Salas -Trejo, Dolores
  • Sanchez Contador, Carmen
  • Pedraz-Pingarrón, Carmen
  • Moreno, María Pilar
  • Santamariña, Carmen
  • Ederra, María
  • Vioque, Jesús
  • Perez Gómez, Beatriz
  • Pollán, Marina
  • Lope, Virginia
  • Llobet Azpitarte, Rafael|||0000-0002-8278-9740
[EN] Objectives: Mammographic density (MD) is a strong risk factor for breast cancer. The present study evaluates the association between relative caloric intake and MD in Spanish women. Study design: We conducted a cross-sectional study in which 3517 women were recruited from seven breast cancer screening centers. MD was measured by an experienced radiologist using craniocaudal mammography and Boyd's semi-quantitative scale. Information was collected through an epidemiological survey. Predicted calories were calculated using linear regression models, including the basal metabolic rate and physical activity as explanatory variables. Overeating and caloric restriction were defined taking into account the 99% confidence interval of the predicted value. Odds ratios (OR) and 95% confidence intervals (95%CI) were estimated using center-specific mixed ordinal logistic regression models, adjusted for age, menopausal status, body mass index, parity, tobacco use, family history of breast cancer, previous biopsies, age at menarche and adherence to a Western diet. Main outcome measure: Mammographic density. Results: Those women with an excessive caloric intake ( > 40% above predicted) presented higher MD (OR = 1.41, 95%CI = 0.97-2.03; p = 0.070). For every 20% increase in relative caloric consumption the probability of having higher MD increased by 5% (OR = 1.05, 95%CI = 0.98-1.14; p = 0.178), not observing differences between the categories of explanatory variables. Caloric restriction was not associated with MD in our study. Conclusions: This is the first study exploring the association between MD and the effect of caloric deficit or excessive caloric consumption according to the energy requirements of each woman. Although caloric restriction does not seem to affect breast density, a caloric intake above predicted levels seems to increase this phenotype, This study was supported by the Research Grant FIS PI060386 from Spanish Public Health Research Fund (Fondo de Investigacion Sanitaria); the Carlos III Institute of Health (Institute de Salud Carlos III)PI15CIII/0029 and PI15CIII/00013; the EPY 1306/06Collaboration Agreement between Astra-Zeneca and the Carlos III Institute of Health; and a grant from the Spanish Federation of Breast Cancer Patients (FECMA EPY 1169/10).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Fully automated delineation of the optic radiation for surgical planning using clinically feasible sequences

  • Reid, Lee B.
  • Martínez-Heras, Eloy
  • Jeffree, Rosalind L.
  • Alexander, Hamish
  • Trinder, Julie
  • Solana, Elisabeth
  • Llufriu, Sara
  • Rose, Stephen
  • Prior, Marita
  • Fripp, Jurgen
  • Manjón Herrera, José Vicente|||0000-0001-6640-927X
[EN] Quadrantanopia caused by inadvertent severing of Meyer's Loop of the optic radiation is a well-recognised complication of temporal lobectomy for conditions such as epilepsy. Dissection studies indicate that the anterior extent of Meyer's Loop varies considerably between individuals. Quantifying this for individual patients is thus an important step to improve the safety profile of temporal lobectomies. Previous attempts to delineate Meyer's Loop using diffusion MRI tractography have had difficulty estimating its full anterior extent, required manual ROI placement, and/or relied on advanced diffusion sequences that cannot be acquired routinely in most clinics. Here we present CONSULT: a pipeline that can delineate the optic radiation from raw DICOM data in a completely automated way via a combination of robust pre-processing, segmentation, and alignment stages, plus simple improvements that bolster the efficiency and reliability of standard tractography. We tested CONSULT on 696 scans of predominantly healthy participants (539 unique brains), including both advanced acquisitions and simpler acquisitions that could be acquired in clinically acceptable timeframes. Delineations completed without error in 99.4% of the scans. The distance between Meyer's Loop and the temporal pole closely matched both averages and ranges reported in dissection studies for all tested sequences. Median scan-rescan error of this distance was 1¿mm. When tested on two participants with considerable pathology, delineations were successful and realistic. Through this, we demonstrate not only how to identify Meyer's Loop with clinically feasible sequences, but also that this can be achieved without fundamental changes to tractography algorithms or complex post-processing methods., Advance Queensland, Grant/Award Number: R-09964-01; Fundacion Merck Salud; Proyecto Societat Catalana Neurologia; Ministerio de Economia, Industria y Competitividad of Spain, Grant/Award Number: DPI2017-87743-R; Red Espanola de Esclerosis Multiple, Grant/Award Numbers: RD12/0032/0002, RD12/0060/01-02, RD16/0015/0002, RD16/0015/0003; Spanish Government; Instituto de Salud Carlos III, Grant/Award Numbers: FIS 2015 PI15/00061, FIS 2015 - PI15/00587, FIS 2018 - PI18/01030
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Magnetic Resonance Assessment of Left Ventricular Ejection Fraction at Any Time Post-Infarction for Prediction of Subsequent Events in a Large Multicenter STEMI Registry

  • Gavara-Doñate, Josep|||0000-0002-3483-7066
  • Moratal, David|||0000-0002-2825-3646
  • Marcos-Garces, Victor
  • Lopez-Lereu, Maria P.
  • Monmeneu, José V.
  • Rios-Navarro, César
  • De Dios, Elena
  • Pérez, Nerea
  • Merenciano, Héctor
  • Gabaldon, Ana
  • Cànoves, Joaquim
  • Racugno, Paolo
  • Bonanad, Clara
  • Miñana, Gema
  • Nunez, Julio
  • Nunez, Eduardo
[EN] Background Magnetic resonance imaging (MRI) is the most accurate imaging technique for left ventricular ejection fraction (LVEF) quantification, but as yet the prognostic value of LVEF assessment at any time after ST-segment elevation myocardial infarction (STEMI) for subsequent major adverse cardiac event (MACE) prediction is uncertain. Purpose To explore the prognostic impact of MRI-derived LVEF at any time post-STEMI to predict subsequent MACE (cardiovascular death or re-admission for acute heart failure). Study Type Prospective. Population One thousand thirteen STEMI patients were included in a multicenter registry. Field Strength/Sequence 1.5-T. Balanced steady-state free precession (cine imaging) and segmented inversion recovery steady-state free precession (late gadolinium enhancement) sequences. Assessment Post-infarction MRI-derived LVEF (reduced [r]: <40%; mid-range [mr]: 40%-49%; preserved [p]: >= 50%) was sequentially quantified at 1 week and after >3 months of follow-up. Statistical Tests Multi-state Markov model to determine the prognostic value of each LVEF state (r-, mr- or p-) at any time point assessed to predict subsequent MACE. A P-value During a 6.2-year median follow-up, 105 MACE (10%) were registered. Transitions toward improved LVEF predominated and only r-LVEF (at any time assessed) was significantly related to a higher incidence of subsequent MACE. The observed transitions from r-LVEF, mr-LVEF, and p-LVEF states to MACE were: 15.3%, 6%, and 6.7%, respectively. Regarding the adjusted transition intensity ratios, patients in r-LVEF state were 4.52-fold more likely than those in mr-LVEF state and 5.01-fold more likely than those in p-LVEF state to move to MACE state. Nevertheless, no significant differences were found in transitions from mr-LVEF and p-LVEF states to MACE state (P-value = 0.6). Data Conclusion LVEF is an important MRI index for simple and dynamic post-STEMI risk stratification. Detection of r-LVEF by MRI at any time during follow-up identifies a subset of patients at high risk of subsequent events. Level of Evidence 2 Technical Efficacy Stage 2, This work was supported by "Instituto de Salud Carlos III," "Fondos Europeos de Desarrollo Regional FEDER" (grants PI15/00531, PI17/01836, PI20/00637, and CIBERCV16/11/00486), and "Marato TV3" (grant 20153030-31-32), a grant from the Catalonian Society of Cardiology 2015 and a grant from La Caixa Foundation (HR17-00527). David Moratal and Jose Gavara acknowledge financial support from the "Conselleria d'Educacio, Investigacio, Cultura i Esport, Generalitat Valenciana" (grants AEST/2019/037 and AEST/2020/029), "Agencia Valenciana de la Innovacion, Generalitat Valenciana" (ref. INNCAD00/19/085 and INNCAD/2020/84), and "Centro para el Desarrollo Tecnologico Industrial" (Programa Eurostars-2, actuacion Interempresas Internacional), Spanish "Ministerio de Ciencia, Innovacion y Universidades" (ref. CIIP-20192020).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Metabolomic patterns, redox-related genes and metals, and bone fragility endpoints in the Hortega Study

  • Galvez-Fernandez, Marta
  • Rodríguez-Hernández, Zulema
  • Grau-Perez, Maria
  • Chaves, F. Javier
  • García-García, Ana Bárbara
  • Amigo, Nuria
  • Monleón, Daniel
  • Garcia-Barrera, Tamara
  • Gomez-Ariza, Jose L.
  • Briongos-Figuero, Laisa S.
  • Perez-Castrillon, Jose L.
  • Redón, Josep
  • Tellez-Plaza, Maria
  • Martin-Escudero, Juan C.
[EN] Background: The potential joint influence of metabolites on bone fragility has been rarely evaluated. We assessed the association of plasma metabolic patterns with bone fragility endpoints (primarily, incident osteoporosisrelated bone fractures, and, secondarily, bone mineral density BMD) in the Hortega Study participants. Redox balance plays a key role in bone metabolism. We also assessed differential associations in participant subgroups by redox-related metal exposure levels and candidate genetic variants. Material and methods: In 467 participants older than 50 years from the Hortega Study, a representative sample from a region in Spain, we estimated metabolic principal components (mPC) for 54 plasma metabolites from NMR-spectrometry. Metals biomarkers were measured in plasma by AAS and in urine by HPLC-ICPMS. Redoxrelated SNPs (N = 341) were measured by oligo-ligation assay. Results: The prospective association with incident bone fractures was inverse for mPC1 (non-essential and essential amino acids, including branched-chain, and bacterial co-metabolites, including isobutyrate, trimethylamines and phenylpropionate, versus fatty acids and VLDL) and mPC4 (HDL), but positive for mPC2 (essential amino acids, including aromatic, and bacterial co-metabolites, including isopropanol and methanol). Findings from BMD models were consistent. Participants with decreased selenium and increased antimony, arsenic and, suggestively, cadmium exposures showed higher mPC2-associated bone fractures risk. Genetic variants annotated to 19 genes, with the strongest evidence for NCF4, NOX4 and XDH, showed differential metabolic-related bone fractures risk. Conclusions: Metabolic patterns reflecting amino acids, microbiota co-metabolism and lipid metabolism were associated with bone fragility endpoints. Carriers of redox-related variants may benefit from metabolic interventions to prevent the consequences of bone fragility depending on their antimony, arsenic, selenium, and, possibly, cadmium, exposure levels., Funding statement The work was funded by theo State Research Agency at the Ministerio de Ciencia Innovacion y Universidades of Spain (PID2019-108973RB-C21, PID2019-108973RB-C22 and PCIN-2017-117) ; the Generalitat Valenciana of Spain (IDIFEDER/2021/072, GRUPOS 03/101, PROMETEO/2009/029, ACOMP/2013/039, IDIFEDER/2021/072 and GRISOLIAP/2021/119) ; the EU Joint Programming Initiative Healthy Diet Healthy Life (HDHL) GUTMOM (INTIMIC-085) ; the Strategic Action for Research in Health sciences [CP12/03080, PI15/00071, PI10/0082, PI13/01848, PI14/00874, PI16/01402, PI17/00544 and PI11/00726] ; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN) (CIBER-02-08-2009, CB06/03 and CB12/03/30016) ; the Castilla-Leon Government (GRS/279/A/08) and European Network of Excellence Ingenious Hypercare (EPSS-037093) from the European Commission. The Strategic Action for Research in Health sciences and CIBEROBN are initiatives from Carlos III Health Institute Madrid and co-funded with European Funds for Regional Development (FEDER) . M.G-P received the support of a fellowship from "la Caixa" Foundation (ID 100010434, fellowship code LCF/BQ/IN18/11660001) . The funding bodies had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

The Drosophila junctophilin gene is functionally equivalent to its four mammalian counterparts and is a modifier of a Huntingtin poly-Q expansion and the Notch pathway

  • Calpena-Corpas, Eduardo
  • Lopez del Amo, V
  • Chakraborty M
  • Llamusi, B
  • Artero R
  • Espinos, Carmen
  • Galindo, Máximo Ibo|||0000-0001-8448-9760
[EN] Members of the Junctophilin (JPH) protein family have emerged as key actors in all excitable cells, with crucial implications for human pathophysiology. In mammals, this family consists of four members (JPH1-JPH4) that are differentially expressed throughout excitable cells. The analysis of knockout mice lacking JPH subtypes has demonstrated their essential contribution to physiological functions in skeletal and cardiac muscles and in neurons. Moreover, mutations in the human JPH2 gene are associated with hypertrophic and dilated cardiomyopathies; mutations in JPH3 are responsible for the neurodegenerative Huntington's disease-like-2 (HDL2), whereas JPH1 acts as a genetic modifier in Charcot-Marie-Tooth 2K peripheral neuropathy. Drosophila melanogaster has a single junctophilin (jp) gene, as is the case in all invertebrates, which might retain equivalent functions of the four homologous JPH genes present in mammalian genomes. Therefore, owing to the lack of putatively redundant genes, a jp Drosophila model could provide an excellent platform to model the Junctophilin-related diseases, to discover the ancestral functions of the JPH proteins and to reveal new pathways. By up-and downregulation of Jp in a tissue-specific manner in Drosophila, we show that altering its levels of expression produces a phenotypic spectrum characterized by muscular deficits, dilated cardiomyopathy and neuronal alterations. Importantly, our study has demonstrated that Jp modifies the neuronal degeneration in a Drosophila model of Huntington's disease, and it has allowed us to uncover an unsuspected functional relationship with the Notch pathway. Therefore, this Drosophila model has revealed new aspects of Junctophilin function that can be relevant for the disease mechanisms of their human counterparts., This work was supported by project grants from Association Francaise contre les Myopathies [AFM 18540 to M.I.G.], Instituto de Salud Carlos III (ISCIII) [PI12/000453 and PI15/000187 to C.E.], Generalitat Valenciana [PROMETEOII/2014/067 to R.A. as partner], and a collaborative grant from the International Rare Diseases Research Consortium (IRDiRC) and ISCIII [IR11/TREAT-CMT to M.I.G. (partner 12) and C.E. (partner 6)]. C.E. has a 'Miguel Servet' contract funded by the ISCIII and Centro de Investigacion Principe Felipe [CPII14/00002]; M.C. was the recipient of a Santiago Grisolia award from Generalitat Valenciana [GrisoliaP/2013/A/044].
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Characterization of molecular mechanisms underlying the axonal Charcot-Marie-Tooth neuropathy caused by MORC2 mutations

  • Sancho, Paula
  • Bartesaghi, Luca
  • Miossec, Olivia
  • García-García, Francisco
  • Ramírez-Jiménez, Laura
  • Siddell, Anna
  • Ajkesson, Elisabet
  • Hedlund, Eva
  • Lassuthova, Petra
  • Pascual-Pascual, Samuel I.
  • Sevilla, Teresa
  • Kennerson, Marina
  • Lupo, Vincenzo
  • Chrast, Roman
  • Espinós-Armero, Carmen Ángeles
[EN] Mutations in MORC2 lead to an axonal form of Charcot-Marie-Tooth (CMT) neuropathy type 2Z. To date, 31 families have been described with mutations in MORC2, indicating that this gene is frequently involved in axonal CMT cases. While the genetic data clearly establish the causative role of MORC2 in CMT2Z, the impact of its mutations on neuronal biology and their phenotypic consequences in patients remains to be clarified. We show that the full-length form of MORC2 is highly expressed in both embryonic and adult human neural tissues and that Morc2 expression is dynamically regulated in both the developing and the maturing murine nervous system. To determine the effect of the most common MORC2 mutations, p.S87L and p.R252W, we used several in vitro cell culture paradigms. Both mutations induced transcriptional changes in patient-derived fibroblasts and when expressed in rodent sensory neurons. These changes were more pronounced and accompanied by abnormal axonal morphology, in neurons expressing the MORC2 p.S87L mutation, which is associated with a more severe clinical phenotype. These data provide insight into the neuronal specificity of the mutated MORC2-mediated phenotype and highlight the importance of neuronal cell models to study the pathophysiology of CMT2Z., Instituto de Salud Carlos III (ISCIII) - Subdireccion General de Evaluacion y Fomento de la Investigacion within the framework of the National R+D+I Plan (PI15/00187 to C. E. and PI16/00403 to T. S.), co-funded with FEDER funds; Ramon Areces Foundation (CIVP17A2810 to C. E.); Generalitat Valenciana (PROMETEO/2018/135 to C. E. and T. S.); AFM-Telethon (21500 to C. E. and R. C.); National Health and Medical Research Council of Australia Grant (APP1046680 to M. K.); Czech Health Research Council (AZV16-30206A to P. L.); Swedish StratNeuro program grant; Swedish Research Council (2015-02394 to R. C.). C. E. had a 'Miguel Servet' contract funded by the ISCIII and the Centro de Investigacion Principe Felipe (CPII14/00002). P. S. is the recipient of a FPU-PhD fellowship funded by the Spanish Ministry of Education, Culture and Sport [FPU15/00964]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Occupation and mammographic density: A population-based study (DDM-Occup)

  • García-Pérez, Javier
  • Pollán, Marina
  • Pérez-Gómez, Beatriz
  • González-Sánchez, Mario
  • Cortés Barragán, Rosa Ana
  • Maqueda Blasco, Jerónimo
  • González-Galarzo, María Carmen
  • Alba, Miguel Ángel
  • van der Haar, Rudolf
  • Casas, Silvia
  • Vicente, Cándida
  • Medina, Pilar
  • Ederra, María
  • Santamariña, Carmen
  • Moreno, María Pilar
  • Llobet Azpitarte, Rafael|||0000-0002-8278-9740
[EN] Introduction: High mammographic density is one of the main risk factors for breast cancer. Although several occupations have been associated with breast cancer, there are no previous occupational studies exploring the association with mammographic density. Our objective was to identify occupations associated with high mammographic density in Spanish female workers. Methods: We conducted a population-based cross-sectional study of occupational determinants of high mammographic density in Spain, based on 1476 women, aged 45-68 years, recruited from seven screening centers within the Spanish Breast Cancer Screening Program network. Reproductive, family, personal, and occupational history data were collected. The latest occupation of each woman was collected and coded according to the 1994 National Classification of Occupations. Mammographic density was assessed from the cranio-caudal mammogram of the left breast using a semi-automated computer-assisted tool. Association between mammographic density and occupation was evaluated by using mixed linear regression models, using log-transformed percentage of mammographic density as dependent variable. Models were adjusted for age, body mass index,menopausal status, parity, smoking, alcohol intake, educational level, type of mammography, first-degree relative with breast cancer, and hormonal replacement therapy use. Screening center and professional reader were included as random effects terms. Results: Mammographic density was higher, although non-statistically significant, among secondary school teachers (e(beta) = 1.41; 95%CI = 0.98-2.03) and nurses (e(beta) = 1.23; 95%CI = 0.96-1.59), whereas workers engaged in the care of people (e(beta) = 0.81; 95%CI = 0.66-1.00) and housewives (e(beta) = 0.87; 95%CI = 0.79-0.95) showed an inverse association with mammographic density. A positive trend for every 5 years working as secondary school teachers was also detected (p-value = 0.035). Conclusions: Nurses and secondary school teachers were the occupations with the highest mammographic density in our study, showing the latter a positive trend with duration of employment. Future studies are necessary to confirm if these results are due to chance or are the result of a true association whose causal hypothesis is, for the moment, unknown., This study was funded by Strategic Action of Intramural Health (Accion Estrategica de Salud Intramural - AESI PI15CIII/00013); the Scientific Foundation of the Spanish Association Against Cancer (Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (AECC) EVP-1178/14); the Research Grant FIS PI060386 & PS09/790 from Spain's Health Research Fund (Fondo de Invesdgacion Sanitaria); the EPY 1306/06 Collaboration Agreement between Astra-Zeneca and the Carlos III Institute of Health; and a grant from the Spanish Federation of Breast Cancer patients (FECMA 485 EPY 1170-10).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Mammographic density in the environs of multiple industrial sources

  • Jiménez, Tamara
  • Pollán, Marina
  • Domínguez-Castillo, Alejandro
  • Lucas, Pilar
  • Sierra, María Ángeles
  • Castelló, Adela
  • Fernández de Larrea-Baz, Nerea
  • Lora-Pablos, David
  • Salas-Trejo, Dolores
  • Martinez, Inmaculada
  • Pino, Marina Nieves
  • Martínez-Cortés, Mercedes
  • Pérez-Gómez, Beatriz
  • Lope, Virginia
  • Javier García-Pérez
  • Llobet Azpitarte, Rafael|||0000-0002-8278-9740
[EN] Background: Mammographic density (MD), defined as the percentage of dense fibroglandular tissue in the breast, is a modifiable marker of the risk of developing breast cancer. Our objective was to evaluate the effect of residential proximity to an increasing number of industrial sources in MD. Methods: A cross-sectional study was conducted on 1225 premenopausal women participating in the DDM-Madrid study. We calculated distances between women's houses and industries. The association between MD and proximity to an increasing number of industrial facilities and industrial clusters was explored using multiple linear regression models. Results: We found a positive linear trend between MD and proximity to an increasing number of industrial sources for all industries, at distances of 1.5 km (p-trend = 0.055) and 2 km (p-trend = 0.083). Moreover, 62 specific industrial clusters were analyzed, highlighting the significant associations found between MD and proximity to the following 6 industrial clusters: cluster 10 and women living at ¿1.5 km (ß = 10.78, 95 % confidence interval (95%CI) = 1.59; 19.97) and at ¿2 km (ß = 7.96, 95%CI = 0.21; 15.70); cluster 18 and women residing at ¿3 km (ß = 8.48, 95% CI = 0.01; 16.96); cluster 19 and women living at ¿3 km (ß = 15.72, 95%CI = 1.96; 29.49); cluster 20 and women living at ¿3 km (ß = 16.95, 95%CI = 2.90; 31.00); cluster 48 and women residing at ¿3 km (ß = 15.86, 95%CI = 3.95; 27.77); and cluster 52 and women living at ¿2.5 km (ß = 11.09, 95%CI = 0.12; 22.05). These clusters include the following industrial activities: surface treatment of metals/plastic, surface treatment using organic solvents, production/processing of metals, recycling of animal waste, hazardous waste, urban waste-water treatment plants, inorganic chemical industry, cement and lime, galvanization, and food/beverage sector. Conclusions: Our results suggest that women living in the proximity to an increasing number of industrial sources and those near certain types of industrial clusters have higher MD, This work was supported by the Carlos III Institute of Health (AESI PI15CIII/0029, AESI PI15CIII/00013, and EPY-505/19-PFIS).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Occupational exposures and mammographic density in Spanish women

  • Lope, Virginia
  • García-Pérez, Javier
  • Pérez-Gómez, Beatriz
  • Pedraza-Flechas, Ana María
  • Alguacil, Juan
  • González-Galarzo, María Carmen
  • Alba, Miguel Angel
  • van der Haar, Rudolf
  • Cortés Barragán, Rosa Ana
  • Pedraz-Pingarrón, Carmen
  • Moreo, María Pilar
  • Santamariña, Carmen
  • Ederra, María
  • Vidal, Carmen
  • Salas-Trejo, Dolores
  • Llobet Azpitarte, Rafael|||0000-0002-8278-9740
[EN] Objectives The association between occupational exposures and mammographic density (MD), a marker of breast cancer risk, has not been previously explored. Our objective was to investigate the influence of occupational exposure to chemical, physical and microbiological agents on MD in adult women. Methods This is a population-based cross-sectional study based on 1476 female workers aged 45-65 years from seven Spanish breast cancer screening programmes. Occupational history was surveyed by trained staff. Exposure to occupational agents was assessed using the Spanish job-exposure matrix MatEmESp. Percentage of MD was measured by two radiologists using a semiautomatic computer tool. The association was estimated using mixed log-linear regression models adjusting for age, education, body mass index, menopausal status, parity, smoking, alcohol intake, type of mammography, family history of breast cancer and hormonal therapy use, and including screening centre and professional reader as random effects terms. Results Although no association was found with most of the agents, women occupationally exposed to perchloroethylene (e(beta)=1.51; 95% CI 1.04 to 2.19), ionising radiation (e(beta)=1.23; 95% CI 0.99 to 1.52) and mould spores (e(beta)=1.44; 95% CI 1.01 to 2.04) tended to have higher MD. The percentage of density increased 12% for every 5 years exposure to perchloroethylene or mould spores, 11% for every 5 years exposure to aliphatic/alicyclic hydrocarbon solvents and 3% for each 5 years exposure to ionising radiation. Conclusions Exposure to perchloroethylene, ionising radiation, mould spores or aliphatic/alicyclic hydrocarbon solvents in occupational settings could be associated with higher MD. Further studies are needed to clarify the accuracy and the reasons for these findings., This study was funded by the Spanish Ministry of Economy and Competitiveness - Carlos II Institute of Health (ISCI) (AESI PI15CI/00013); the Scientific Foundation of the Spanish Association Against Cancer (Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (AEC) - EVP-1178/14); the Spanish Public Health Research Fund (FIS PI060386 & PS09/0790); the collaboration agreement between Astra-Zeneca and the ISCI (EPY1306/06) and a grant from the Spanish Federation of Breast Cancer Patients (FECMA 485 EPY 1170-10).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Machine Learning Model in Obesity to Predict Weight Loss One Year after Bariatric Surgery: A Pilot Study

  • Nadal, Enrique|||0000-0002-2808-298X
  • Ródenas, Juan José|||0000-0003-2195-7920
  • Benito, Esther
  • Ródenas-Navarro, Ana María
  • Palanca, Ana
  • Martinez-Hervas, Sergio
  • Civera, Miguel
  • Ortega, Joaquín
  • Alabadi, Blanca
  • Piqueras, Laura
  • Real, Jose T.
[EN] Roux-en-Y gastric bypass (RYGB) is a treatment for severe obesity. However, many patients have insufficient total weight loss (TWL) after RYGB. Although multiple factors have been involved, their influence is incompletely known. The aim of this exploratory study was to evaluate the feasibility and reliability of the use of machine learning (ML) techniques to estimate the success in weight loss after RYGP, based on clinical, anthropometric and biochemical data, in order to identify morbidly obese patients with poor weight responses. We retrospectively analyzed 118 patients, who underwent RYGB at the Hospital Clínico Universitario of Valencia (Spain) between 2013 and 2017. We applied a ML approach using local linear embedding (LLE) as a tool for the evaluation and classification of the main parameters in conjunction with evolutionary algorithms for the optimization and adjustment of the parameter model. The variables associated with one-year postoperative %TWL were obstructive sleep apnea, osteoarthritis, insulin treatment, preoperative weight, insulin resistance index, apolipoprotein A, uric acid, complement component 3, and vitamin B12. The model correctly classified 71.4% of subjects with TWL < 30% although 36.4% with TWL ¿ 30% were incorrectly classified as ¿unsuccessful procedures¿. The ML-model processed moderate discriminatory precision in the validation set. Thus, in severe obesity, ML-models can be useful to assist in the selection of patients before bariatric surgery., This research was funded by Instituto de Salud Carlos III, grant numbers PI15/00082, PIE15/00013, PI21/00220, and Conselleria de Educacion, Cultura y Deporte, Generalitat Valenciana, grant number AICO 2019/250 to L.P. and Prometeo/2021/046 to J.J.R. This work was also supported by Ministerio de Economia, Industria y Competitividad, grant number SAF2014-57845-R and by Ministerio de Ciencia e Innovacion, Agencia Estatal de Investigacion (MCIN/AEI/10.13039/501100011033) and Fondo Europeo de Desarrollo Regional (FEDER) (Project PID2022-141512NB-I00) to J.J.R. The authors also received financial support from CIBER de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), a research network of the Ministry of Health, Madrid, to J.T.R.